<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN"  "JATS-archivearticle1-mathml3.dtd"><article article-type="research-article" dtd-version="1.2" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn pub-type="epub" publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">70989</article-id><article-id pub-id-type="doi">10.7554/eLife.70989</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Immunology and Inflammation</subject></subj-group></article-categories><title-group><article-title>Sepsis leads to lasting changes in phenotype and function of memory CD8 T cells</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-175168"><name><surname>Jensen</surname><given-names>Isaac J</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-3107-3961</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund11"/><xref ref-type="other" rid="fund12"/><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-241466"><name><surname>Li</surname><given-names>Xiang</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-241467"><name><surname>McGonagill</surname><given-names>Patrick W</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-201856"><name><surname>Shan</surname><given-names>Qiang</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-241468"><name><surname>Fosdick</surname><given-names>Micaela G</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-2427-532X</contrib-id><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-241469"><name><surname>Tremblay</surname><given-names>Mikaela M</given-names></name><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-29908"><name><surname>Houtman</surname><given-names>Jon CD</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="other" rid="fund10"/><xref ref-type="other" rid="fund14"/><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-202024"><name><surname>Xue</surname><given-names>Hai-Hui</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-9163-7669</contrib-id><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="other" rid="fund7"/><xref ref-type="other" rid="fund8"/><xref ref-type="other" rid="fund9"/><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-175163"><name><surname>Griffith</surname><given-names>Thomas S</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-7205-9859</contrib-id><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="aff" rid="aff8">8</xref><xref ref-type="aff" rid="aff9">9</xref><xref ref-type="aff" rid="aff10">10</xref><xref ref-type="aff" rid="aff11">11</xref><xref ref-type="other" rid="fund4"/><xref ref-type="other" rid="fund6"/><xref ref-type="other" rid="fund13"/><xref ref-type="fn" rid="con9"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-241470"><name><surname>Peng</surname><given-names>Weiqun</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="fund8"/><xref ref-type="other" rid="fund9"/><xref ref-type="fn" rid="con10"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" corresp="yes" id="author-174304"><name><surname>Badovinac</surname><given-names>Vladimir P</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-3180-2439</contrib-id><email>vladimir-badovinac@uiowa.edu</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund2"/><xref ref-type="other" rid="fund3"/><xref ref-type="other" rid="fund5"/><xref ref-type="fn" rid="con11"/><xref ref-type="fn" rid="conf2"/></contrib><aff id="aff1"><label>1</label><institution>Department of Pathology, University of Iowa</institution><addr-line><named-content content-type="city">Iowa City</named-content></addr-line><country>United States</country></aff><aff id="aff2"><label>2</label><institution>Department of Physics, The George Washington University</institution><addr-line><named-content content-type="city">Washington</named-content></addr-line><country>United States</country></aff><aff id="aff3"><label>3</label><institution>Department of Surgery, University of Iowa</institution><addr-line><named-content content-type="city">Iowa City</named-content></addr-line><country>United States</country></aff><aff id="aff4"><label>4</label><institution>Center for Discovery and Innovation, Hackensack University Medical Center</institution><addr-line><named-content content-type="city">Nutley</named-content></addr-line><country>United States</country></aff><aff id="aff5"><label>5</label><institution>Interdisciplinary Graduate Program in Molecular Medicine, University of Iowa</institution><addr-line><named-content content-type="city">Iowa City</named-content></addr-line><country>United States</country></aff><aff id="aff6"><label>6</label><institution>Interdisciplinary Graduate Program in Molecular Medicine, University of Iowa</institution><addr-line><named-content content-type="city">Iowa City</named-content></addr-line><country>United States</country></aff><aff id="aff7"><label>7</label><institution>Microbiology, Immunology, and Cancer Biology PhD Program, University of Minnesota</institution><addr-line><named-content content-type="city">Minneapolis</named-content></addr-line><country>United States</country></aff><aff id="aff8"><label>8</label><institution>Department of Urology, University of Minnesota</institution><addr-line><named-content content-type="city">Minneapolis</named-content></addr-line><country>United States</country></aff><aff id="aff9"><label>9</label><institution>Center for Immunology, University of Minnesota</institution><addr-line><named-content content-type="city">Minneapolis</named-content></addr-line><country>United States</country></aff><aff id="aff10"><label>10</label><institution>Masonic Cancer Center, University of Minnesota</institution><addr-line><named-content content-type="city">Minneapolis</named-content></addr-line><country>United States</country></aff><aff id="aff11"><label>11</label><institution>Minneapolis VA Health Care System</institution><addr-line><named-content content-type="city">Minneapolis</named-content></addr-line><country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Belz</surname><given-names>Gabrielle T</given-names></name><role>Reviewing Editor</role><aff><institution>The University of Queensland</institution><country>Australia</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Rath</surname><given-names>Satyajit</given-names></name><role>Senior Editor</role><aff><institution>Indian Institute of Science Education and Research (IISER)</institution><country>India</country></aff></contrib></contrib-group><pub-date date-type="publication" publication-format="electronic"><day>15</day><month>10</month><year>2021</year></pub-date><pub-date pub-type="collection"><year>2021</year></pub-date><volume>10</volume><elocation-id>e70989</elocation-id><history><date date-type="received" iso-8601-date="2021-06-04"><day>04</day><month>06</month><year>2021</year></date><date date-type="accepted" iso-8601-date="2021-10-14"><day>14</day><month>10</month><year>2021</year></date></history><permissions><copyright-statement>© 2021, Jensen et al</copyright-statement><copyright-year>2021</copyright-year><copyright-holder>Jensen et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-70989-v2.pdf"/><self-uri content-type="figures-pdf" xlink:href="elife-70989-figures-v2.pdf"/><abstract><p>The global health burden due to sepsis and the associated cytokine storm is substantial. While early intervention has improved survival during the cytokine storm, those that survive can enter a state of chronic immunoparalysis defined by transient lymphopenia and functional deficits of surviving cells. Memory CD8 T cells provide rapid cytolysis and cytokine production following re-encounter with their cognate antigen to promote long-term immunity, and CD8 T cell impairment due to sepsis can pre-dispose individuals to re-infection. While the acute influence of sepsis on memory CD8 T cells has been characterized, if and to what extent pre-existing memory CD8 T cells recover remains unknown. Here, we observed that central memory CD8 T cells (T<sub>CM</sub>) from septic patients proliferate more than those from healthy individuals. Utilizing LCMV immune mice and a CLP model to induce sepsis, we demonstrated that T<sub>CM</sub> proliferation is associated with numerical recovery of pathogen-specific memory CD8 T cells following sepsis-induced lymphopenia. This increased proliferation leads to changes in composition of memory CD8 T cell compartment and altered tissue localization. Further, memory CD8 T cells from sepsis survivors have an altered transcriptional profile and chromatin accessibility indicating long-lasting T cell intrinsic changes. The sepsis-induced changes in the composition of the memory CD8 T cell pool and transcriptional landscape culminated in altered T cell function and reduced capacity to control <italic>L. monocytogenes</italic> infection. Thus, sepsis leads to long-term alterations in memory CD8 T cell phenotype, protective function and localization potentially changing host capacity to respond to re-infection.</p></abstract><abstract abstract-type="executive-summary"><title>eLife digest</title><p>A dirty cut, a nasty burn, a severe COVID infection; there are many ways for someone to develop sepsis. This life-threatening condition emerges when the immune system overreacts to a threat and ends up damaging the body.</p><p>Even when patients survive, they are often left with a partially impaired immune system that cannot adequately protect against microbes and cancer; this is known as immunoparalysis. Memory CD8 T cells, a type of immune cell that is compromised by sepsis, are a long-lived population of cells that ‘remember’ previous infection or vaccination, and then react faster to prevent the same illness if the person ever encounters the same threat again. Yet it is unclear how exactly sepsis harms the function and representation of memory CD8 T cells, and the immune system in general.</p><p>Jensen et al. investigated this question, first by showing that sepsis leads to a profound loss of memory CD8 T cells, but that surviving memory CD8 T cells multiply quickly – especially a subpopulation known as central memory CD8 T cells – to re-establish the memory CD8 T cell population. Since the central memory CD8 T cells proliferate better than the other memory T cells this alters the overall composition of the pool of memory CD8 T cells, with central memory cells becoming overrepresented.</p><p>Further experiments revealed that this biasing toward central memory T cells, due to sepsis, created long-term changes in the distribution of memory CD8 T cells throughout the body. The way the genetic information of these cells was packaged had also been altered, as well as which genes were switched on or off. Overall, these changes reduced the ability of memory CD8 T cells to control infections.</p><p>Together, these findings help to understand how immunoparalysis can emerge after sepsis, and what could be done to correct it. These findings could also be applied to other conditions – such as COVID-19 – which may cause similar long-term changes to the immune system.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>CD8 T cell</kwd><kwd>central memory</kwd><kwd>homeostatic proliferation</kwd><kwd>sepsis</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd><kwd>Mouse</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>R01AI114543</award-id><principal-award-recipient><name><surname>Badovinac</surname><given-names>Vladimir P</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>R21AI147064</award-id><principal-award-recipient><name><surname>Badovinac</surname><given-names>Vladimir P</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>R21AI151183</award-id><principal-award-recipient><name><surname>Badovinac</surname><given-names>Vladimir P</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>R01GM115462</award-id><principal-award-recipient><name><surname>Griffith</surname><given-names>Thomas S</given-names></name></principal-award-recipient></award-group><award-group id="fund5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>R35GM134880</award-id><principal-award-recipient><name><surname>Badovinac</surname><given-names>Vladimir P</given-names></name></principal-award-recipient></award-group><award-group id="fund6"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>R35GM140881</award-id><principal-award-recipient><name><surname>Griffith</surname><given-names>Thomas S</given-names></name></principal-award-recipient></award-group><award-group id="fund7"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>R01AI112579</award-id><principal-award-recipient><name><surname>Xue</surname><given-names>Hai-Hui</given-names></name></principal-award-recipient></award-group><award-group id="fund8"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>R01AI121080</award-id><principal-award-recipient><name><surname>Xue</surname><given-names>Hai-Hui</given-names></name><name><surname>Peng</surname><given-names>Weiqun</given-names></name></principal-award-recipient></award-group><award-group id="fund9"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>R01AI139874</award-id><principal-award-recipient><name><surname>Xue</surname><given-names>Hai-Hui</given-names></name><name><surname>Peng</surname><given-names>Weiqun</given-names></name></principal-award-recipient></award-group><award-group id="fund10"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>R21AI157121</award-id><principal-award-recipient><name><surname>Houtman</surname><given-names>Jon CD</given-names></name></principal-award-recipient></award-group><award-group id="fund11"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>T32AI007511</award-id><principal-award-recipient><name><surname>jensen</surname><given-names>Isaac J</given-names></name></principal-award-recipient></award-group><award-group id="fund12"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>T32AI007485</award-id><principal-award-recipient><name><surname>jensen</surname><given-names>Isaac J</given-names></name></principal-award-recipient></award-group><award-group id="fund13"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100007217</institution-id><institution>Veterans Health Administration HSR and D</institution></institution-wrap></funding-source><award-id>I0BX001324</award-id><principal-award-recipient><name><surname>Griffith</surname><given-names>Thomas S</given-names></name></principal-award-recipient></award-group><award-group id="fund14"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000054</institution-id><institution>National Cancer Institute</institution></institution-wrap></funding-source><award-id>P30CA086862</award-id><principal-award-recipient><name><surname>Houtman</surname><given-names>Jon CD</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>Sepsis leads to lasting changes in the composition of the pre-existing memory CD8 T cell compartment leading to altered localization, changes in their transcriptional landscape and chromatin accessibility, differential function, and reduced capacity to control infection.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Dysregulated systemic inflammatory responses define septic events and the associated cytokine storm, which is comprised of both pro- and anti-inflammatory cytokines (<xref ref-type="bibr" rid="bib8">CDC, 2020</xref>; <xref ref-type="bibr" rid="bib68">Singer et al., 2016</xref>). Sepsis leads to a substantial global health and economic burden wherein nine people develop sepsis every 6 s and two of those individuals die (<xref ref-type="bibr" rid="bib60">Rudd et al., 2020</xref>). In the United States alone the cost to treat sepsis is &gt;$20 billion with a mortality rate of ~20 % (<xref ref-type="bibr" rid="bib8">CDC, 2020</xref>). While a 20 % mortality rate is high, it is also a vast improvement over the last 30 years where mortality had been at ~50 % (<xref ref-type="bibr" rid="bib21">Dombrovskiy et al., 2007</xref>; <xref ref-type="bibr" rid="bib25">Gaieski et al., 2013</xref>). This reduction in mortality rate has largely been through early intervention as the complexity of the cytokine storm has, dishearteningly, lead to the failure of &gt;100 phase II and III clinical trials targeting the pro-inflammatory aspects of the cytokine storm (<xref ref-type="bibr" rid="bib43">Marshall, 2014</xref>). Yet, even as survival of the cytokine storm has increased it has also become apparent that previously septic individuals are still at increased risk for mortality, this defines the sepsis-induced immunoparalysis state (<xref ref-type="bibr" rid="bib19">Delano and Ward, 2016a</xref>; <xref ref-type="bibr" rid="bib20">Delano and Ward, 2016b</xref>; <xref ref-type="bibr" rid="bib21">Dombrovskiy et al., 2007</xref>; <xref ref-type="bibr" rid="bib22">Donnelly et al., 2015</xref>).</p><p>Sepsis-induced immunoparalysis is characterized by an increased susceptibility to both new and previously encountered unrelated infections and cancer (<xref ref-type="bibr" rid="bib17">Danahy et al., 2019</xref>; <xref ref-type="bibr" rid="bib32">Jensen et al., 2018a</xref>; <xref ref-type="bibr" rid="bib38">Kutza et al., 1998</xref>; <xref ref-type="bibr" rid="bib80">Walton et al., 2014</xref>). Alternately, sepsis-induced immunoparalysis reduces susceptibility to development of autoimmunity, cumulatively demonstrating immunologic impairment (<xref ref-type="bibr" rid="bib34">Jensen et al., 2020</xref>). These profound impairments are sufficient to reduce the 5 year survival of septic cohorts, relative to non-septic cohorts; consequently, the majority of sepsis-associated mortality is late mortality secondary to the cytokine storm (<xref ref-type="bibr" rid="bib21">Dombrovskiy et al., 2007</xref>; <xref ref-type="bibr" rid="bib22">Donnelly et al., 2015</xref>; <xref ref-type="bibr" rid="bib25">Gaieski et al., 2013</xref>). This immunologic impairment is typified by transient lymphopenia and reduced capacity of various surviving lymphocyte populations to perform effector function (<xref ref-type="bibr" rid="bib30">Hotchkiss et al., 2016</xref>; <xref ref-type="bibr" rid="bib29">Hotchkiss et al., 2013</xref>), including CD4 (<xref ref-type="bibr" rid="bib6">Cabrera-Perez et al., 2014</xref>; <xref ref-type="bibr" rid="bib7">Cabrera-Perez et al., 2015</xref>; <xref ref-type="bibr" rid="bib11">Chen et al., 2017</xref>; <xref ref-type="bibr" rid="bib34">Jensen et al., 2020</xref>; <xref ref-type="bibr" rid="bib47">Martin et al., 2020</xref>; <xref ref-type="bibr" rid="bib71">Sjaastad et al., 2020b</xref>) and CD8 T cells (<xref ref-type="bibr" rid="bib14">Condotta et al., 2013</xref>; <xref ref-type="bibr" rid="bib16">Danahy et al., 2017</xref>; <xref ref-type="bibr" rid="bib17">Danahy et al., 2019</xref>; <xref ref-type="bibr" rid="bib23">Duong et al., 2014</xref>; <xref ref-type="bibr" rid="bib64">Serbanescu et al., 2016</xref>; <xref ref-type="bibr" rid="bib83">Xie et al., 2019</xref>), B cells (<xref ref-type="bibr" rid="bib28">Hotchkiss et al., 2001</xref>; <xref ref-type="bibr" rid="bib69">Sjaastad et al., 2018</xref>; <xref ref-type="bibr" rid="bib78">Unsinger et al., 2010</xref>), NK cells (<xref ref-type="bibr" rid="bib31">Hou et al., 2014</xref>; <xref ref-type="bibr" rid="bib36">Jensen et al., 2021b</xref>; <xref ref-type="bibr" rid="bib33">Jensen et al., 2018b</xref>; <xref ref-type="bibr" rid="bib73">Souza-Fonseca-Guimaraes et al., 2012</xref>), and dendritic cells (DCs) (<xref ref-type="bibr" rid="bib54">Poehlmann et al., 2009</xref>; <xref ref-type="bibr" rid="bib58">Roquilly et al., 2017</xref>; <xref ref-type="bibr" rid="bib74">Strother et al., 2016</xref>). We and others have characterized numerous impairments early after sepsis induction; however, the extent to which those cell populations recover in number and function remains largely unknown.</p><p>Specifically, sepsis-induced lymphopenia impacts both memory and naïve CD8 T cells early after sepsis (<xref ref-type="bibr" rid="bib15">Condotta et al., 2015</xref>; <xref ref-type="bibr" rid="bib14">Condotta et al., 2013</xref>; <xref ref-type="bibr" rid="bib23">Duong et al., 2014</xref>; <xref ref-type="bibr" rid="bib32">Jensen et al., 2018a</xref>; <xref ref-type="bibr" rid="bib42">Markwart et al., 2014</xref>). Additionally, those memory CD8 T cells that survive the cytokine storm are less capable of undergoing antigen-dependent effector function and responding to inflammatory cues (bystander activation). These intrinsic impairments, in conjunction with the numeric deficits imposed by the lymphopenic environment, reduce host capacity to control both infection (i.e. viral and bacterial) and cancer (<xref ref-type="bibr" rid="bib16">Danahy et al., 2017</xref>; <xref ref-type="bibr" rid="bib17">Danahy et al., 2019</xref>; <xref ref-type="bibr" rid="bib23">Duong et al., 2014</xref>; <xref ref-type="bibr" rid="bib27">Gurung et al., 2011</xref>). Additionally, extrinsic factors, such as reduced integrin expression on endothelia (<xref ref-type="bibr" rid="bib16">Danahy et al., 2017</xref>) or altered monocyte/ macrophage activity (<xref ref-type="bibr" rid="bib35">Jensen et al., 2021a</xref>; <xref ref-type="bibr" rid="bib59">Roquilly et al., 2020</xref>), can influence CD8 T cell capacity to migrate into sites of infection. Even when T cells are spared from the cytokine storm by vascular exclusion (i.e. tissue residence) CD8 T cell-mediated protection can be hampered by inability of other cells (e.g. endothelia) to respond to the inflammatory cues provided by CD8 T cells (<xref ref-type="bibr" rid="bib16">Danahy et al., 2017</xref>). Yet, these impairments are largely characterized proximal to the septic insult. However, sepsis-induced impairments are long-lasting and may not be consistent across time (<xref ref-type="bibr" rid="bib32">Jensen et al., 2018a</xref>). Specifically, the lymphopenic environment is transient yet the ability to control cancer can remain reduced long after numeric recovery is complete (<xref ref-type="bibr" rid="bib17">Danahy et al., 2019</xref>). Thus, while there does not appear to be preferential susceptibility to sepsis, if and how different subsets of memory CD8 T cells recover may dramatically shape how hosts respond to pathogen re-encounter and thereby contribute to the immunoparalysis state.</p><p>Here, using samples from septic patients and well described experimental models we demonstrate increased proliferation of CD8 T cells (particularly central memory cells [T<sub>CM</sub>]) in septic patients and mice after cecal ligation and puncture (CLP)-induced sepsis, relative to non-septic controls. As a consequence of this increased proliferation, there is a remodeling of the memory CD8 T cell pool. This compositional change in turn leads to lasting changes in the localization, function, and protective capacity of pre-existing memory CD8 T cells.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>Increased CD8 T cell proliferation in septic patients</title><p>The sepsis-induced immunoparalysis state poses a substantial threat to the health and long-term survival of septic patients (<xref ref-type="bibr" rid="bib19">Delano and Ward, 2016a</xref>; <xref ref-type="bibr" rid="bib20">Delano and Ward, 2016b</xref>; <xref ref-type="bibr" rid="bib21">Dombrovskiy et al., 2007</xref>; <xref ref-type="bibr" rid="bib22">Donnelly et al., 2015</xref>). A major contributing factor to sepsis-induced immunoparalysis is the intrinsic and numerical deficits imposed on naive and memory CD8 T cells (<xref ref-type="bibr" rid="bib32">Jensen et al., 2018a</xref>). In particular, deficits in existing memory CD8 T cells can enhance host susceptibility to pathogens against which the host was previously immune or vaccinated. To understand how CD8 T cells respond to septic insult and the lymphopenic state, septic patients were recruited within 24 hr of admission and the frequency and number of CD8 T cells in the peripheral blood were compared to that of healthy controls. Patient cohorts did not exhibit substantial demographic differences though septic patients were severely ill, as defined by APACHE II and SOFA scores (<xref ref-type="table" rid="table1">Table 1</xref>). While there was not a difference in the frequency of CD8 T cells among lymphocytes between septic patients and healthy controls (<xref ref-type="fig" rid="fig1">Figure 1a and b</xref>), there was a cohort of septic patients with a substantially reduced number of CD8 T cells per mL of blood (<xref ref-type="fig" rid="fig1">Figure 1c</xref>) reflecting the sepsis-induced lymphopenia. It is relevant to consider that admission time may not correspond to the onset of sepsis such that admitted patients may have not yet experienced or already recovered from sepsis-associated lymphopenia. Thus, numeric variability in samples may reflect a broad range of insult and recovery within the 24 hr of admission. Notably, robust induction of Ki67 expression, a marker of recent proliferation, by CD8 T cells (<xref ref-type="fig" rid="fig1">Figure 1a and d</xref>) was observed, regardless of degree of lymphopenia.</p><table-wrap id="table1" position="float"><label>Table 1.</label><caption><title>Patient demographics.</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Patients</th><th align="left" valign="bottom">Septic (n = 27)</th><th align="left" valign="bottom">Control (n = 16)</th><th align="left" valign="bottom">p-value</th></tr></thead><tbody><tr><td align="left" valign="bottom">Age (mean ± SD)</td><td align="left" valign="bottom">59.3±16.3</td><td align="left" valign="bottom">51.6±13.2</td><td align="left" valign="bottom">ns</td></tr><tr><td align="left" valign="bottom">Male (%)</td><td align="left" valign="bottom">40.7%</td><td align="left" valign="bottom">37.5%</td><td align="left" valign="bottom">ns</td></tr><tr><td align="left" valign="bottom">Caucasian (%)</td><td align="left" valign="bottom">100%</td><td align="left" valign="bottom">81.3%</td><td align="left" valign="bottom">0.0454</td></tr><tr><td align="left" valign="bottom">APACHE II Score (mean ± SD)</td><td align="left" valign="bottom">11.1±5.9</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">SOFA Score (mean ± SD)</td><td align="left" valign="bottom">4.6±4.3</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">% in Septic Shock</td><td align="left" valign="bottom">55.6%</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Time Post-Admission (hrs)</td><td align="left" valign="bottom">6.1±5.6</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr></tbody></table></table-wrap><fig-group><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Increased proliferation among CD8 T cells of septic patients.</title><p>(<bold>A</bold>) Representative gating for CD8 T cell subsets and Ki67 expression from healthy controls and septic patients (within 24 hr of hospital admission). (<bold>B</bold>) Frequency and (<bold>C</bold>) number of CD8 T cells among lymphocytes in healthy controls and septic patients. Dashed lines indicate the normal range for the number of CD8 T cells per mL of blood. (<bold>D</bold>) Frequency of Ki67 expressing CD8 T cells in healthy controls and septic patients. (<bold>E</bold>) Frequency Ki67 expressing cells among Naïve, Effector (T<sub>Eff</sub>), Effector Memory (T<sub>EM</sub>), Central Memory (T<sub>CM</sub>), and Stem Cell Memory (T<sub>SCM</sub>) CD8 T cells from healthy controls and septic patients. Data are representative of 2 independent experiments with 16–27 patients per group. *=p &lt; 0.05. Error bars in represent standard error of the mean.</p><p><supplementary-material id="fig1sdata1"><label>Figure 1—source data 1.</label><caption><title>Source data for <xref ref-type="fig" rid="fig1">Figure 1</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-70989-fig1-data1-v2.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-70989-fig1-v2.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 1.</label><caption><title>Composition of total and proliferating CD8 T cells in healthy controls and septic hosts.</title><p>(<bold>A</bold>) Frequency of Naïve, Effector (T<sub>Eff</sub>), Effector Memory (T<sub>EM</sub>), Central Memory (T<sub>CM</sub>), and Stem Cell Memory (T<sub>SCM</sub>) among CD8 T cells. (<bold>B</bold>) Frequency of Ki67-expressing cells among Naïve, Effector (T<sub>Eff</sub>), Effector Memory (T<sub>EM</sub>), Central Memory (T<sub>CM</sub>), and Stem Cell Memory (T<sub>SCM</sub>) CD8 T cells. Data are representative of two independent experiments with 16–27 patients per group. Error bars in represent standard error of the mean.</p><p><supplementary-material id="fig1s1sdata1"><label>Figure 1—figure supplement 1—source data 1.</label><caption><title>Source data for <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-70989-fig1-figsupp1-data1-v2.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-70989-fig1-figsupp1-v2.tif"/></fig></fig-group><p>This proliferation could either represent newly evoked effector CD8 T cell responses to the sepsis-inducing pathogens or homeostatic proliferation of surviving T cells induced by lymphopenic environment (<xref ref-type="bibr" rid="bib12">Cheung et al., 2009</xref>; <xref ref-type="bibr" rid="bib18">Davenport et al., 2019</xref>; <xref ref-type="bibr" rid="bib32">Jensen et al., 2018a</xref>; <xref ref-type="bibr" rid="bib77">Unsinger et al., 2009</xref>). To address this, the frequency of Ki67 expressing cells was evaluated between naïve (CCR7<sup>+</sup>CD45RA<sup>+</sup>CD45RO<sup>-</sup>), effector (T<sub>Eff</sub>; CCR7<sup>-</sup>CD45RA<sup>+</sup>CD45RO<sup>-</sup>), effector memory (T<sub>EM</sub>; CCR7<sup>-</sup>CD45RA<sup>-</sup>CD45RO<sup>+</sup>), central memory (T<sub>CM</sub>; CCR7<sup>+</sup>CD45RA<sup>-</sup>CD45RO<sup>+</sup>), and stem cell memory (T<sub>SCM</sub>; CCR7<sup>+</sup>CD45RA<sup>+</sup>CD45RO<sup>+</sup>) CD8 T cells (<xref ref-type="bibr" rid="bib13">Cieri et al., 2013</xref>; <xref ref-type="bibr" rid="bib62">Sarkar et al., 2019</xref>). If the proliferation was in response to the septic insult only T<sub>Eff</sub> CD8 T cells should be prominently proliferating relative to healthy controls; however, there was only modest induction of Ki67 among T<sub>Eff</sub> CD8 T cells (<xref ref-type="fig" rid="fig1">Figure 1e</xref>). Intriguingly, robust proliferation among naïve, T<sub>CM</sub>, and T<sub>SCM</sub> CD8 T cells was observed, suggesting proliferation may reflect numerical recovery after sepsis-induced lymphopenia (<xref ref-type="fig" rid="fig1">Figure 1e</xref>). Notably, there was not a significant increase in Ki67<sup>+</sup> T<sub>EM</sub> CD8 T cells from septic patients (<xref ref-type="fig" rid="fig1">Figure 1e</xref>). These data suggest that there is differential proliferation by memory CD8 T cell subsets in septic hosts. Given this differential proliferation by memory CD8 T cell subsets, an altered composition of the memory CD8 T cell pool would be anticipated after sepsis. Indeed, there was a modest, although not statistically different, increase in the frequency of both T<sub>CM</sub> and T<sub>SCM</sub> CD8 T cells in septic patients, relative to healthy controls, even at this early time point (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1a</xref>). Importantly, when evaluating the representation of CD8 T cell subsets among Ki67-expressing CD8 T cells, T<sub>CM</sub> and T<sub>SCM</sub> CD8 T cells were not proportionally increased (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1b</xref>), with T<sub>CM</sub> being the most prominent among cells that recently proliferated. Collectively, these data suggest that sepsis may alter the composition of the memory CD8 T cell compartment due to intrinsic differences in the capacity of different memory CD8 T cell subsets to proliferate.</p></sec><sec id="s2-2"><title>Pre-existing memory 8 T cells numerically recover after sepsis</title><p>To further address how sepsis may alter the composition of the CD8 T cell compartment due to differential capacity memory CD8 T cell subsets to sense signals of the ‘empty’ environment and undergo homeostatic proliferation, we utilized a murine LCMV-infection model to establish memory CD8 T cells followed by a cecal ligation and puncture (CLP; <xref ref-type="fig" rid="fig2">Figure 2a</xref>). To facilitate resolution/analyses of the memory CD8 T cell compartment a physiologically relevant number of naïve Thy1.1<sup>+</sup> TCR-Tg P14 CD8 T cells, specific for the GP<sub>33</sub> epitope of LCMV, were adoptively transferred into Thy1.2<sup>+</sup> recipient mice. Mice were then infected with LCMV-Arm, an acute infection which elicits a robust and well characterized memory CD8 T cell response (<xref ref-type="bibr" rid="bib1">Badovinac et al., 2007</xref>). This system of memory generation and sepsis induction enables rigorous interrogation of a defined population of “pre-existing” memory CD8 T cells (memory cells that exist prior to sepsis induction) wherein both the time of the priming infection and septic event are known. Additionally, naïve and antigen-experienced (Ag-exp) CD8 T cells can be differentiated based on the expression of surrogate markers of activation CD8a and CD11a (naïve: CD8a<sup>hi</sup>CD11a<sup>lo</sup>; Ag-exp: CD8a<sup>lo</sup>CD11a<sup>hi</sup>) (<xref ref-type="bibr" rid="bib56">Rai et al., 2009</xref>). This enables evaluation of endogenous naïve and Ag-exp CD8 T cells in addition to the Ag-exp P14 CD8 T cells (<xref ref-type="fig" rid="fig2">Figure 2b</xref>). Further depth of interrogation is achieved with memory P14 CD8 T cells, relative to the bulk antigen-experienced CD8 T cell population, given that memory P14 CD8 T cells are not specific for antigens evoked/released during the septic event, and the influence of sepsis on this discrete pre-existing memory CD8 T cell population delineates from potential ‘secondary’ antigen encounter and from potential and anticipated novel Ag-specific CD8 T cell responses to the septic event.</p><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>Pre-existing memory CD8 T cells numerically recover with time after sepsis.</title><p>(<bold>A</bold>) Experimental Design: Antigen-experienced P14 chimeric mice were generated by adoptive transfer of 5 × 10<sup>3</sup> naïve Thy1.1<sup>+</sup> TCR-transgenic P14 CD8 T cells to Thy1.2<sup>+</sup> C57Bl/6 mice that were subsequently infected with LCMV-Armstrong (LCMV-Arm). Mice underwent Sham or CLP surgery 30 days after infection. The number of endogenous naïve, endogenous antigen-experienced, and antigen-experienced P14 CD8 T cells was monitored in the blood. (<bold>B</bold>) Representative gating for endogenous naïve, endogenous antigen-experienced, and antigen-experienced P14 CD8 T cells. (<bold>C</bold>) Percent survival of endogenous naïve, endogenous antigen-experienced, and antigen-experienced P14 CD8 T cells in the blood 2 days after either Sham or CLP surgery, relative to a pre-surgery bleed. (<bold>D</bold>) Representative gating of Ki67 on P14 CD8 T cells. (<bold>E</bold>) Frequency of Ki67-expressing P14 CD8 T cells in the blood of Sham and CLP hosts 9 days post-surgery. (<bold>F</bold>) The number of P14 CD8 T cells per mL of blood in Sham and CLP hosts prior to (d0), or 2 days (d2), 2 weeks (2 wk), and 4 weeks (4 wk) after surgery. Values above the bars indicate the fold difference (Sham/CLP) in the number of P14 CD8 T cells. (<bold>C–E</bold>) Are representative of 3 independent experiments with 5–6 mice per group. (<bold>F</bold>) Is cumulative from two independent experiments with 10–12 mice per group. *=p &lt; 0.05. Error bars represent standard error of the mean.</p><p><supplementary-material id="fig2sdata1"><label>Figure 2—source data 1.</label><caption><title>Source data for <xref ref-type="fig" rid="fig2">Figure 2C</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-70989-fig2-data1-v2.xlsx"/></supplementary-material></p><p><supplementary-material id="fig2sdata2"><label>Figure 2—source data 2.</label><caption><title>Source data for <xref ref-type="fig" rid="fig2">Figure 2E</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-70989-fig2-data2-v2.xlsx"/></supplementary-material></p><p><supplementary-material id="fig2sdata3"><label>Figure 2—source data 3.</label><caption><title>Source data for <xref ref-type="fig" rid="fig2">Figure 2F</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-70989-fig2-data3-v2.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-70989-fig2-v2.tif"/></fig><p>Following septic insult, the lymphopenic state impacted naïve and Ag-exp cells to the same degree (<xref ref-type="fig" rid="fig2">Figure 2c</xref>), as has been previously reported (<xref ref-type="bibr" rid="bib14">Condotta et al., 2013</xref>; <xref ref-type="bibr" rid="bib23">Duong et al., 2014</xref>; <xref ref-type="bibr" rid="bib32">Jensen et al., 2018a</xref>). Importantly, the memory P14 CD8 T cells were similarly susceptible to sepsis-induced lymphopenia as the endogenous Ag-exp cells (<xref ref-type="fig" rid="fig2">Figure 2c</xref>). Additionally, there was induction of Ki67 expression by memory P14 CD8 T cells after sepsis (<xref ref-type="fig" rid="fig2">Figure 2d and e</xref>), demonstrating that the P14 CD8 T cells can be used to model the influence of sepsis on pre-existing memory CD8 T cells. When the number of memory P14 CD8 T cells per mL of blood was quantified, we observed numeric loss and recovery of P14 CD8 T cells in CLP hosts (<xref ref-type="fig" rid="fig2">Figure 2f</xref>), similar to prior reports of homeostatic proliferation following sepsis-induced lymphopenia (<xref ref-type="bibr" rid="bib77">Unsinger et al., 2009</xref>). Thus, pre-existing memory CD8 T cells numerically recover with time after sepsis, potentially due to increased proliferation in response to the sepsis-induced lymphopenic environment.</p></sec><sec id="s2-3"><title>Numeric recovery following sepsis increases the proportion of central memory CD8 T cells</title><p>To address how this numeric recovery may alter the composition of the memory T cell compartment phenotypic characterization of splenic memory P14 CD8 T cells from Sham and CLP mice was performed &gt;30 days post-surgery (<xref ref-type="fig" rid="fig3">Figure 3a</xref>). Additionally, FlowSOM was utilized to cluster memory P14 CD8 T cells based on surface marker expression of CD8a, CD11a, Thy1.1, CD62L, KLRG1, CD127, CX3CR1, CXCR3, CD25, CD27, CD69, CD103, and CD122 in an unbiased manner (<xref ref-type="bibr" rid="bib79">Van Gassen et al., 2015</xref>). Memory P14 CD8 T cells were similarly evaluated by tSNE analysis and FlowSOM-defined clusters were then projected into the tSNE (<xref ref-type="fig" rid="fig3">Figure 3b and c</xref>). Notably, Sham and CLP hosts had differential representation of two of the most prominent clusters (6 and 8) with cluster six being enriched in Sham P14 CD8 T cells and cluster eight in CLP P14 CD8 T cells (<xref ref-type="fig" rid="fig3">Figure 3d and e</xref>). Clusters 6 and 8 were then compared to define distinctions between Sham and CLP cells (<xref ref-type="fig" rid="fig3">Figure 3g</xref>). Memory P14 CD8 T cells enriched in Sham mice (cluster 6) were CD62L<sup>-</sup>KLRG1<sup>+</sup>CD127<sup>-</sup>CX3CR1<sup>+</sup>CXCR3<sup>lo</sup>, while memory P14 CD8 T cells enriched in CLP mice (cluster 8) were CD62L<sup>+</sup>KLRG1<sup>-</sup>CD127<sup>+</sup>CX3CR1<sup>-</sup>CXCR3<sup>lo/med</sup> (<xref ref-type="fig" rid="fig3">Figure 3h</xref>). Clusters 6 and 8 therefore appear to define T<sub>EM</sub> and T<sub>CM</sub> CD8 T cells, respectively. Definition of these subsets was predominantly by the expression of CD62L, although the expression of KLRG1, CD127, CX3CR1, and CXCR3 conformed with the respective phenotypes as well (<xref ref-type="bibr" rid="bib46">Martin and Badovinac, 2018</xref>). Thus, CLP P14 CD8 T cells are enriched for T<sub>CM</sub> with a reduced representation of T<sub>EM</sub>, corresponding to the increased proliferation of CD8 T<sub>CM</sub> observed in septic patients (<xref ref-type="fig" rid="fig1">Figure 1e</xref>; <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1b</xref>).</p><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>Sepsis alters the phenotypic composition of pre-existing memory CD8 T cells.</title><p>(<bold>A</bold>) Experimental Design: Antigen-experienced P14 chimeric mice were generated by adoptive transfer of 5 × 10<sup>3</sup> naive Thy1.1<sup>+</sup> TCR-transgenic P14 CD8 T cells to Thy1.2<sup>+</sup> CD57Bl/6 mice that were subsequently infected with LCMV-Armstrong (LCMV-Arm). Mice underwent Sham or CLP surgery 30 days after infection. Phenotypic marker expression on P14 CD8 T cells was then assessed 30 days after surgery. (<bold>B</bold>) Representative antigen-experienced P14 CD8 T cells used in FlowSOM and tSNE analyses. (<bold>C</bold>) tSNE displaying FlowSOM defined clusters among P14 CD8 T cells based on surface marker expression of CD8a, CD11a, Thy1.1, CD62L, KLRG1, CD127, CX3CR1, CXCR3, CD25, CD27, CD69, CD103, and CD122. (<bold>D</bold>) Sham and CLP tSNE plots displaying clusters most robustly enriched in corresponding group. (<bold>E</bold>) Change (Δ) in the frequency of P14 CD8 T cells in each cluster (Sham-CLP); clusters biased toward Sham are &gt;0, clusters biased toward CLP are &lt;0. (<bold>G</bold>) tSNE plots displaying the clusters 6 (enriched in Sham hosts) and 8 (enriched in CLP hosts). (<bold>H</bold>) Surface expression of CD62L, KLRG1, CD127, CX3CR1, and CXCR3 comparing clusters 6 and 8. Data are representative of two independent experiments with 2–3 mice per group. Error bars indicate standard error of the mean.</p><p><supplementary-material id="fig3sdata1"><label>Figure 3—source data 1.</label><caption><title>Source data for <xref ref-type="fig" rid="fig3">Figure 3</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-70989-fig3-data1-v2.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-70989-fig3-v2.tif"/></fig><p>T<sub>CM</sub> have a higher capacity to undergo homeostatic proliferation, relative to T<sub>EM</sub>, which accounts for the gradual shift toward T<sub>CM</sub> with time after antigen encounter (<xref ref-type="bibr" rid="bib46">Martin and Badovinac, 2018</xref>; <xref ref-type="bibr" rid="bib44">Martin et al., 2015</xref>; <xref ref-type="bibr" rid="bib81">Wherry et al., 2003</xref>). Therefore, to address whether the higher proliferative potential of T<sub>CM</sub> accounted for the shift to CD8 T<sub>CM</sub> following sepsis, Ki67 expression in splenic T<sub>EM</sub> and T<sub>CM</sub> P14 CD8 T cells was interrogated at various times after Sham or CLP surgery (<xref ref-type="fig" rid="fig4">Figure 4a</xref>). Indeed, both T<sub>CM</sub> and T<sub>EM</sub> proliferated in CLP hosts greater than their Sham counterparts, following lymphopenia (<xref ref-type="fig" rid="fig4">Figure 4b</xref>). However, P14 CD8 T<sub>CM</sub> cells proliferated more robustly than their T<sub>EM</sub> counterparts in CLP hosts. Importantly, P14 CD8 T<sub>CM</sub> cells proliferated more than their T<sub>EM</sub> counterparts in Sham hosts across all timepoints, consistent with prior reports of higher homeostatic proliferation among T<sub>CM</sub> cells (<xref ref-type="bibr" rid="bib81">Wherry et al., 2003</xref>). To confirm the higher degree of proliferation in P14 CD8 T<sub>CM</sub> cells following sepsis, BrdU incorporation was evaluated over the course of a week beginning at D9 post-surgery, the timepoint at which differential proliferation had been observed by Ki67 expression (<xref ref-type="fig" rid="fig4">Figure 4c</xref>). Similar to the results with Ki67, elevated proliferation was observed in both T<sub>CM</sub> and T<sub>EM</sub> P14 CD8 T cells from CLP hosts, relative to Sham hosts (<xref ref-type="fig" rid="fig4">Figure 4d</xref>). Additionally, P14 CD8 T<sub>CM</sub> cells had higher incorporation of BrdU (relative to T<sub>EM</sub> counterparts) in both Sham and CLP hosts with P14 CD8 T<sub>CM</sub> cells from CLP hosts having the highest degree of BrdU incorporation. Similar results were also demonstrated in endogenous Ag-exp CD8 T cells reaffirming the findings in the TCR-Tg memory P14 CD8 T cells. This proliferative difference was further associated with an increase in the frequency of T<sub>CM</sub> among P14 CD8 T cells at D16 post-surgery, the time at which BrdU assessment was performed (<xref ref-type="fig" rid="fig4">Figure 4e</xref>). Additionally, a trending increase in the representation of T<sub>CM</sub> was observed among Ag-exp CD8 T cells in CLP hosts, relative to Sham hosts, at the same time in spite of potential novel effector CD8 T cell responses to the septic insult.</p><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>Central memory CD8 T cells more robustly proliferate after sepsis.</title><p>(<bold>A</bold>) Experimental Design: Antigen-experienced P14 chimeric mice were generated by adoptive transfer of 5 × 10<sup>3</sup> naive Thy1.1<sup>+</sup> TCR-transgenic P14 CD8 T cells to Thy1.2<sup>+</sup> C57Bl/6 mice that were subsequently infected with LCMV-Armstrong (LCMV-Arm). Mice underwent Sham or CLP surgery 30 days after infection. The frequency of Ki67 expressing central and effector memory P14 CD8 T cells was monitored in the spleen after surgery. (<bold>B</bold>) Frequency of Ki67 expressing cells among central (CD62L<sup>+</sup>) and effector (CD62L<sup>-</sup>) memory P14 CD8 T cells in Sham and CLP hosts prior to (d0) or 5-, 9-, and 16 days after surgery. *=p &lt; 0.05 CD62L<sup>+</sup> v CD62L<sup>-</sup> CLP P14 CD8 T cells; <sup>&amp;</sup>=p &lt; 0.05 CD62L<sup>+</sup> v CD62L<sup>-</sup> Sham P14 CD8 T cells; <sup>#</sup>=p &lt; 0.05 Sham v CLP CD62L<sup>+</sup> P14 CD8 T cells; <sup>%</sup>=p &lt; 0.05 Sham v CLP CD62L<sup>-</sup> P14 CD8 T cells (<bold>C</bold>) Experimental Design: Antigen-experienced P14 chimeric mice were generated by adoptive transfer of 5 × 10<sup>3</sup> naïve Thy1.1<sup>+</sup> TCR-transgenic P14 CD8 T cells to Thy1.2<sup>+</sup> C57Bl/6 mice that were subsequently infected with LCMV-Arm. Mice underwent Sham or CLP surgery 30 days after infection followed by BrdU administration 9 days later. BrdU incorporation by central and effector memory endogenous and P14 CD8 T cells was assessed 7 days later. (<bold>D</bold>) Frequency of CD62L<sup>+</sup> and CD62L<sup>-</sup> memory P14 CD8 T cells and endogenous CD8 T cells that have incorporated BrdU. (<bold>E</bold>) Frequency of CD62L<sup>+</sup> P14 CD8 T cells and endogenous CD8 T cells 16 days after surgery. (<bold>F</bold>) Experimental Design: Antigen-experienced P14 chimeric mice were generated by adoptive transfer of 5 × 10<sup>3</sup> naive Thy1.1<sup>+</sup> TCR-transgenic P14CD8 T cells to Thy1.2<sup>+</sup> C57Bl/6 mice that were subsequently infected with LCMV-Arm. Mice underwent Sham or CLP surgery 30 days after infection. The frequency of P14 CD8 T cells among lymphocytes in the spleen, liver, PBL, mediastinal lymph node (medLN), and mesenteric lymph node (mesLN) was then determined 30 days after surgery. Preferential localization was determined by the ratio of P14 CD8 T cells in the tissues compared relative to the spleen. (<bold>G</bold>) Ratio of the frequency of P14 CD8 T cells among lymphocytes in the liver, PBL, medLN, and mesLN relative to the spleen. All data are representative of at least two independent experiments with 4–8 mice per group. *=p &lt; 0.05. Error bars represent standard error of the mean.</p><p><supplementary-material id="fig4sdata1"><label>Figure 4—source data 1.</label><caption><title>Source data for <xref ref-type="fig" rid="fig4">Figure 4B</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-70989-fig4-data1-v2.xlsx"/></supplementary-material></p><p><supplementary-material id="fig4sdata2"><label>Figure 4—source data 2.</label><caption><title>Source data for <xref ref-type="fig" rid="fig4">Figure 4D and E</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-70989-fig4-data2-v2.xlsx"/></supplementary-material></p><p><supplementary-material id="fig4sdata3"><label>Figure 4—source data 3.</label><caption><title>Source data for <xref ref-type="fig" rid="fig4">Figure 4G</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-70989-fig4-data3-v2.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-70989-fig4-v2.tif"/></fig><p>In addition to differential capacity to undergo homeostatic proliferation T<sub>CM</sub> and T<sub>EM</sub> have different localization throughout the body. T<sub>CM</sub> preferentially localizes to lymphatic tissue while T<sub>EM</sub> preferentially circulates and traverse non-lymphatic tissue (<xref ref-type="bibr" rid="bib26">Gerlach et al., 2016</xref>; <xref ref-type="bibr" rid="bib48">Masopust et al., 2001</xref>; <xref ref-type="bibr" rid="bib50">Mueller et al., 2013</xref>). To further address this shift in the representation of T<sub>CM</sub> and T<sub>EM</sub>, the localization of memory P14 CD8 T cells was evaluated in the liver, peripheral blood lymphocytes (PBL), mediastinal lymph nodes (mLN), and mesenteric lymph nodes (mesLN) relative to the spleen (<xref ref-type="fig" rid="fig4">Figure 4f</xref>). Spleen was chosen as the baseline for comparison as it is a mixture of circulation with lymphatic tissue. PBL was chosen to emphasize circulating cells, while liver was chosen as a non-lymphatic tissue because it is a highly vascular tissue with direct contact to blood coming from the abdominal cavity and thus relevant to the septic insult. MedLN are the site of initial infection with LCMV-Arm following i.p. infection and is therefore relevant to the generation of the initial memory response (<xref ref-type="bibr" rid="bib52">Olson et al., 2012</xref>), while mesLN drain the gut tissue and are relevant to CLP induction. Thus, if sepsis leads to a global shift toward central memory we expected to see a reduced proportion of memory P14 CD8 T cells in the liver and PBL and a greater proportion in the medLN and mesLN in CLP hosts, relative to Sham. Indeed, the ratio of P14 CD8 T cells among lymphocytes in the liver and PBL, relative to the spleen, had a trending reduction in CLP hosts, compared to Sham hosts (<xref ref-type="fig" rid="fig4">Figure 4g</xref>). Conversely, the ratio of P14 CD8 T cells among lymphocytes in the medLN and mesLN relative to the spleen, were significantly increased in CLP hosts, compared to Sham hosts. These data demonstrate differential localization of CD8 T cells in Sham and CLP hosts corresponding to the change in the representation of T<sub>EM</sub> and T<sub>CM</sub>. Cumulatively, the data in <xref ref-type="fig" rid="fig4">Figure 4</xref> demonstrate that preferential proliferation by T<sub>CM</sub> alters the composition and localization of pre-existing memory CD8 T cells after sepsis. Thus, pre-existing differences in the biology of central and effector memory T cells are the underlying mechanism by which central memory CD8 T cells become over-represented in pre-existing memory populations after sepsis.</p></sec><sec id="s2-4"><title>Sepsis leads to long-term changes in memory CD8 T cell transcription and chromatin accessibility</title><p>Beyond localization T<sub>CM</sub> and T<sub>EM</sub> have differential functions mediated by discrete transcriptional and epigenetic landscapes (<xref ref-type="bibr" rid="bib9">Chang et al., 2014</xref>; <xref ref-type="bibr" rid="bib37">Kaech and Cui, 2012</xref>; <xref ref-type="bibr" rid="bib49">Milner et al., 2020</xref>). Therefore, to address how the sepsis-induced changes in the composition of pre-existing memory CD8 T cells may alter the overall transcriptional regulation of memory CD8 T cells RNA-sequencing was performed on memory P14 CD8 T cells from Sham and CLP hosts both 1- and 31 days post-surgery (<xref ref-type="fig" rid="fig5">Figure 5a</xref>). Numerous transcriptional differences between the four groups were identified (<xref ref-type="fig" rid="fig5">Figure 5b–d</xref>). Notably, when evaluated by principal component analysis (PCA) there was clear distinction between the Sham and CLP groups at each timepoint (<xref ref-type="fig" rid="fig5">Figure 5b</xref>); however, this distinction narrowed at D31 relative to D1 potentially reflecting some degree of recovery from the initial the cytokine storm. Additionally, D1 and D31 were distinct within their respective surgical groups recapitulating prior literature demonstrating how memory changes with time after antigen encounter (<xref ref-type="bibr" rid="bib18">Davenport et al., 2019</xref>; <xref ref-type="bibr" rid="bib45">Martin et al., 2017</xref>). Importantly, numerous gene changes (269 total; 174 down, 95up) were present at D31 post-surgery in CLP hosts, relative to Sham controls (<xref ref-type="fig" rid="fig5">Figure 5c and d</xref>). To understand how these lasting transcriptional changes related to the septic insult, the significantly different genes expressed at D31 by Sham and CLP memory P14 CD8 T cells were clustered into three groups (<xref ref-type="fig" rid="fig5">Figure 5e</xref>). Given our observation of faster transition to central memory by CD8 T cells after sepsis the first cluster of genes identified were those that were similarly changed when comparing D1 to D31 Sham and D31 Sham to CLP P14 CD8 T cells. These changes constituted 99 of the 269 transcriptional (<xref ref-type="table" rid="table2">Table 2</xref>) differences between Sham and CLP memory P14 CD8 T cells at D31 and validate the observations in the prior figures of more rapid adoption of time-dependent changes in memory (i.e. conversion to central memory) (e.g. changes in clusters 6 and 8 of <xref ref-type="fig" rid="fig3">Figure 3</xref>). The remaining genes were then evaluated for the presence of a sepsis-induced transcriptional ‘scar’ to delineate conserved changes as a result of the septic event. These changes constituted the second cluster and were identified by the similar transcriptional changes for D1 Sham to CLP and D31 Sham to CLP. This sepsis-induced ‘scar’ constituted 113 of the 269 gene changes observed (<xref ref-type="table" rid="table2">Table 2</xref>) and demonstrates that some of the transcriptional changes evoked early after sepsis persist. Finally, there remained a third cluster of 57 gene changes (<xref ref-type="table" rid="table2">Table 2</xref>) that were neither associated with time-dependent changes in CD8 T cell memory nor were they associated with the early sepsis induced changes to memory CD8 T cells. Thus, novel transcriptional changes also arise in memory CD8 T cells during the post-septic environment. Summarily, these data demonstrate that sepsis leads to lasting changes in the transcriptional landscape of memory CD8 T cells. These changes are associated with the more rapid acquisition of time-dependent changes by memory CD8 T cells in CLP hosts, a sepsis-induced transcriptional scar, and novel transcriptional changes acquired in the post-septic environment.</p><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>Sepsis alters the gene expression and chromatin accessibility of pre-existing memory CD8 T cells.</title><p>(<bold>A</bold>) Experimental Design: Antigen-experienced P14 chimeric mice were generated by adoptive transfer of 5 × 10<sup>3</sup> naive Thy1.1<sup>+</sup> TCR-transgenic P14 CD8 T cells to Thy1.2<sup>+</sup> C57Bl/6 mice that were subsequently infected with LCMV-Arm. Mice underwent Sham or CLP surgery 30 days after infection. Splenic P14 CD8 T cells were FACS-sorted one or 31 after surgery for RNA extraction. P14 CD8 T cells were isolated from 3 D1-Sham hosts, 3 D1-CLP hosts, 3 D31-Sham hosts, and 2 D31-CLP hosts. (<bold>B</bold>) Principal Component analysis of P14 CD8 T cells from Sham and CLP hosts either 1- or 31 days post-surgery. (<bold>C</bold>) Number of statistically significant gene changes as a result of indicated comparisons. (<bold>D</bold>) Gene expression heatmap of genes with statistically significant changes (fold change &gt;1.5, p &lt; 0.05) as a result of any comparison. (<bold>E</bold>) Gene expression heatmap of genes with statistically significant changes (fold change &gt;1.5, p &lt; 0.05) between D31 Sham and CLP P14 CD8 T cells. Clusters were consecutively defined by similar expressional changes in: D1 to D31 Sham P14 CD8 T cells and D31 Sham to CLP P14 CD8 T cells [Cluster 1], D1 Sham to CLP P14 CD8 T cells and D31 Sham to CLP P14 CD8 T cells [Cluster 2], and non-defined by prior categorization [Cluster 3] (<bold>F</bold>) Experimental Design: Antigen-experienced P14 chimeric mice were generated by adoptive transfer of 5 × 10<sup>3</sup> naive Thy1.1<sup>+</sup> TCR-transgenic P14 CD8 T cells to Thy1.2<sup>+</sup> C57Bl/6 mice that were subsequently infected with LCMV-Arm. Mice underwent Sham or CLP surgery 30 days after infection. Splenic P14 CD8 T cells were FACS-sorted 31 days after surgery for assessment of chromatin accessibility. P14 CD8 T cells were isolated from 2 D31-Sham hosts and 3 D31-CLP hosts. (<bold>G</bold>) Total number of differential chromatin accessibility peaks (DCAPs, fold change &gt;2 p &lt; 0.05) and delineation of those within either a promoter, gene body, or intergenic regions assigned to the most proximal to a transcription start site. (<bold>H</bold>) List of genes whose change in transcript is concordant with changes in chromatin accessibility along with the relative change and known function in CD8 T cells. (<bold>I</bold>) Example of differentially expressed peaks (indicated by the red box) within the <italic>P2R×7</italic> and <italic>Sell</italic> gene loci from representative Sham and CLP P14s. (<bold>J</bold>) List of genes whose expression defined the phenotypically distinct populations between Sham and CLP P14 CD8 T cells in <xref ref-type="fig" rid="fig3">Figure 3</xref> alongside their fold change in transcript and the p-value associated with that fold-change.</p><p><supplementary-material id="fig5sdata1"><label>Figure 5—source data 1.</label><caption><title>Source data for <xref ref-type="fig" rid="fig5">Figure 5C and D</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-70989-fig5-data1-v2.xlsx"/></supplementary-material></p><p><supplementary-material id="fig5sdata2"><label>Figure 5—source data 2.</label><caption><title>Source data for <xref ref-type="fig" rid="fig5">Figure 5E</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-70989-fig5-data2-v2.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-70989-fig5-v2.tif"/></fig><table-wrap id="table2" position="float"><label>Table 2.</label><caption><title>Gene clusters.</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="top">gene_id</th><th align="left" valign="top">Relative FC D32 sham vs CLP</th><th align="left" valign="top">p_value_</th><th align="left" valign="top">Cluster #</th></tr></thead><tbody><tr><td align="left" valign="top">Cdc6</td><td align="char" char="." valign="top">4.03064298</td><td align="char" char="." valign="top">0.00005</td><td align="left" valign="top">Cluster 1</td></tr><tr><td align="left" valign="top">Tppp3</td><td align="char" char="." valign="top">4.88825654</td><td align="char" char="." valign="top">0.00005</td><td align="left" valign="top">Cluster 1</td></tr><tr><td align="left" valign="top">Neil3</td><td align="char" char="." valign="top">3.66496647</td><td align="char" char="." valign="top">0.00005</td><td align="left" valign="top">Cluster 1</td></tr><tr><td align="left" valign="top">Hist1h1e</td><td align="char" char="." valign="top">3.76231332</td><td align="char" char="." valign="top">0.00005</td><td align="left" valign="top">Cluster 1</td></tr><tr><td align="left" valign="top">Mcm10</td><td align="char" char="." valign="top">3.47460746</td><td align="char" char="." valign="top">0.00005</td><td align="left" valign="top">Cluster 1</td></tr><tr><td align="left" valign="top">Ttc8</td><td align="char" char="." valign="top">3.38918878</td><td align="char" char="." valign="top">0.00005</td><td align="left" valign="top">Cluster 1</td></tr><tr><td align="left" valign="top">Stmn1</td><td align="char" char="." valign="top">2.06406728</td><td align="char" char="." valign="top">0.0508</td><td align="left" valign="top">Cluster 1</td></tr><tr><td align="left" valign="top">Gpr34</td><td align="char" char="." valign="top">3.41697573</td><td align="char" char="." valign="top">0.00005</td><td align="left" valign="top">Cluster 1</td></tr><tr><td align="left" valign="top">Ppp2r2c</td><td align="char" char="." valign="top">1.83454208</td><td align="char" char="." valign="top">0.0437</td><td align="left" valign="top">Cluster 1</td></tr><tr><td align="left" valign="top">Kntc1</td><td align="char" char="." valign="top">2.99415727</td><td align="char" char="." valign="top">0.00005</td><td align="left" valign="top">Cluster 1</td></tr><tr><td align="left" valign="top">Bfsp1</td><td align="char" char="." valign="top">1.60516322</td><td align="char" char="." valign="top">0.03045</td><td align="left" valign="top">Cluster 1</td></tr><tr><td align="left" valign="top">Birc5</td><td align="char" char="." valign="top">2.8137029</td><td align="char" char="." valign="top">0.00005</td><td align="left" valign="top">Cluster 1</td></tr><tr><td align="left" valign="top">Ccdc136</td><td align="char" char="." valign="top">2.28917856</td><td align="char" char="." valign="top">0.0344</td><td align="left" valign="top">Cluster 1</td></tr><tr><td align="left" valign="top">Gm5124</td><td align="char" char="." valign="top">1.60472157</td><td align="char" char="." valign="top">0.03095</td><td align="left" valign="top">Cluster 1</td></tr><tr><td align="left" valign="top">Ccnb2</td><td align="char" char="." valign="top">2.49461988</td><td align="char" char="." valign="top">0.00005</td><td align="left" valign="top">Cluster 1</td></tr><tr><td align="left" valign="top">Apol7b</td><td align="char" char="." valign="top">2.6692603</td><td align="char" char="." valign="top">0.00005</td><td align="left" valign="top">Cluster 1</td></tr><tr><td align="left" valign="top">Tktl1</td><td align="char" char="." valign="top">1.9334132</td><td align="char" char="." valign="top">0.02895</td><td align="left" valign="top">Cluster 1</td></tr><tr><td align="left" valign="top">Dtl</td><td align="char" char="." valign="top">2.59828557</td><td align="char" char="." valign="top">0.00005</td><td align="left" valign="top">Cluster 1</td></tr><tr><td align="left" valign="top">Pask</td><td align="char" char="." valign="top">2.7640812</td><td align="char" char="." valign="top">0.00005</td><td align="left" valign="top">Cluster 1</td></tr><tr><td align="left" valign="top">Crip2</td><td align="char" char="." valign="top">2.52029044</td><td align="char" char="." valign="top">0.0004</td><td align="left" valign="top">Cluster 1</td></tr><tr><td align="left" valign="top">Clspn</td><td align="char" char="." valign="top">2.45116907</td><td align="char" char="." valign="top">0.00015</td><td align="left" valign="top">Cluster 1</td></tr><tr><td align="left" valign="top">Mki67</td><td align="char" char="." valign="top">2.61164716</td><td align="char" char="." valign="top">0.00005</td><td align="left" valign="top">Cluster 1</td></tr><tr><td align="left" valign="top">Fam64a</td><td align="char" char="." valign="top">2.65731637</td><td align="char" char="." valign="top">0.0006</td><td align="left" valign="top">Cluster 1</td></tr><tr><td align="char" char="." valign="top">2810408I11Rik</td><td align="char" char="." valign="top">1.5215239</td><td align="char" char="." valign="top">0.06725</td><td align="left" valign="top">Cluster 1</td></tr><tr><td align="left" valign="top">Rad51ap1</td><td align="char" char="." valign="top">1.63064417</td><td align="char" char="." valign="top">0.00235</td><td align="left" valign="top">Cluster 1</td></tr><tr><td align="left" valign="top">Tnfsf4</td><td align="char" char="." valign="top">2.37518519</td><td align="char" char="." valign="top">0.0009</td><td align="left" valign="top">Cluster 1</td></tr><tr><td align="left" valign="top">E2f1</td><td align="char" char="." valign="top">2.34354094</td><td align="char" char="." valign="top">0.031</td><td align="left" valign="top">Cluster 1</td></tr><tr><td align="left" valign="top">Cep55</td><td align="char" char="." valign="top">2.4930123</td><td align="char" char="." valign="top">0.0004</td><td align="left" valign="top">Cluster 1</td></tr><tr><td align="left" valign="top">Morn3</td><td align="char" char="." valign="top">2.12074329</td><td align="char" char="." valign="top">0.00035</td><td align="left" valign="top">Cluster 1</td></tr><tr><td align="left" valign="top">Aurkb</td><td align="char" char="." valign="top">2.4030389</td><td align="char" char="." valign="top">0.00005</td><td align="left" valign="top">Cluster 1</td></tr><tr><td align="left" valign="top">Hist2h2bb</td><td align="char" char="." valign="top">2.02820011</td><td align="char" char="." valign="top">0.0464</td><td align="left" valign="top">Cluster 1</td></tr><tr><td align="left" valign="top">Exo1</td><td align="char" char="." valign="top">2.36813282</td><td align="char" char="." valign="top">0.00005</td><td align="left" valign="top">Cluster 1</td></tr><tr><td align="left" valign="top">Fcrlb</td><td align="char" char="." valign="top">1.52457593</td><td align="char" char="." valign="top">0.04225</td><td align="left" valign="top">Cluster 1</td></tr><tr><td align="left" valign="top">Tmem176a</td><td align="char" char="." valign="top">1.59714799</td><td align="char" char="." valign="top">0.0361</td><td align="left" valign="top">Cluster 1</td></tr><tr><td align="left" valign="top">Socs2</td><td align="char" char="." valign="top">2.02128114</td><td align="char" char="." valign="top">0.00155</td><td align="left" valign="top">Cluster 1</td></tr><tr><td align="left" valign="top">Ncapg2</td><td align="char" char="." valign="top">1.97320931</td><td align="char" char="." valign="top">0.00745</td><td align="left" valign="top">Cluster 1</td></tr><tr><td align="left" valign="top">Klra9</td><td align="char" char="." valign="top">2.11296665</td><td align="char" char="." valign="top">0.00005</td><td align="left" valign="top">Cluster 1</td></tr><tr><td align="left" valign="top">Chek1</td><td align="char" char="." valign="top">1.59507471</td><td align="char" char="." valign="top">0.05475</td><td align="left" valign="top">Cluster 1</td></tr><tr><td align="left" valign="top">Rad51</td><td align="char" char="." valign="top">1.58587164</td><td align="char" char="." valign="top">0.00005</td><td align="left" valign="top">Cluster 1</td></tr><tr><td align="left" valign="top">Dscc1</td><td align="char" char="." valign="top">1.74867599</td><td align="char" char="." valign="top">0.00015</td><td align="left" valign="top">Cluster 1</td></tr><tr><td align="left" valign="top">Bzrap1</td><td align="char" char="." valign="top">1.61419626</td><td align="char" char="." valign="top">0.00005</td><td align="left" valign="top">Cluster 1</td></tr><tr><td align="left" valign="top">Cd300e</td><td align="char" char="." valign="top">1.519849</td><td align="char" char="." valign="top">0.07755</td><td align="left" valign="top">Cluster 1</td></tr><tr><td align="left" valign="top">Gm1720</td><td align="char" char="." valign="top">1.94574412</td><td align="char" char="." valign="top">0.0019</td><td align="left" valign="top">Cluster 1</td></tr><tr><td align="left" valign="top">Brca1</td><td align="char" char="." valign="top">1.5604888</td><td align="char" char="." valign="top">0.05435</td><td align="left" valign="top">Cluster 1</td></tr><tr><td align="left" valign="top">Gm14124</td><td align="char" char="." valign="top">1.64708499</td><td align="char" char="." valign="top">0.03685</td><td align="left" valign="top">Cluster 1</td></tr><tr><td align="left" valign="top">Shcbp1</td><td align="char" char="." valign="top">1.79205262</td><td align="char" char="." valign="top">0.00005</td><td align="left" valign="top">Cluster 1</td></tr><tr><td align="left" valign="top">Nebl</td><td align="char" char="." valign="top">1.8053468</td><td align="char" char="." valign="top">0.04325</td><td align="left" valign="top">Cluster 1</td></tr><tr><td align="left" valign="top">Ckap2l</td><td align="char" char="." valign="top">1.73019782</td><td align="char" char="." valign="top">0.0003</td><td align="left" valign="top">Cluster 1</td></tr><tr><td align="left" valign="top">Cdkn2a</td><td align="char" char="." valign="top">1.82961741</td><td align="char" char="." valign="top">0.00085</td><td align="left" valign="top">Cluster 1</td></tr><tr><td align="left" valign="top">Phlda3</td><td align="char" char="." valign="top">1.63185741</td><td align="char" char="." valign="top">0.03825</td><td align="left" valign="top">Cluster 1</td></tr><tr><td align="left" valign="top">Adgre4</td><td align="char" char="." valign="top">1.57646266</td><td align="char" char="." valign="top">0.00005</td><td align="left" valign="top">Cluster 1</td></tr><tr><td align="left" valign="top">Klri2</td><td align="char" char="." valign="top">1.56007674</td><td align="char" char="." valign="top">0.0011</td><td align="left" valign="top">Cluster 1</td></tr><tr><td align="left" valign="top">Mmp25</td><td align="char" char="." valign="top">1.54571785</td><td align="char" char="." valign="top">0.04745</td><td align="left" valign="top">Cluster 1</td></tr><tr><td align="left" valign="top">Nenf</td><td align="char" char="." valign="top">1.5307705</td><td align="char" char="." valign="top">0.0182</td><td align="left" valign="top">Cluster 1</td></tr><tr><td align="left" valign="top">Igf1</td><td align="char" char="." valign="top">–1.524316</td><td align="char" char="." valign="top">0.01</td><td align="left" valign="top">Cluster 1</td></tr><tr><td align="left" valign="top">Rac3</td><td align="char" char="." valign="top">–1.5034855</td><td align="char" char="." valign="top">0.07065</td><td align="left" valign="top">Cluster 1</td></tr><tr><td align="left" valign="top">Trf</td><td align="char" char="." valign="top">–1.6496992</td><td align="char" char="." valign="top">0.00015</td><td align="left" valign="top">Cluster 1</td></tr><tr><td align="left" valign="top">Chaf1a</td><td align="char" char="." valign="top">–1.6002474</td><td align="char" char="." valign="top">0.0011</td><td align="left" valign="top">Cluster 1</td></tr><tr><td align="left" valign="top">Orc1</td><td align="char" char="." valign="top">–1.6245667</td><td align="char" char="." valign="top">0.04185</td><td align="left" valign="top">Cluster 1</td></tr><tr><td align="left" valign="top">Fignl1</td><td align="char" char="." valign="top">–1.7257028</td><td align="char" char="." valign="top">0.0216</td><td align="left" valign="top">Cluster 1</td></tr><tr><td align="left" valign="top">D430020J02Rik</td><td align="char" char="." valign="top">–1.6263897</td><td align="char" char="." valign="top">0.0051</td><td align="left" valign="top">Cluster 1</td></tr><tr><td align="left" valign="top">Cenph</td><td align="char" char="." valign="top">–1.8078839</td><td align="char" char="." valign="top">0.0047</td><td align="left" valign="top">Cluster 1</td></tr><tr><td align="left" valign="top">Blvrb</td><td align="char" char="." valign="top">–1.8434164</td><td align="char" char="." valign="top">0.0457</td><td align="left" valign="top">Cluster 1</td></tr><tr><td align="left" valign="top">Cpne7</td><td align="char" char="." valign="top">–1.5149666</td><td align="char" char="." valign="top">0.02655</td><td align="left" valign="top">Cluster 1</td></tr><tr><td align="left" valign="top">Psrc1</td><td align="char" char="." valign="top">–1.7535019</td><td align="char" char="." valign="top">0.00145</td><td align="left" valign="top">Cluster 1</td></tr><tr><td align="left" valign="top">Uhrf1</td><td align="char" char="." valign="top">–1.5739852</td><td align="char" char="." valign="top">0.0013</td><td align="left" valign="top">Cluster 1</td></tr><tr><td align="left" valign="top">Plbd1</td><td align="char" char="." valign="top">–1.7851892</td><td align="char" char="." valign="top">0.0021</td><td align="left" valign="top">Cluster 1</td></tr><tr><td align="left" valign="top">Rgs12</td><td align="char" char="." valign="top">–1.8455643</td><td align="char" char="." valign="top">0.01885</td><td align="left" valign="top">Cluster 1</td></tr><tr><td align="left" valign="top">Hpgd</td><td align="char" char="." valign="top">–1.8522078</td><td align="char" char="." valign="top">0.06025</td><td align="left" valign="top">Cluster 1</td></tr><tr><td align="left" valign="top">P2<italic>r</italic>×7</td><td align="char" char="." valign="top">–2.0648257</td><td align="char" char="." valign="top">0.01595</td><td align="left" valign="top">Cluster 1</td></tr><tr><td align="left" valign="top">Bub1b</td><td align="char" char="." valign="top">–2.2247142</td><td align="char" char="." valign="top">0.0223</td><td align="left" valign="top">Cluster 1</td></tr><tr><td align="char" char="." valign="top">4833418N02Rik</td><td align="char" char="." valign="top">–2.3048295</td><td align="char" char="." valign="top">0.011</td><td align="left" valign="top">Cluster 1</td></tr><tr><td align="left" valign="top">Ube2c</td><td align="char" char="." valign="top">–1.621509</td><td align="char" char="." valign="top">0.0124</td><td align="left" valign="top">Cluster 1</td></tr><tr><td align="left" valign="top">Cadm1</td><td align="char" char="." valign="top">–2.3409109</td><td align="char" char="." valign="top">0.00015</td><td align="left" valign="top">Cluster 1</td></tr><tr><td align="left" valign="top">Tyrobp</td><td align="char" char="." valign="top">–2.4355709</td><td align="char" char="." valign="top">0.00335</td><td align="left" valign="top">Cluster 1</td></tr><tr><td align="left" valign="top">Jup</td><td align="char" char="." valign="top">–2.4842838</td><td align="char" char="." valign="top">0.0023</td><td align="left" valign="top">Cluster 1</td></tr><tr><td align="left" valign="top">Pyroxd2</td><td align="char" char="." valign="top">–2.2264265</td><td align="char" char="." valign="top">0.0282</td><td align="left" valign="top">Cluster 1</td></tr><tr><td align="left" valign="top">Gins1</td><td align="char" char="." valign="top">–1.8339216</td><td align="char" char="." valign="top">0.00005</td><td align="left" valign="top">Cluster 1</td></tr><tr><td align="left" valign="top">Gm4013</td><td align="char" char="." valign="top">–2.7505116</td><td align="char" char="." valign="top">0.01255</td><td align="left" valign="top">Cluster 1</td></tr><tr><td align="left" valign="top">Axl</td><td align="char" char="." valign="top">–2.6625156</td><td align="char" char="." valign="top">0.00005</td><td align="left" valign="top">Cluster 1</td></tr><tr><td align="left" valign="top">Nr6a1</td><td align="char" char="." valign="top">–2.729109</td><td align="char" char="." valign="top">0.00125</td><td align="left" valign="top">Cluster 1</td></tr><tr><td align="left" valign="top">Hspa2</td><td align="char" char="." valign="top">–2.796573</td><td align="char" char="." valign="top">0.00005</td><td align="left" valign="top">Cluster 1</td></tr><tr><td align="left" valign="top">Spry2</td><td align="char" char="." valign="top">–2.7405966</td><td align="char" char="." valign="top">0.00005</td><td align="left" valign="top">Cluster 1</td></tr><tr><td align="left" valign="top">Mpeg1</td><td align="char" char="." valign="top">–2.8281527</td><td align="char" char="." valign="top">0.00005</td><td align="left" valign="top">Cluster 1</td></tr><tr><td align="left" valign="top">Ticrr</td><td align="char" char="." valign="top">–2.9418017</td><td align="char" char="." valign="top">0.00005</td><td align="left" valign="top">Cluster 1</td></tr><tr><td align="left" valign="top">Plxdc1</td><td align="char" char="." valign="top">–2.9468017</td><td align="char" char="." valign="top">0.00005</td><td align="left" valign="top">Cluster 1</td></tr><tr><td align="left" valign="top">Ly86</td><td align="char" char="." valign="top">–3.2898687</td><td align="char" char="." valign="top">0.0019</td><td align="left" valign="top">Cluster 1</td></tr><tr><td align="left" valign="top">Cd302</td><td align="char" char="." valign="top">–3.3417875</td><td align="char" char="." valign="top">0.00005</td><td align="left" valign="top">Cluster 1</td></tr><tr><td align="left" valign="top">C6</td><td align="char" char="." valign="top">–3.3367417</td><td align="char" char="." valign="top">0.0003</td><td align="left" valign="top">Cluster 1</td></tr><tr><td align="left" valign="top">Slc37a2</td><td align="char" char="." valign="top">–3.3489759</td><td align="char" char="." valign="top">0.00005</td><td align="left" valign="top">Cluster 1</td></tr><tr><td align="left" valign="top">Gm2011</td><td align="char" char="." valign="top">–3.4732831</td><td align="char" char="." valign="top">0.00005</td><td align="left" valign="top">Cluster 1</td></tr><tr><td align="left" valign="top">H2-T3</td><td align="char" char="." valign="top">–2.0828371</td><td align="char" char="." valign="top">0.00935</td><td align="left" valign="top">Cluster 1</td></tr><tr><td align="left" valign="top">Wnt2b</td><td align="char" char="." valign="top">–3.5079301</td><td align="char" char="." valign="top">0.0004</td><td align="left" valign="top">Cluster 1</td></tr><tr><td align="left" valign="top">Clec12a</td><td align="char" char="." valign="top">–3.0562022</td><td align="char" char="." valign="top">0.00895</td><td align="left" valign="top">Cluster 1</td></tr><tr><td align="left" valign="top">Mmp17</td><td align="char" char="." valign="top">–4.1251312</td><td align="char" char="." valign="top">0.00005</td><td align="left" valign="top">Cluster 1</td></tr><tr><td align="left" valign="top">Ncaph</td><td align="char" char="." valign="top">–4.1603359</td><td align="char" char="." valign="top">0.0417</td><td align="left" valign="top">Cluster 1</td></tr><tr><td align="left" valign="top">Kcnj10</td><td align="char" char="." valign="top">–4.2878368</td><td align="char" char="." valign="top">0.00005</td><td align="left" valign="top">Cluster 1</td></tr><tr><td align="left" valign="top">Cd163</td><td align="char" char="." valign="top">–4.2866184</td><td align="char" char="." valign="top">0.0001</td><td align="left" valign="top">Cluster 1</td></tr><tr><td align="left" valign="top">Il11</td><td align="char" char="." valign="top">–5.666901</td><td align="char" char="." valign="top">0.0001</td><td align="left" valign="top">Cluster 1</td></tr><tr><td align="left" valign="top">Syk</td><td align="char" char="." valign="top">4.80557812</td><td align="char" char="." valign="top">0.0603</td><td align="left" valign="top">Cluster 2</td></tr><tr><td align="char" char="." valign="top">9030619P08Rik</td><td align="char" char="." valign="top">2.73623094</td><td align="char" char="." valign="top">0.0353</td><td align="left" valign="top">Cluster 2</td></tr><tr><td align="left" valign="top">Prss16</td><td align="char" char="." valign="top">2.57604894</td><td align="char" char="." valign="top">0.00005</td><td align="left" valign="top">Cluster 2</td></tr><tr><td align="left" valign="top">Tcf4</td><td align="char" char="." valign="top">2.52783097</td><td align="char" char="." valign="top">0.0069</td><td align="left" valign="top">Cluster 2</td></tr><tr><td align="left" valign="top">Itgad</td><td align="char" char="." valign="top">2.32061951</td><td align="char" char="." valign="top">0.00005</td><td align="left" valign="top">Cluster 2</td></tr><tr><td align="left" valign="top">Abcc3</td><td align="char" char="." valign="top">2.47441931</td><td align="char" char="." valign="top">0.0143</td><td align="left" valign="top">Cluster 2</td></tr><tr><td align="left" valign="top">Hfe</td><td align="char" char="." valign="top">1.91152093</td><td align="char" char="." valign="top">0.00065</td><td align="left" valign="top">Cluster 2</td></tr><tr><td align="left" valign="top">Fcgr3</td><td align="char" char="." valign="top">1.94948898</td><td align="char" char="." valign="top">0.00005</td><td align="left" valign="top">Cluster 2</td></tr><tr><td align="left" valign="top">Rab3il1</td><td align="char" char="." valign="top">2.00253853</td><td align="char" char="." valign="top">0.00255</td><td align="left" valign="top">Cluster 2</td></tr><tr><td align="left" valign="top">Lrp1</td><td align="char" char="." valign="top">2.06172226</td><td align="char" char="." valign="top">0.06585</td><td align="left" valign="top">Cluster 2</td></tr><tr><td align="left" valign="top">Cd5l</td><td align="char" char="." valign="top">1.6117422</td><td align="char" char="." valign="top">0.0645</td><td align="left" valign="top">Cluster 2</td></tr><tr><td align="left" valign="top">Mir2861</td><td align="char" char="." valign="top">1.93355795</td><td align="char" char="." valign="top">0.0162</td><td align="left" valign="top">Cluster 2</td></tr><tr><td align="left" valign="top">Il18</td><td align="char" char="." valign="top">1.64165162</td><td align="char" char="." valign="top">0.07875</td><td align="left" valign="top">Cluster 2</td></tr><tr><td align="left" valign="top">Mir155hg</td><td align="char" char="." valign="top">1.9632828</td><td align="char" char="." valign="top">0.0003</td><td align="left" valign="top">Cluster 2</td></tr><tr><td align="left" valign="top">Irf4</td><td align="char" char="." valign="top">1.83011207</td><td align="char" char="." valign="top">0.00085</td><td align="left" valign="top">Cluster 2</td></tr><tr><td align="left" valign="top">Cmklr1</td><td align="char" char="." valign="top">1.71253206</td><td align="char" char="." valign="top">0.00655</td><td align="left" valign="top">Cluster 2</td></tr><tr><td align="left" valign="top">Mt3</td><td align="char" char="." valign="top">1.61299839</td><td align="char" char="." valign="top">0.00005</td><td align="left" valign="top">Cluster 2</td></tr><tr><td align="left" valign="top">Cd163l1</td><td align="char" char="." valign="top">1.68200967</td><td align="char" char="." valign="top">0.0028</td><td align="left" valign="top">Cluster 2</td></tr><tr><td align="left" valign="top">Palm</td><td align="char" char="." valign="top">1.69858804</td><td align="char" char="." valign="top">0.0309</td><td align="left" valign="top">Cluster 2</td></tr><tr><td align="left" valign="top">Hmox1</td><td align="char" char="." valign="top">1.8719138</td><td align="char" char="." valign="top">0.0014</td><td align="left" valign="top">Cluster 2</td></tr><tr><td align="left" valign="top">Mertk</td><td align="char" char="." valign="top">1.69725108</td><td align="char" char="." valign="top">0.05425</td><td align="left" valign="top">Cluster 2</td></tr><tr><td align="left" valign="top">Esm1</td><td align="char" char="." valign="top">1.55538421</td><td align="char" char="." valign="top">0.08875</td><td align="left" valign="top">Cluster 2</td></tr><tr><td align="left" valign="top">Lrrc25</td><td align="char" char="." valign="top">1.53588266</td><td align="char" char="." valign="top">0.01125</td><td align="left" valign="top">Cluster 2</td></tr><tr><td align="left" valign="top">Lgmn</td><td align="char" char="." valign="top">1.53366352</td><td align="char" char="." valign="top">0.0421</td><td align="left" valign="top">Cluster 2</td></tr><tr><td align="left" valign="top">Mafb</td><td align="char" char="." valign="top">1.59909428</td><td align="char" char="." valign="top">0.00005</td><td align="left" valign="top">Cluster 2</td></tr><tr><td align="left" valign="top">Havcr2</td><td align="char" char="." valign="top">1.61859719</td><td align="char" char="." valign="top">0.00005</td><td align="left" valign="top">Cluster 2</td></tr><tr><td align="left" valign="top">Epb4.1l3</td><td align="char" char="." valign="top">1.64271249</td><td align="char" char="." valign="top">0.0257</td><td align="left" valign="top">Cluster 2</td></tr><tr><td align="left" valign="top">Siglece</td><td align="char" char="." valign="top">1.58382507</td><td align="char" char="." valign="top">0.0091</td><td align="left" valign="top">Cluster 2</td></tr><tr><td align="left" valign="top">Prr5</td><td align="char" char="." valign="top">–1.5418463</td><td align="char" char="." valign="top">0.05615</td><td align="left" valign="top">Cluster 2</td></tr><tr><td align="left" valign="top">Pla2g7</td><td align="char" char="." valign="top">–1.5675528</td><td align="char" char="." valign="top">0.00005</td><td align="left" valign="top">Cluster 2</td></tr><tr><td align="left" valign="top">Dusp14</td><td align="char" char="." valign="top">–1.6724627</td><td align="char" char="." valign="top">0.02015</td><td align="left" valign="top">Cluster 2</td></tr><tr><td align="left" valign="top">Tgm2</td><td align="char" char="." valign="top">–1.6678575</td><td align="char" char="." valign="top">0.04595</td><td align="left" valign="top">Cluster 2</td></tr><tr><td align="left" valign="top">Riiad1</td><td align="char" char="." valign="top">–1.5429946</td><td align="char" char="." valign="top">0.00005</td><td align="left" valign="top">Cluster 2</td></tr><tr><td align="left" valign="top">Lilrb4a</td><td align="char" char="." valign="top">–1.6883324</td><td align="char" char="." valign="top">0.00685</td><td align="left" valign="top">Cluster 2</td></tr><tr><td align="left" valign="top">Ninj2</td><td align="char" char="." valign="top">–1.5669531</td><td align="char" char="." valign="top">0.08315</td><td align="left" valign="top">Cluster 2</td></tr><tr><td align="left" valign="top">Cish</td><td align="char" char="." valign="top">–1.6443416</td><td align="char" char="." valign="top">0.0508</td><td align="left" valign="top">Cluster 2</td></tr><tr><td align="left" valign="top">Cenpe</td><td align="char" char="." valign="top">–1.8650444</td><td align="char" char="." valign="top">0.07995</td><td align="left" valign="top">Cluster 2</td></tr><tr><td align="left" valign="top">Cenpm</td><td align="char" char="." valign="top">–1.5922104</td><td align="char" char="." valign="top">0.00155</td><td align="left" valign="top">Cluster 2</td></tr><tr><td align="left" valign="top">Tpx2</td><td align="char" char="." valign="top">–1.5558403</td><td align="char" char="." valign="top">0.05695</td><td align="left" valign="top">Cluster 2</td></tr><tr><td align="left" valign="top">Oip5</td><td align="char" char="." valign="top">–1.7861225</td><td align="char" char="." valign="top">0.00005</td><td align="left" valign="top">Cluster 2</td></tr><tr><td align="left" valign="top">Cdca7</td><td align="char" char="." valign="top">–1.5875434</td><td align="char" char="." valign="top">0.04035</td><td align="left" valign="top">Cluster 2</td></tr><tr><td align="left" valign="top">Ckap2</td><td align="char" char="." valign="top">–1.6603956</td><td align="char" char="." valign="top">0.00425</td><td align="left" valign="top">Cluster 2</td></tr><tr><td align="left" valign="top">Ncapg</td><td align="char" char="." valign="top">–1.8932803</td><td align="char" char="." valign="top">0.019</td><td align="left" valign="top">Cluster 2</td></tr><tr><td align="left" valign="top">Ssc4d</td><td align="char" char="." valign="top">–1.9973193</td><td align="char" char="." valign="top">0.0063</td><td align="left" valign="top">Cluster 2</td></tr><tr><td align="left" valign="top">Stkld1</td><td align="char" char="." valign="top">–1.8746276</td><td align="char" char="." valign="top">0.04135</td><td align="left" valign="top">Cluster 2</td></tr><tr><td align="left" valign="top">Cdca8</td><td align="char" char="." valign="top">–1.6650517</td><td align="char" char="." valign="top">0.0087</td><td align="left" valign="top">Cluster 2</td></tr><tr><td align="left" valign="top">Cdc45</td><td align="char" char="." valign="top">–1.9715619</td><td align="char" char="." valign="top">0.00405</td><td align="left" valign="top">Cluster 2</td></tr><tr><td align="left" valign="top">Lrp11</td><td align="char" char="." valign="top">–1.9542283</td><td align="char" char="." valign="top">0.0003</td><td align="left" valign="top">Cluster 2</td></tr><tr><td align="left" valign="top">Mcm5</td><td align="char" char="." valign="top">–1.965633</td><td align="char" char="." valign="top">0.012</td><td align="left" valign="top">Cluster 2</td></tr><tr><td align="left" valign="top">Cks1b</td><td align="char" char="." valign="top">–2.0197826</td><td align="char" char="." valign="top">0.0137</td><td align="left" valign="top">Cluster 2</td></tr><tr><td align="left" valign="top">Apitd1</td><td align="char" char="." valign="top">–1.614175</td><td align="char" char="." valign="top">0.01045</td><td align="left" valign="top">Cluster 2</td></tr><tr><td align="left" valign="top">Spc24</td><td align="char" char="." valign="top">–2.1192151</td><td align="char" char="." valign="top">0.00145</td><td align="left" valign="top">Cluster 2</td></tr><tr><td align="left" valign="top">Serpine2</td><td align="char" char="." valign="top">–2.0231734</td><td align="char" char="." valign="top">0.00005</td><td align="left" valign="top">Cluster 2</td></tr><tr><td align="left" valign="top">Brip1</td><td align="char" char="." valign="top">–1.6461742</td><td align="char" char="." valign="top">0.092</td><td align="left" valign="top">Cluster 2</td></tr><tr><td align="left" valign="top">Pole</td><td align="char" char="." valign="top">–2.2240204</td><td align="char" char="." valign="top">0.0253</td><td align="left" valign="top">Cluster 2</td></tr><tr><td align="left" valign="top">Lig1</td><td align="char" char="." valign="top">–1.7583399</td><td align="char" char="." valign="top">0.0015</td><td align="left" valign="top">Cluster 2</td></tr><tr><td align="left" valign="top">Cenpn</td><td align="char" char="." valign="top">–1.7057202</td><td align="char" char="." valign="top">0.00005</td><td align="left" valign="top">Cluster 2</td></tr><tr><td align="left" valign="top">Gm19434</td><td align="char" char="." valign="top">–2.012432</td><td align="char" char="." valign="top">0.0005</td><td align="left" valign="top">Cluster 2</td></tr><tr><td align="left" valign="top">Carns1</td><td align="char" char="." valign="top">–2.0274411</td><td align="char" char="." valign="top">0.0205</td><td align="left" valign="top">Cluster 2</td></tr><tr><td align="left" valign="top">Mpp2</td><td align="char" char="." valign="top">–1.5418367</td><td align="char" char="." valign="top">0.00775</td><td align="left" valign="top">Cluster 2</td></tr><tr><td align="left" valign="top">Mustn1</td><td align="char" char="." valign="top">–2.061708</td><td align="char" char="." valign="top">0.0017</td><td align="left" valign="top">Cluster 2</td></tr><tr><td align="left" valign="top">Rn45s</td><td align="char" char="." valign="top">–2.10963</td><td align="char" char="." valign="top">0.07705</td><td align="left" valign="top">Cluster 2</td></tr><tr><td align="left" valign="top">Sema6b</td><td align="char" char="." valign="top">–2.2547383</td><td align="char" char="." valign="top">0.0119</td><td align="left" valign="top">Cluster 2</td></tr><tr><td align="left" valign="top">Cfp</td><td align="char" char="." valign="top">–2.0456935</td><td align="char" char="." valign="top">0.0001</td><td align="left" valign="top">Cluster 2</td></tr><tr><td align="left" valign="top">App</td><td align="char" char="." valign="top">–2.211262</td><td align="char" char="." valign="top">0.00935</td><td align="left" valign="top">Cluster 2</td></tr><tr><td align="left" valign="top">Car9</td><td align="char" char="." valign="top">–2.0062063</td><td align="char" char="." valign="top">0.02255</td><td align="left" valign="top">Cluster 2</td></tr><tr><td align="char" char="." valign="top">1700102P08Rik</td><td align="char" char="." valign="top">–2.4325509</td><td align="char" char="." valign="top">0.0268</td><td align="left" valign="top">Cluster 2</td></tr><tr><td align="left" valign="top">Snhg10</td><td align="char" char="." valign="top">–2.345361</td><td align="char" char="." valign="top">0.00015</td><td align="left" valign="top">Cluster 2</td></tr><tr><td align="left" valign="top">Lima1</td><td align="char" char="." valign="top">–2.3391753</td><td align="char" char="." valign="top">0.07585</td><td align="left" valign="top">Cluster 2</td></tr><tr><td align="left" valign="top">Selm</td><td align="char" char="." valign="top">–2.0294095</td><td align="char" char="." valign="top">0.00265</td><td align="left" valign="top">Cluster 2</td></tr><tr><td align="left" valign="top">Slc41a3</td><td align="char" char="." valign="top">–2.1887998</td><td align="char" char="." valign="top">0.0001</td><td align="left" valign="top">Cluster 2</td></tr><tr><td align="left" valign="top">Src</td><td align="char" char="." valign="top">–2.6392902</td><td align="char" char="." valign="top">0.00015</td><td align="left" valign="top">Cluster 2</td></tr><tr><td align="left" valign="top">Miat</td><td align="char" char="." valign="top">–2.5487856</td><td align="char" char="." valign="top">0.0109</td><td align="left" valign="top">Cluster 2</td></tr><tr><td align="left" valign="top">Cd79a</td><td align="char" char="." valign="top">–2.5900501</td><td align="char" char="." valign="top">0.00055</td><td align="left" valign="top">Cluster 2</td></tr><tr><td align="left" valign="top">Plxnb2</td><td align="char" char="." valign="top">–2.9874612</td><td align="char" char="." valign="top">0.00005</td><td align="left" valign="top">Cluster 2</td></tr><tr><td align="left" valign="top">Pla2g2d</td><td align="char" char="." valign="top">–1.529167</td><td align="char" char="." valign="top">0.0268</td><td align="left" valign="top">Cluster 2</td></tr><tr><td align="left" valign="top">Lyz2</td><td align="char" char="." valign="top">–2.9362402</td><td align="char" char="." valign="top">0.04775</td><td align="left" valign="top">Cluster 2</td></tr><tr><td align="left" valign="top">Cdk3-ps</td><td align="char" char="." valign="top">–3.0692156</td><td align="char" char="." valign="top">0.00265</td><td align="left" valign="top">Cluster 2</td></tr><tr><td align="left" valign="top">Mir6236</td><td align="char" char="." valign="top">–2.5029162</td><td align="char" char="." valign="top">0.0004</td><td align="left" valign="top">Cluster 2</td></tr><tr><td align="left" valign="top">Smagp</td><td align="char" char="." valign="top">–1.9662967</td><td align="char" char="." valign="top">0.00005</td><td align="left" valign="top">Cluster 2</td></tr><tr><td align="left" valign="top">AF251705</td><td align="char" char="." valign="top">–2.8636993</td><td align="char" char="." valign="top">0.0226</td><td align="left" valign="top">Cluster 2</td></tr><tr><td align="left" valign="top">Gfra2</td><td align="char" char="." valign="top">–2.8780666</td><td align="char" char="." valign="top">0.00005</td><td align="left" valign="top">Cluster 2</td></tr><tr><td align="left" valign="top">Tmem91</td><td align="char" char="." valign="top">–3.2171875</td><td align="char" char="." valign="top">0.00005</td><td align="left" valign="top">Cluster 2</td></tr><tr><td align="left" valign="top">Pld4</td><td align="char" char="." valign="top">–1.5079912</td><td align="char" char="." valign="top">0.02785</td><td align="left" valign="top">Cluster 2</td></tr><tr><td align="left" valign="top">Itgb5</td><td align="char" char="." valign="top">–1.6713455</td><td align="char" char="." valign="top">0.00225</td><td align="left" valign="top">Cluster 2</td></tr><tr><td align="left" valign="top">Treml4</td><td align="char" char="." valign="top">–3.2826024</td><td align="char" char="." valign="top">0.0001</td><td align="left" valign="top">Cluster 2</td></tr><tr><td align="left" valign="top">Cd14</td><td align="char" char="." valign="top">–2.7112347</td><td align="char" char="." valign="top">0.00005</td><td align="left" valign="top">Cluster 2</td></tr><tr><td align="left" valign="top">Marcks</td><td align="char" char="." valign="top">–3.1963602</td><td align="char" char="." valign="top">0.00005</td><td align="left" valign="top">Cluster 2</td></tr><tr><td align="left" valign="top">Cmbl</td><td align="char" char="." valign="top">–2.6693158</td><td align="char" char="." valign="top">0.00005</td><td align="left" valign="top">Cluster 2</td></tr><tr><td align="left" valign="top">Klra3</td><td align="char" char="." valign="top">–2.5417462</td><td align="char" char="." valign="top">0.03455</td><td align="left" valign="top">Cluster 2</td></tr><tr><td align="left" valign="top">Ctsh</td><td align="char" char="." valign="top">–3.5891694</td><td align="char" char="." valign="top">0.00565</td><td align="left" valign="top">Cluster 2</td></tr><tr><td align="left" valign="top">Klra8</td><td align="char" char="." valign="top">–3.3087585</td><td align="char" char="." valign="top">0.0001</td><td align="left" valign="top">Cluster 2</td></tr><tr><td align="left" valign="top">Cd81</td><td align="char" char="." valign="top">–3.3276415</td><td align="char" char="." valign="top">0.00005</td><td align="left" valign="top">Cluster 2</td></tr><tr><td align="left" valign="top">C1qb</td><td align="char" char="." valign="top">–3.7316146</td><td align="char" char="." valign="top">0.00005</td><td align="left" valign="top">Cluster 2</td></tr><tr><td align="left" valign="top">Aif1</td><td align="char" char="." valign="top">–3.2695906</td><td align="char" char="." valign="top">0.01525</td><td align="left" valign="top">Cluster 2</td></tr><tr><td align="left" valign="top">Bank1</td><td align="char" char="." valign="top">–3.0876517</td><td align="char" char="." valign="top">0.002</td><td align="left" valign="top">Cluster 2</td></tr><tr><td align="left" valign="top">C1qc</td><td align="char" char="." valign="top">–3.0727492</td><td align="char" char="." valign="top">0.0001</td><td align="left" valign="top">Cluster 2</td></tr><tr><td align="left" valign="top">Apoe</td><td align="char" char="." valign="top">–3.5282676</td><td align="char" char="." valign="top">0.00005</td><td align="left" valign="top">Cluster 2</td></tr><tr><td align="left" valign="top">Clec4a3</td><td align="char" char="." valign="top">–2.9215824</td><td align="char" char="." valign="top">0.00015</td><td align="left" valign="top">Cluster 2</td></tr><tr><td align="left" valign="top">Tgfbi</td><td align="char" char="." valign="top">–3.5641054</td><td align="char" char="." valign="top">0.00005</td><td align="left" valign="top">Cluster 2</td></tr><tr><td align="left" valign="top">Mrc1</td><td align="char" char="." valign="top">–3.6479097</td><td align="char" char="." valign="top">0.03025</td><td align="left" valign="top">Cluster 2</td></tr><tr><td align="left" valign="top">Sirpa</td><td align="char" char="." valign="top">–4.0829446</td><td align="char" char="." valign="top">0.00005</td><td align="left" valign="top">Cluster 2</td></tr><tr><td align="left" valign="top">Clec1b</td><td align="char" char="." valign="top">–1.7537681</td><td align="char" char="." valign="top">0.0004</td><td align="left" valign="top">Cluster 2</td></tr><tr><td align="left" valign="top">Klra14-ps</td><td align="char" char="." valign="top">–3.8984753</td><td align="char" char="." valign="top">0.00005</td><td align="left" valign="top">Cluster 2</td></tr><tr><td align="left" valign="top">Ccr3</td><td align="char" char="." valign="top">–2.5323907</td><td align="char" char="." valign="top">0.06515</td><td align="left" valign="top">Cluster 2</td></tr><tr><td align="left" valign="top">C1qa</td><td align="char" char="." valign="top">–3.5880749</td><td align="char" char="." valign="top">0.00005</td><td align="left" valign="top">Cluster 2</td></tr><tr><td align="left" valign="top">Vcam1</td><td align="char" char="." valign="top">–3.6726209</td><td align="char" char="." valign="top">0.0011</td><td align="left" valign="top">Cluster 2</td></tr><tr><td align="left" valign="top">Tbxas1</td><td align="char" char="." valign="top">–4.4023688</td><td align="char" char="." valign="top">0.00005</td><td align="left" valign="top">Cluster 2</td></tr><tr><td align="left" valign="top">Csf1r</td><td align="char" char="." valign="top">–4.0805398</td><td align="char" char="." valign="top">0.00005</td><td align="left" valign="top">Cluster 2</td></tr><tr><td align="left" valign="top">Fcna</td><td align="char" char="." valign="top">–3.3668046</td><td align="char" char="." valign="top">0.00005</td><td align="left" valign="top">Cluster 2</td></tr><tr><td align="left" valign="top">Adgre1</td><td align="char" char="." valign="top">–3.7926073</td><td align="char" char="." valign="top">0.00005</td><td align="left" valign="top">Cluster 2</td></tr><tr><td align="left" valign="top">Adamdec1</td><td align="char" char="." valign="top">–4.9789792</td><td align="char" char="." valign="top">0.00005</td><td align="left" valign="top">Cluster 2</td></tr><tr><td align="left" valign="top">Tnfrsf8</td><td align="char" char="." valign="top">–2.2700751</td><td align="char" char="." valign="top">0.0008</td><td align="left" valign="top">Cluster 2</td></tr><tr><td align="left" valign="top">Aldh2</td><td align="char" char="." valign="top">2.4260512</td><td align="char" char="." valign="top">0.00025</td><td align="left" valign="top">Cluster 3</td></tr><tr><td align="left" valign="top">Slc40a1</td><td align="char" char="." valign="top">2.40044187</td><td align="char" char="." valign="top">0.0057</td><td align="left" valign="top">Cluster 3</td></tr><tr><td align="left" valign="top">Zfp385a</td><td align="char" char="." valign="top">2.16534965</td><td align="char" char="." valign="top">0.06435</td><td align="left" valign="top">Cluster 3</td></tr><tr><td align="left" valign="top">Spag5</td><td align="char" char="." valign="top">1.88610893</td><td align="char" char="." valign="top">0.00005</td><td align="left" valign="top">Cluster 3</td></tr><tr><td align="left" valign="top">Nusap1</td><td align="char" char="." valign="top">1.84390075</td><td align="char" char="." valign="top">0.09965</td><td align="left" valign="top">Cluster 3</td></tr><tr><td align="left" valign="top">B9d1</td><td align="char" char="." valign="top">1.78604818</td><td align="char" char="." valign="top">0.0031</td><td align="left" valign="top">Cluster 3</td></tr><tr><td align="left" valign="top">Top2a</td><td align="char" char="." valign="top">1.74249558</td><td align="char" char="." valign="top">0.0044</td><td align="left" valign="top">Cluster 3</td></tr><tr><td align="left" valign="top">Alox5ap</td><td align="char" char="." valign="top">1.64982614</td><td align="char" char="." valign="top">0.09075</td><td align="left" valign="top">Cluster 3</td></tr><tr><td align="left" valign="top">Sgol2a</td><td align="char" char="." valign="top">1.61420186</td><td align="char" char="." valign="top">0.05365</td><td align="left" valign="top">Cluster 3</td></tr><tr><td align="left" valign="top">Cdk1</td><td align="char" char="." valign="top">1.59276453</td><td align="char" char="." valign="top">0.0489</td><td align="left" valign="top">Cluster 3</td></tr><tr><td align="left" valign="top">Pla2g4b</td><td align="char" char="." valign="top">1.58954405</td><td align="char" char="." valign="top">0.04465</td><td align="left" valign="top">Cluster 3</td></tr><tr><td align="left" valign="top">Fam174b</td><td align="char" char="." valign="top">1.54600394</td><td align="char" char="." valign="top">0.00895</td><td align="left" valign="top">Cluster 3</td></tr><tr><td align="left" valign="top">Spc25</td><td align="char" char="." valign="top">1.51665085</td><td align="char" char="." valign="top">0.0962</td><td align="left" valign="top">Cluster 3</td></tr><tr><td align="left" valign="top">Ppp1r13l</td><td align="char" char="." valign="top">–1.5091602</td><td align="char" char="." valign="top">0.0399</td><td align="left" valign="top">Cluster 3</td></tr><tr><td align="left" valign="top">Neto2</td><td align="char" char="." valign="top">–1.5160875</td><td align="char" char="." valign="top">0.0106</td><td align="left" valign="top">Cluster 3</td></tr><tr><td align="left" valign="top">Eif3j2</td><td align="char" char="." valign="top">–1.5188243</td><td align="char" char="." valign="top">0.03625</td><td align="left" valign="top">Cluster 3</td></tr><tr><td align="left" valign="top">Gm28042</td><td align="char" char="." valign="top">–1.5257346</td><td align="char" char="." valign="top">0.02945</td><td align="left" valign="top">Cluster 3</td></tr><tr><td align="left" valign="top">Gm4532</td><td align="char" char="." valign="top">–1.5651414</td><td align="char" char="." valign="top">0.05395</td><td align="left" valign="top">Cluster 3</td></tr><tr><td align="left" valign="top">Sowahc</td><td align="char" char="." valign="top">–1.5972355</td><td align="char" char="." valign="top">0.09105</td><td align="left" valign="top">Cluster 3</td></tr><tr><td align="left" valign="top">Tnfrsf21</td><td align="char" char="." valign="top">–1.6215854</td><td align="char" char="." valign="top">0.04005</td><td align="left" valign="top">Cluster 3</td></tr><tr><td align="left" valign="top">Gm3435</td><td align="char" char="." valign="top">–1.6321142</td><td align="char" char="." valign="top">0.01435</td><td align="left" valign="top">Cluster 3</td></tr><tr><td align="left" valign="top">Zfp112</td><td align="char" char="." valign="top">–1.6371301</td><td align="char" char="." valign="top">0.04985</td><td align="left" valign="top">Cluster 3</td></tr><tr><td align="left" valign="top">Nr1h3</td><td align="char" char="." valign="top">–1.6602966</td><td align="char" char="." valign="top">0.07725</td><td align="left" valign="top">Cluster 3</td></tr><tr><td align="char" char="." valign="top">2810468N07Rik</td><td align="char" char="." valign="top">–1.6797191</td><td align="char" char="." valign="top">0.0173</td><td align="left" valign="top">Cluster 3</td></tr><tr><td align="left" valign="top">Hck</td><td align="char" char="." valign="top">–1.6894024</td><td align="char" char="." valign="top">0.04875</td><td align="left" valign="top">Cluster 3</td></tr><tr><td align="left" valign="top">Pth1r</td><td align="char" char="." valign="top">–1.7203976</td><td align="char" char="." valign="top">0.06865</td><td align="left" valign="top">Cluster 3</td></tr><tr><td align="left" valign="top">Tagln3</td><td align="char" char="." valign="top">–1.7598763</td><td align="char" char="." valign="top">0.05825</td><td align="left" valign="top">Cluster 3</td></tr><tr><td align="left" valign="top">Hist1h4d</td><td align="char" char="." valign="top">–1.7606181</td><td align="char" char="." valign="top">0.0688</td><td align="left" valign="top">Cluster 3</td></tr><tr><td align="left" valign="top">Tubb3</td><td align="char" char="." valign="top">–1.803737</td><td align="char" char="." valign="top">0.00005</td><td align="left" valign="top">Cluster 3</td></tr><tr><td align="left" valign="top">Klre1</td><td align="char" char="." valign="top">–1.8122236</td><td align="char" char="." valign="top">0.02795</td><td align="left" valign="top">Cluster 3</td></tr><tr><td align="left" valign="top">Spi1</td><td align="char" char="." valign="top">–1.8248628</td><td align="char" char="." valign="top">0.0498</td><td align="left" valign="top">Cluster 3</td></tr><tr><td align="left" valign="top">Fcgr4</td><td align="char" char="." valign="top">–1.8961012</td><td align="char" char="." valign="top">0.01005</td><td align="left" valign="top">Cluster 3</td></tr><tr><td align="left" valign="top">Mrgpre</td><td align="char" char="." valign="top">–1.9259777</td><td align="char" char="." valign="top">0.00455</td><td align="left" valign="top">Cluster 3</td></tr><tr><td align="left" valign="top">Chrne</td><td align="char" char="." valign="top">–1.9429018</td><td align="char" char="." valign="top">0.03985</td><td align="left" valign="top">Cluster 3</td></tr><tr><td align="left" valign="top">Tctex1d2</td><td align="char" char="." valign="top">–1.9516374</td><td align="char" char="." valign="top">0.00005</td><td align="left" valign="top">Cluster 3</td></tr><tr><td align="left" valign="top">Sdc3</td><td align="char" char="." valign="top">–1.9572554</td><td align="char" char="." valign="top">0.0026</td><td align="left" valign="top">Cluster 3</td></tr><tr><td align="left" valign="top">Tlr7</td><td align="char" char="." valign="top">–1.9874423</td><td align="char" char="." valign="top">0.0019</td><td align="left" valign="top">Cluster 3</td></tr><tr><td align="left" valign="top">Slc11a1</td><td align="char" char="." valign="top">–2.0856253</td><td align="char" char="." valign="top">0.001</td><td align="left" valign="top">Cluster 3</td></tr><tr><td align="left" valign="top">Gzma</td><td align="char" char="." valign="top">–2.102273</td><td align="char" char="." valign="top">0.00005</td><td align="left" valign="top">Cluster 3</td></tr><tr><td align="left" valign="top">Cpsf4l</td><td align="char" char="." valign="top">–2.1529279</td><td align="char" char="." valign="top">0.0146</td><td align="left" valign="top">Cluster 3</td></tr><tr><td align="left" valign="top">Clec4a1</td><td align="char" char="." valign="top">–2.2106337</td><td align="char" char="." valign="top">0.0132</td><td align="left" valign="top">Cluster 3</td></tr><tr><td align="left" valign="top">Fcer1g</td><td align="char" char="." valign="top">–2.2631622</td><td align="char" char="." valign="top">0.0002</td><td align="left" valign="top">Cluster 3</td></tr><tr><td align="left" valign="top">Ncf2</td><td align="char" char="." valign="top">–2.2765987</td><td align="char" char="." valign="top">0.00205</td><td align="left" valign="top">Cluster 3</td></tr><tr><td align="left" valign="top">Slpi</td><td align="char" char="." valign="top">–2.2838533</td><td align="char" char="." valign="top">0.00005</td><td align="left" valign="top">Cluster 3</td></tr><tr><td align="left" valign="top">Cd244</td><td align="char" char="." valign="top">–2.4303599</td><td align="char" char="." valign="top">0.0011</td><td align="left" valign="top">Cluster 3</td></tr><tr><td align="left" valign="top">Ptgs1</td><td align="char" char="." valign="top">–2.5181601</td><td align="char" char="." valign="top">0.0003</td><td align="left" valign="top">Cluster 3</td></tr><tr><td align="left" valign="top">Cybb</td><td align="char" char="." valign="top">–2.7556258</td><td align="char" char="." valign="top">0.0001</td><td align="left" valign="top">Cluster 3</td></tr><tr><td align="left" valign="top">Matk</td><td align="char" char="." valign="top">–3.0595087</td><td align="char" char="." valign="top">0.00005</td><td align="left" valign="top">Cluster 3</td></tr><tr><td align="left" valign="top">Ifitm2</td><td align="char" char="." valign="top">–3.1387932</td><td align="char" char="." valign="top">0.01575</td><td align="left" valign="top">Cluster 3</td></tr><tr><td align="left" valign="top">Cdc20b</td><td align="char" char="." valign="top">–3.2338662</td><td align="char" char="." valign="top">0.00705</td><td align="left" valign="top">Cluster 3</td></tr><tr><td align="left" valign="top">Msc</td><td align="char" char="." valign="top">–3.4433671</td><td align="char" char="." valign="top">0.01</td><td align="left" valign="top">Cluster 3</td></tr><tr><td align="left" valign="top">Clec4n</td><td align="char" char="." valign="top">–3.4851723</td><td align="char" char="." valign="top">0.00015</td><td align="left" valign="top">Cluster 3</td></tr><tr><td align="left" valign="top">Rgl1</td><td align="char" char="." valign="top">–3.5597601</td><td align="char" char="." valign="top">0.0001</td><td align="left" valign="top">Cluster 3</td></tr><tr><td align="left" valign="top">Spic</td><td align="char" char="." valign="top">–3.6767727</td><td align="char" char="." valign="top">0.00005</td><td align="left" valign="top">Cluster 3</td></tr><tr><td align="left" valign="top">Hebp1</td><td align="char" char="." valign="top">–3.7616875</td><td align="char" char="." valign="top">0.00025</td><td align="left" valign="top">Cluster 3</td></tr><tr><td align="left" valign="top">Hist1h3e</td><td align="char" char="." valign="top">–4.1043962</td><td align="char" char="." valign="top">0.04245</td><td align="left" valign="top">Cluster 3</td></tr><tr><td align="left" valign="top">Lrg1</td><td align="char" char="." valign="top">–5.383073</td><td align="char" char="." valign="top">0.0033</td><td align="left" valign="top">Cluster 3</td></tr></tbody></table></table-wrap><p>To address how these transcriptional changes may be the result of an altered epigenetic landscape, chromatin accessibility was assessed in Sham and CLP P14 CD8 T cells by ATAC-sequencing at D31 post-surgery (<xref ref-type="fig" rid="fig5">Figure 5f</xref>). While 1646 peaks were differentially expressed, the changes observed were predominantly more peaks (more accessibility) in CLP hosts (<xref ref-type="fig" rid="fig5">Figure 5g</xref>). Of these the majority were either within a gene body or intergenic regions assigned to the nearest a transcription start site. Significant changes in gene expression were then compared with DCAPs to establish whether there was concordance between the gene changes observed and the accessibility of the chromatin. Indeed, there were genes whose chromatin accessibility and transcription is concordant. Importantly, these concordant genes identified potentially relevant changes in CD8 T cell function (<xref ref-type="fig" rid="fig5">Figure 5h and i</xref>). Among these <italic>P2r×7</italic>, <italic>Rad51</italic>, and <italic>Bub1b</italic> all have prior association with CD8 T cell survival, DNA damage repair, and cell cycling (<xref ref-type="bibr" rid="bib2">Baek et al., 2003</xref>; <xref ref-type="bibr" rid="bib4">Borges da Silva et al., 2018</xref>; <xref ref-type="bibr" rid="bib84">Yamamoto et al., 1996</xref>). Thus, the increase in the expression of these genes in CLP P14 CD8 T cells likely reflects the numerical recovery after sepsis and general shift toward T<sub>CM</sub>. Conversely, the increased expression of <italic>Cish</italic> and decreased expression of <italic>Itgad</italic>, which inhibit TCR functional avidity (<xref ref-type="bibr" rid="bib53">Palmer et al., 2015</xref>) and promote cell adhesion (<xref ref-type="bibr" rid="bib67">Siegers et al., 2017</xref>), respectively, demonstrate the function of surviving CD8 T cells may be compromised or altered. This is particularly interesting given that the TCR is itself fixed in these populations thus the variations are not attributable to changes in the composition of the TCR repertoire, a finding that would not be obvious in a polyclonal TCR population. To relate these findings back to the phenotypic differences observed previously, the chromatin accessibility within the <italic>Sell</italic> locus (which encodes CD62L) was compared between P14 CD8 T cells from Sham and CLP hosts (<xref ref-type="fig" rid="fig5">Figure 5i</xref>). Critically, there was increased accessibility in the CD62L locus of P14 CD8 T cells from CLP hosts, relative to Sham (indicated in the boxed regions). Thus, the increased accessibility at the <italic>Sell</italic> locus corresponds to increased transcription at that locus (<xref ref-type="fig" rid="fig5">Figure 5j</xref>) and a subsequent increase in the expression of CD62L (<xref ref-type="fig" rid="fig4">Figure 4</xref>). Importantly, the transcription of the additional phenotypic distinctions observed in <xref ref-type="fig" rid="fig3">Figure 3</xref> largely conformed wherein there was decreased expression of <italic>Cx3cr1</italic> and <italic>Klrg1</italic> (<xref ref-type="fig" rid="fig5">Figure 5j</xref>), though no change in expression was observed for other markers such <italic>Cxcr3</italic> and <italic>Il7r</italic>. Thus, sepsis leads to lasting changes in chromatin accessibility, some of which are concordant with gene expression. The resulting transcriptional changes are likely to reflect functional outcomes consistent with the composition of the memory CD8 T cell population.</p><p>To interrogate putative functional impairments, gene-set enrichment analysis (GSEA) was performed to compare Sham and CLP memory P14 CD8 T cells at D31 post-surgery. When evaluating the top five positively enriched KEGG pathways in CLP P14 CD8 T cells, there was an obvious trend toward cell cycling (<xref ref-type="fig" rid="fig6">Figure 6a</xref>). Specifically, the pathways included: KEGG_Ribosome, _DNA_Replication, _Nucleotide_Excision_Repair, _Proteasome, and _Cell_Cycle. In conjunction with the concordant gene analysis (<xref ref-type="fig" rid="fig5">Figure 5g</xref>), this information further supports the notion that the numerical recovery after sepsis alters the composition of memory CD8 T cells through proliferation. A critical example of this is the substantial enrichment of ribosomal proteins (<xref ref-type="fig" rid="fig6">Figure 6b and c</xref>), putatively necessary for increased translational output during proliferation. Conversely, several pathways were also negatively enriched in CLP P14 CD8 T cells (positively enriched in Sham), including: KEGG_Complement_And_Coagulation_Cascades, _Glycerophopholipid_Metabolism, _FC_Gamma_R_Mediated_Phagocytosis, _Cell_Adhesion_Molecules_CAMS, and _FC_Epsilon_RI_Signaling_Pathway (<xref ref-type="fig" rid="fig6">Figure 6d</xref>). The primary underlying connection between the first two and last two of these appears to be linked to integrin expression and cell adhesion, while the change in glycerophospholipid metabolism may suggest sepsis-induced metabolic alterations. Given that integrin expression was also identified among the concordant genes in <xref ref-type="fig" rid="fig5">Figure 5g</xref>, gene enrichment in KEGG_Cell_Adhesion_Molecules_CAMS was evaluated and reduced expression of additional integrins was observed (<xref ref-type="fig" rid="fig6">Figure 6e and f</xref>). Given the critical nature of integrins in TCR function, including TCR-dependent function and immunologic synapse formation, these data suggest that sepsis alters the intrinsic capacity of pre-existing memory CD8 T cells to recognize cognate antigen. Further, when we compared the transcriptional changes between Sham D31 and CLP D31 with the published data set KAECH_DAY15_EFF_VS_MEMORY_CD8_TCELL we observed that P14s from Sham hosts were biased toward effector CD8 T cells while the P14s from CLP hosts were biased toward memory CD8 T cells, mirroring the shift from effector to central CD8 T cell memory (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1</xref>). This reinforces our observation of sepsis accelerating the adoption of time-dependent changes in the composition of the memory CD8 T cell pool.</p><fig-group><fig id="fig6" position="float"><label>Figure 6.</label><caption><title>Gene set enrichment analysis (GSEA) reveals long-term sepsis-induced differences in molecular pathways of pre-existing memory CD8 T cells.</title><p>Top 5 KEGG pathways positively- (<bold>A</bold>) and negatively- (<bold>D</bold>) enriched in CLP hosts. Enrichment scores for Ribosomal- (<bold>B</bold>) and Adhesion- (<bold>E</bold>) associated genes. Red box indicates leading edge of enriched region; genes enriched in CLP - box to right, genes enriched in Sham – box to left. Gene expression heatmap of core enriched genes for Ribosomal (<bold>C</bold>) and Adhesion (<bold>F</bold>) associated genes.</p><p><supplementary-material id="fig6sdata1"><label>Figure 6—source data 1.</label><caption><title>Source data for <xref ref-type="fig" rid="fig6">Figure 6</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-70989-fig6-data1-v2.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-70989-fig6-v2.tif"/></fig><fig id="fig6s1" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 1.</label><caption><title>Gene set enrichment analysis (GSEA) reinforces that sepsis promotes a shift to T<sub>CM</sub> at transcriptional level.</title><p>The KAECH_DAY15_EFF_VS_MEMORY_CD8_TCELL was used for evaluation. KAECH_DAY15_EFF_VS_MEMORY_CD8_TCELL _UP represents genes enriched in effector CD8 T cells relative to memory CD8 T cells. KAECH_DAY15_EFF_VS_MEMORY_CD8_TCELL _DN represents genes enriched in memory CD8 T cells relative to efector CD8 T cells. Enrichment scores for KAECH_DAY15_EFF_VS_MEMORY_CD8_TCELL _UP- (<bold>A</bold>) and KAECH_DAY15_EFF_VS_MEMORY_CD8_TCELL _DN- (<bold>C</bold>) associated genes. Red box indicates leading edge of enriched region; genes enriched in CLP - box to right, genes enriched in Sham – box to left. Gene expression heatmap of core enriched genes for Ribosomal (<bold>B</bold>) and Adhesion (<bold>D</bold>) associated genes.</p><p><supplementary-material id="fig6s1sdata1"><label>Figure 6—figure supplement 1—source data 1.</label><caption><title>Source data for <xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1A-D</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-70989-fig6-figsupp1-data1-v2.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-70989-fig6-figsupp1-v2.tif"/></fig></fig-group></sec><sec id="s2-5"><title>Sepsis-induced changes in pre-existing memory CD8 T cell composition impact cell function and capacity to control infection</title><p>To address the putative functional alterations resulting from sepsis-induced changes in the memory CD8 T cell pool, the capacity of memory P14 CD8 T cells to undergo TCR-dependent adhesion and immunologic synapse formation &gt;30 days after either Sham or CLP surgery was assessed (<xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1a</xref>). Notably, impairment in adherence capacity was observed in P14 CD8 T cells from CLP hosts under limiting stimulation conditions (low αCD3 concentration; <xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1b, c</xref>); however, when stimulation was not limiting (high αCD3 concentration) Sham and CLP P14 CD8 T cells were equally capable of undergoing TCR-dependent adhesion. The TCR-induced signaling complex was then assessed via TIRF microscopy, under equivalent adherence conditions (high aCD3 concentration), to assess clustering of AKT, a surrogate of the TCR-induced signaling complex. Importantly, despite equal capability to adhere there remained a deficit in the ability to cluster AKT at the cell membrane following TCR stimulation (<xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1d, e</xref>). Thus, sepsis leads to lasting changes in TCR based function of pre-existing memory CD8 T cells.</p><p>To address how these changes in signaling capability may influence cytokine production Sham and CLP splenocytes were disparately CFSE labeled &gt;30 days post-surgery and then mixed for in vitro peptide stimulation (<xref ref-type="fig" rid="fig7">Figure 7a</xref>). Given that APCs from Sham and CLP hosts are shared in this scenario, discrepancies in function are not the result of differences in antigen display. Intriguingly, there was no deficiency in capacity to produce IFNγ, yet P14 CD8 T cells from CLP hosts actually had a higher capacity to produce IL-2 (<xref ref-type="fig" rid="fig7">Figure 7b–d</xref>). Importantly, similar results were observed after peptide (GP33) stimulation of the endogenous virus-specific memory CD8 T cell population (<xref ref-type="fig" rid="fig7s2">Figure 7—figure supplement 2</xref>). Indeed, this finding conforms precisely with the shift toward T<sub>CM</sub> in CLP hosts since T<sub>CM</sub> have greater capacity to produce IL-2 than T<sub>EM</sub>. These data also suggest that changes in the composition of pre-existing memory CD8 cells may dominantly impact the function of the population as a whole.</p><fig-group><fig id="fig7" position="float"><label>Figure 7.</label><caption><title>Sepsis leads to lasting changes in pre-existing memory CD8 T cell function and <italic>Listeria</italic> control.</title><p>(<bold>A</bold>) Experimental Design: Antigen-experienced P14 chimeric mice were generated by adoptive transfer of 5 × 10<sup>3</sup> naive Thy1.1<sup>+</sup> TCR-transgenic P14 CD8 T cells to Thy1.2<sup>+</sup> C57Bl/6 mice that were subsequently infected with LCMV-Arm. Mice underwent Sham or CLP surgery 30 days after infection. Splenocytes from Sham and CLP mice were isolated 30 days after surgery and disparately labeled with CFSE, mixed, and then placed in media alone (i.e. unstimulated) or stimulated GP<sub>33</sub> peptide. Representative profiles (<bold>B</bold>) and quantification of the frequency of IFNγ- (<bold>C</bold>) and IL-2- (<bold>D</bold>) producing P14s stimulated with either media control or GP<sub>33</sub>. Data are representative of two independent experiments with 5 mice per group. (<bold>E</bold>) Experimental Design: Antigen-experienced P14 chimeric mice were generated by adoptive transfer of 5 × 10<sup>3</sup> naive Thy1.1<sup>+</sup> TCR-transgenic P14 CD8 T cells to Thy1.2<sup>+</sup> C57Bl/6 mice that were subsequently infected with LCMV-Arm. Mice underwent Sham or CLP surgery 30 days after infection. Splenic P14 CD8 T cells were enriched from Sham and CLP mice 30 days after surgery and then transferred into naïve mice. Mice that received either Sham or CLP P14 CD8 T cells, or did not receive any cell transfer (i.e. naïve) were then infected with 10<sup>5</sup> CFU of <italic>Listeria monocytogenes</italic> expressing GP<sub>33</sub> (<italic>L.m</italic>.-GP<sub>33</sub>) 1 day later. CFU of <italic>L.m</italic>.-GP<sub>33</sub> per gram of liver (<bold>F</bold>) and spleen (<bold>G</bold>) was assessed 5 days after infection. Data are cumulative of two independent experiments with 5–9 mice per group. *=p &lt; 0.05. Error bars indicate standard error of the mean.</p><p><supplementary-material id="fig7sdata1"><label>Figure 7—source data 1.</label><caption><title>Source data for <xref ref-type="fig" rid="fig7">Figure 7C and D</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-70989-fig7-data1-v2.xlsx"/></supplementary-material></p><p><supplementary-material id="fig7sdata2"><label>Figure 7—source data 2.</label><caption><title>Source data for <xref ref-type="fig" rid="fig7">Figure 7F and G</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-70989-fig7-data2-v2.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-70989-fig7-v2.tif"/></fig><fig id="fig7s1" position="float" specific-use="child-fig"><label>Figure 7—figure supplement 1.</label><caption><title>Sepsis leads to lasting deficit in pre-existing memory CD8 T cell TCR-dependent adhesion and immunologic synapse formation.</title><p>(<bold>A</bold>) Experimental design: Antigen-experienced P14 chimeric mice were generated by adoptive transfer of 5 × 10<sup>3</sup> naive Thy1.1<sup>+</sup> TCR-transgenic P14 CD8 T cells to Thy1.2<sup>+</sup> C57Bl/6 mice that were subsequently infected with LCMV-Arm. Mice underwent Sham or CLP surgery 30 days after infection. Splenic P14 CD8 T cells were enriched 30 days after surgery and evaluated for TCR-dependent adherence or AKT clustering, as an indicator of immunologic synapse formation. (<bold>B</bold>) Representative images of P14 CD8 T cell adherence to αCD3 mAb-coated plates. (<bold>C</bold>) Quantification of Sham and CLP P14 CD8 T cell adherence to plates at indicated concentration of αCD3 mAb. LOD is defined by adherence to wells lacking αCD3 mAb. (<bold>D</bold>) Representative images of AKT staining by TIRF microscopy. (<bold>E</bold>) Mean AKT pixel intensity of adhered cells. Data are of a single experiment with (<bold>B, C</bold>) 3–4 mice per group or (<bold>C, D</bold>) 109–120 cells analyzed per group. *=p &lt; 0.05. Error bars indicate standard error of the mean.</p><p><supplementary-material id="fig7s1sdata1"><label>Figure 7—figure supplement 1—source data 1.</label><caption><title>Source data for <xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1c</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-70989-fig7-figsupp1-data1-v2.xlsx"/></supplementary-material></p><p><supplementary-material id="fig7s1sdata2"><label>Figure 7—figure supplement 1—source data 2.</label><caption><title>Source data for <xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1e</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-70989-fig7-figsupp1-data2-v2.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-70989-fig7-figsupp1-v2.tif"/></fig><fig id="fig7s2" position="float" specific-use="child-fig"><label>Figure 7—figure supplement 2.</label><caption><title>Sepsis leads to lasting changes in pre-existing polyclonal memory CD8 T cell function.</title><p>Antigen-experienced P14 chimeric mice were generated by adoptive transfer of 5 × 10<sup>3</sup> naive Thy1.1<sup>+</sup> TCR-transgenic P14 CD8 T cells to Thy1.2<sup>+</sup> C57Bl/6 mice that were subsequently infected with LCMV-Arm. Mice underwent Sham or CLP surgery 30 days after infection. Splenocytes from Sham and CLP mice were isolated 30 days after surgery and disparately labeled with CFSE, mixed, and then placed in media alone (i.e. unstimulated) or stimulated GP<sub>33</sub> peptide. Quantification of the frequency of IFNγ- (<bold>A</bold>) and IL-2- (<bold>B</bold>) producing P14s stimulated with either media control or GP<sub>33</sub>. Data are representative of two independent experiments with 5 mice per group.</p><p><supplementary-material id="fig7s2sdata1"><label>Figure 7—figure supplement 2—source data 1.</label><caption><title>Source data for <xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-70989-fig7-figsupp2-data1-v2.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-70989-fig7-figsupp2-v2.tif"/></fig></fig-group><p>With the relationship between the composition of the memory CD8 T cell pool and their capacity to promote effector function in mind, we next interrogated the ability of these memory CD8 T cells to control infection. Nolz et al. previously demonstrated that T<sub>EM</sub> more effectively control virulent <italic>Listeria monocytogenes</italic> (<italic>L.m</italic>.) infection compared to T<sub>CM</sub> (<xref ref-type="bibr" rid="bib51">Nolz and Harty, 2011</xref>), likely due to localization of cells in either non-lymphoid tissues (critically the liver) or lymphoid tissues, respectively. Therefore, to address whether the shift toward T<sub>CM</sub> in the CLP host impaired the subsequent capacity to control <italic>L.m</italic>., P14 CD8 T cells were enriched from either Sham or CLP hosts &gt; 30 days post-surgery then transferred to naïve recipients. Transfer of these cells into naive recipients alleviates potential environmental deficits imposed by sepsis and allows for direct assessment of the capacity of the memory CD8 T cells to control infection. Additionally, the use of naive recipients alleviates confounding variables such as bystander responses (<xref ref-type="bibr" rid="bib24">Ehl et al., 1997</xref>; <xref ref-type="bibr" rid="bib40">Lertmemongkolchai et al., 2001</xref>). One day after transfer, mice that received either no cell transfer, P14 CD8 T cells from Sham mice, or P14 CD8 T cells from CLP were challenged with virulent <italic>L.m</italic>. expressing GP<sub>33</sub>. <italic>L.m</italic>. challenge occurred 1 day after cell transfer to allow time for the cells to distribute and localize to their respective niches. GP<sub>33</sub> expression by <italic>L.m</italic>. enables the memory P14 CD8 T cells to mediate antigen-specific control. Colony-forming units (CFU) in both the liver and spleen were assessed 5 days post-infection (<xref ref-type="fig" rid="fig7">Figure 7e</xref>). Recipients that received memory P14 CD8 T cells from either Sham or CLP hosts more robustly controlled <italic>L.m</italic>. infection than the naive hosts that did not receive any memory CD8 T cells (<xref ref-type="fig" rid="fig7">Figure 7f and g</xref>). However, memory P14 CD8 T cells from Sham recipients were significantly better at controlling <italic>L.m</italic>. than those from CLP recipients; 77- and 20-fold differences control in the liver and spleen, respectively (<xref ref-type="fig" rid="fig7">Figure 7f and g</xref>). This improved control by memory P14 CD8 T cells from Sham hosts demonstrates the higher capacity of T<sub>EM</sub> to control <italic>L.m</italic>. infection. Thus, our data cumulatively demonstrate how sepsis-induced changes in the composition of the pre-existing memory CD8 T cells alters the functional capability of the memory CD8 T cell population as a whole, thereby altering the host response to infection.</p></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>In the present study, we demonstrate that sepsis leads to a lasting change in the composition of the memory CD8 T cell compartment in the sepsis survivors. This occurs as a result of proliferation in the lymphopenic environment that occurs after sepsis, seen in both patients and mice, wherein T<sub>CM</sub> have higher proliferative capacity than T<sub>EM</sub>. This biasing toward T<sub>CM</sub> alters the localization of memory CD8 T cells. Further, the memory CD8 T cell pool has an altered transcriptional landscape and chromatin accessibility, which is associated both with the transition toward T<sub>CM</sub> and functional alterations. The culmination of these sepsis-induced changes alters the function of the memory CD8 T cells and reduces their capacity to control virulent <italic>L.m</italic>. infection.</p><p>There are several important implications of the present study, and the biasing toward T<sub>CM</sub>, that are relevant to our understanding of the immunoparalysis state. Among these is the relationship to tissue resident memory CD8 T cells (T<sub>RM</sub>), which provide sensing and alarm function at sites of prior infection (<xref ref-type="bibr" rid="bib48">Masopust et al., 2001</xref>; <xref ref-type="bibr" rid="bib63">Schenkel et al., 2013</xref>). The present study focuses on the influence of sepsis on circulating T<sub>EM</sub> and T<sub>CM</sub> CD8 T cells; however, the substantial population of T<sub>RM</sub> throughout the body may be an interesting source of future interrogation. Danahy et al. previously demonstrated that T<sub>RM</sub> were not susceptible to sepsis-induced lymphopenia, due to their exclusion from the vasculature (<xref ref-type="bibr" rid="bib16">Danahy et al., 2017</xref>). In the present study, recovery in cellularity was observed with time after sepsis, but the biasing toward T<sub>CM</sub> may pose a particular problem for T<sub>RM</sub>. Specifically, Slütter et al. demonstrated that lung T<sub>RM</sub> are seeded from circulating T<sub>EM</sub> (<xref ref-type="bibr" rid="bib72">Slütter et al., 2017</xref>). Thus, the challenge to the T<sub>RM</sub> may be twofold: (1) the reduced seeding of cells during the lymphopenic state and (2) reduced T<sub>EM</sub> pool from which to seed the T<sub>RM</sub>. This reduction may culminate in a more rapid waning of lung T<sub>RM</sub> and reinforce susceptibility to previously encountered infections. Moreover, the detrimental effects of sepsis on memory CD8 T cells may also be relevant to other major inflammatory events and poorly controlled infections (e.g. SARS-CoV-2) and should be considerations in the long-term consequences for similarly impacted individuals (<xref ref-type="bibr" rid="bib41">Li et al., 2020</xref>; <xref ref-type="bibr" rid="bib61">Sariol and Perlman, 2020</xref>).</p><p>While the immunoparalysis state is often viewed directly through the lens of the detriments that may arise, it is also relevant to consider other means by which the host immune response may be shaped. The loss of T<sub>EM</sub> here demonstrates their critical role in fighting some infections (i.e. <italic>L.m</italic>.) (<xref ref-type="bibr" rid="bib51">Nolz and Harty, 2011</xref>); however, T<sub>CM</sub> are also a potent population that can critically mediate control in other infection scenarios. Thus, infections for which T<sub>CM</sub> can provide critical control may be unimpaired or even enhanced in the post-septic environment. This is potentially complicated by intrinsic deficits that may be present in the memory cells, as observed in our GSEA analysis and by CD8 T cell extrinsic impairments. Therefore, future studies should consider additional interrogation of mechanisms by which the immune system is altered beyond detrimental aspects. Additionally, while our interrogation focused on a shift of pre-existing memory CD8 T cells toward a central memory phenotype, it remains possible that other T cell populations (e.g. different antigen specificities) may bias toward effector memory. This may be particularly relevant to memory T cell populations whose TCR has some low degree of cross reactivity with antigens present on microbes released during the septic event. These considerations may be important for future therapeutic interrogation in the specific targeting of the appropriate deficits.</p><p>Additionally, it is relevant to consider that proliferation, as demarcated by Ki67, was also observed in naïve CD8 T cells of septic patients. While not the focus of the present study this is also observed in our mouse model. The proliferation by naïve CD8 T cells in septic hosts suggests that CD8 T cells are proliferating in response to the lymphopenic environment. Indeed, naive cells undergo antigen-independent proliferation in other lymphopenic environments, such <italic>as Rag</italic><sup>-/-</sup> or irradiated hosts, wherein they adopt conventional markers of antigen experience along with some effector functionality (<xref ref-type="bibr" rid="bib12">Cheung et al., 2009</xref>; <xref ref-type="bibr" rid="bib55">Pribikova et al., 2018</xref>; <xref ref-type="bibr" rid="bib77">Unsinger et al., 2009</xref>; <xref ref-type="bibr" rid="bib82">White et al., 2017</xref>). Thus, it may be relevant to consider how the proliferation of these cells also alter the composition of the memory CD8 T cell compartment and shapes host response to subsequent infection for which they may be specific.</p><p>Our novel characterization of how numeric recovery in the lymphopenic environment alters the composition of the memory CD8 T cell compartment demonstrates how sepsis can lead to lasting changes in host immunity. However, the implications of these changes may extend beyond the enhanced susceptibility to infection described here to potentially reframe our understanding of the immunoparalysis state. Future interrogation of these lasting effects will likely be required to best address the deficits that arise in the immunoparalysis state. Further understanding how sepsis shapes both naive and memory T cells may also alternately produce therapeutic interventions to benefit other diseases. One such example may be in the promotion of T<sub>CM</sub> over T<sub>EM</sub>, or vice versa, for specific vaccination strategies. Such outcomes and lines of investigation would be highly instructive for understanding how prior immune history shapes subsequent host immune responses.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><table-wrap id="keyresource" position="anchor"><label>Key resources table</label><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Reagent type (species) or resource</th><th align="left" valign="bottom">Designation</th><th align="left" valign="bottom">Source or reference</th><th align="left" valign="bottom">Identifiers</th><th align="left" valign="bottom">Additional information</th></tr></thead><tbody><tr><td align="left" valign="bottom">Strain, strain background (<italic>Mus musculus</italic>)</td><td align="left" valign="bottom">C57BL6/J</td><td align="left" valign="bottom">Jackson Laboratory</td><td align="left" valign="bottom">Stock No: 000664(RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:IMSR_JAX:000664">IMSR_JAX:000664</ext-link>)</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>Mus musculus</italic>)</td><td align="left" valign="bottom">B6.PL(84NS)/Cy</td><td align="left" valign="bottom">Jackson Laboratory</td><td align="left" valign="bottom">Stock No: 000983(RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:IMSR_JAX:000406">IMSR_JAX:000406</ext-link>)</td><td align="left" valign="bottom">C57BL6/JThy1.1</td></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>Mus musculus</italic>)</td><td align="left" valign="bottom">B6.Cg-Tcratm1Mom Tg(TcrLCMV)327Sdz(P14)</td><td align="left" valign="bottom">Jackson Laboratory</td><td align="left" valign="bottom">Stock No: 37394-JAX(RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:IMSR_TAC:4138">IMSR_TAC:4138</ext-link>)</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>Mus musculus</italic>)</td><td align="left" valign="bottom">Thy1.1/1.1- B6.Cg-Tcratm1Mom Tg(TcrLCMV)327Sdz</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">Thy1.1/1.1 P14</td><td align="left" valign="bottom">Can be acquired <break/>through lab <break/>contact or <break/>breeding of <break/>above commercially <break/>available strains</td></tr><tr><td align="left" valign="bottom">Strain, strain background (Lymphocytic choriomeningitis virus)</td><td align="left" valign="bottom">Lymphocytic choriomeningitis virus Armstrong strain(LCMV-Arm)</td><td align="left" valign="bottom">Armstrong, C. and Lillie, R.D. Experimental lymphocytic choriomeningitis of monkeys and mice produced by a virus encountered in studies of the 1933 St Louis encephalitis epidemic. <italic>Public Health Reports</italic> 49, 1019–1027 (1934)</td><td align="left" valign="bottom">LCMV-Arm</td><td align="left" valign="bottom">Can be acquired through lab contact.</td></tr><tr><td align="left" valign="bottom">Strain, strain background (virulent Listeria monocytogenes)</td><td align="left" valign="bottom">Virulent recombinant <italic>Listeria monocytogenes</italic> expressing GP33-41(XFL203 <italic>L.m</italic>.-GP33)</td><td align="left" valign="bottom">Shen et al. Recombinant Listeria monocytogenes as a live vaccine vehicle for the induction of protective anti-viral cell-mediated immunity. <italic>PNAS</italic> 92(9) 3987–3991 (1995)</td><td align="left" valign="bottom"><italic>L.m</italic>.-GP33</td><td align="left" valign="bottom">Can be acquired through lab contact.</td></tr><tr><td align="left" valign="bottom">Peptide, recombinant protein</td><td align="left" valign="bottom">GP33-44</td><td align="left" valign="bottom">AnaSpec</td><td align="left" valign="bottom">Catalog #:AS-61296</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">CD8a(Rat monoclonal)</td><td align="left" valign="bottom">Biolegend</td><td align="left" valign="bottom">5H10-1(RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_312762">AB_312762</ext-link>)</td><td align="left" valign="bottom">FACs(1:400)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">CD11a(Rat monoclonal)</td><td align="left" valign="bottom">Biolegend</td><td align="left" valign="bottom">M17/4(RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_312776">AB_312776</ext-link>)</td><td align="left" valign="bottom">FACs(1:300)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Thy1.1(Mouse monoclonal)</td><td align="left" valign="bottom">eBioscience</td><td align="left" valign="bottom">HIS51(RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_1257173">AB_1257173</ext-link>)</td><td align="left" valign="bottom">FACs(1:1000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">KLRG1(Mouse monoclonal)</td><td align="left" valign="bottom">eBioscience</td><td align="left" valign="bottom">2F1(RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_540279">AB_540279</ext-link>)</td><td align="left" valign="bottom">FACs(1:100)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">CD127(Rat monoclonal)</td><td align="left" valign="bottom">eBioscience</td><td align="left" valign="bottom">eBioSB/199</td><td align="left" valign="bottom">FACs(1:100)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">CD62L(Rat monoclonal)</td><td align="left" valign="bottom">Biolegend</td><td align="left" valign="bottom">MEL-14(RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_1853103">AB_1853103</ext-link>)</td><td align="left" valign="bottom">FACs(1:100)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">CX3CR1(Mouse monoclonal)</td><td align="left" valign="bottom">eBioscience</td><td align="left" valign="bottom">SA011F11(RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2565701">AB_2565701</ext-link>)</td><td align="left" valign="bottom">FACs(1:100)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">CXCR3(Armenian Hamster monoclonal)</td><td align="left" valign="bottom">eBioscience</td><td align="left" valign="bottom">CXCR3-173(RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_1210593">AB_1210593</ext-link>)</td><td align="left" valign="bottom">FACs(1:100)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">CD27(Armenian Hamster monoclonal)</td><td align="left" valign="bottom">eBioscience</td><td align="left" valign="bottom">LG.7F9</td><td align="left" valign="bottom">FACs(1:100)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">CD69(Hamster monoclonal)</td><td align="left" valign="bottom">Biolegend</td><td align="left" valign="bottom">H1.2F3(RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_1853105">AB_1853105</ext-link>)</td><td align="left" valign="bottom">FACs(1:100)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">CD103(Hamster monoclonal)</td><td align="left" valign="bottom">Biolegend</td><td align="left" valign="bottom">2E7(RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_469040">AB_469040</ext-link>)</td><td align="left" valign="bottom">FACs(1:100)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">CD25(Mouse monoclonal)</td><td align="left" valign="bottom">Biolegend</td><td align="left" valign="bottom">PC61.5</td><td align="left" valign="bottom">FACs(1:100)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">CD122(Rat monoclonal)</td><td align="left" valign="bottom">Biolegend</td><td align="left" valign="bottom">TM-b1</td><td align="left" valign="bottom">FACs(1:100)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">IFNγ(Rat monoclonal)</td><td align="left" valign="bottom">eBioscience</td><td align="left" valign="bottom">XMG1.2(RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_465410">AB_465410</ext-link>)</td><td align="left" valign="bottom">FACs(1:100)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">IL-2(Rat monoclonal)</td><td align="left" valign="bottom">Biolegend</td><td align="left" valign="bottom">JES6-5H4(RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_315298">AB_315298</ext-link>)</td><td align="left" valign="bottom">FACs(1:100)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Ki67(Mouse monoclonal)</td><td align="left" valign="bottom">BD Pharmingen</td><td align="left" valign="bottom">B56(RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2858243">AB_2858243</ext-link>)</td><td align="left" valign="bottom">FACs(1:100)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">BrdU(Mouse monoclonal)</td><td align="left" valign="bottom">Biolegend</td><td align="left" valign="bottom">Bu20a(RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_1595472">AB_1595472</ext-link>)</td><td align="left" valign="bottom">FACs(1:100)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">CD45RA(Mouse monoclonal)</td><td align="left" valign="bottom">Tonbo</td><td align="left" valign="bottom">HI100</td><td align="left" valign="bottom">FACs(1:100)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">CD45RO(Mouse monoclonal)</td><td align="left" valign="bottom">Tonbo</td><td align="left" valign="bottom">UCHL1</td><td align="left" valign="bottom">FACs(1:100)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">CD3(Mouse monoclonal)</td><td align="left" valign="bottom">Biolegend</td><td align="left" valign="bottom">HIT3a</td><td align="left" valign="bottom">FACs(1:100)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">CD8a(Mouse monoclonal)</td><td align="left" valign="bottom">Biolegend</td><td align="left" valign="bottom">HIT8a</td><td align="left" valign="bottom">FACs(1:100)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">CCR7(Mouse monoclonal)</td><td align="left" valign="bottom">Biolegend</td><td align="left" valign="bottom">G043H7</td><td align="left" valign="bottom">FACs(1:100)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">CD3(Mouse monoclonal)</td><td align="left" valign="bottom">Biolegend</td><td align="left" valign="bottom">OKT3</td><td align="left" valign="bottom">Plate coating(0–10 μg)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">CD8a(Rat monoclonal)</td><td align="left" valign="bottom">Biolegend</td><td align="char" char="ndash" valign="bottom">53–6.7</td><td align="left" valign="bottom">FACs(1:100)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">AKT(rabbit monoclonal)</td><td align="left" valign="bottom">Cell Signaling Technology</td><td align="char" char="." valign="bottom">11E7</td><td align="left" valign="bottom">TIRF microscopy(1:20)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-rabbit IgG(donkey monoclonal)</td><td align="left" valign="bottom">Biolegend</td><td align="left" valign="bottom">Poly4064</td><td align="left" valign="bottom">TIRF microscopy(1:100)</td></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">Foxp3/ Transcription Factor Staining Buffer Set</td><td align="left" valign="bottom">Invitrogen</td><td align="char" char="hyphen" valign="bottom">00-5523-00</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">GraphPad Prism</td><td align="left" valign="bottom">GraphPad Prism 8</td><td align="left" valign="bottom">Version 8.4.2 (464)(RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_002798">SCR_002798</ext-link>)</td><td align="left" valign="bottom"/></tr></tbody></table></table-wrap><sec id="s4-1"><title>Mice</title><p>Inbred C57Bl/6 (B6, Thy1.2) and TCR-transgenic (TCR-Tg) P14 (Thy1.1) mice were purchased from the National Cancer Institute (Frederick, MD) and maintained in the animal facilities at the University of Iowa at the appropriate biosafety level according to the University of Iowa Animal Care and Use Committee and National Institutes of Health guidelines. Male and female mice &gt; 6 weeks of age were used for experiments; no discernable differences were observed based on sex of the animals.</p></sec><sec id="s4-2"><title>Generation of antigen-experienced CD8 T cells; P14 chimeras</title><p>To generate antigen-experienced CD8 T cells 5 × 10<sup>3</sup> naïve P14 TCR-Tg CD8 T cells were adoptively transferred into recipient mice, followed a day later by infection with 10<sup>5</sup> plaque forming units (PFU) of Lymphocytic Choriomeningitis Virus-Armstrong (LCMV-Arm) by intraperitoneal (i.p.) injection.</p></sec><sec id="s4-3"><title>Institutional setting and IRB approval</title><p>Patients were recruited at the University of Iowa Hospitals and Clinics, an 811-bed academic tertiary care center. Blood sample acquisition, patient data collection, and analysis were approved by the University of Iowa Institutional Review Board (ID #201804822). Informed consent was obtained from patients or their legally authorized representatives.</p></sec><sec id="s4-4"><title>Sepsis patient selection and data collection</title><p>Subjects 18 years of age or older meeting Sepsis-3 criteria for sepsis or septic shock (<xref ref-type="bibr" rid="bib68">Singer et al., 2016</xref>) secondary to intra-abdominal infection, soft tissue infection, bloodstream infection, or pneumonia were enrolled. Exclusion criteria were infection requiring antibiotics in the past month, hospitalization for infection in the past year, and chemotherapy or radiation within the past year were excluded. Demographics and baseline characteristics including age, gender, race, APACHE II score, SOFA score, and presence of septic shock were collected. EDTA-treated blood samples were collected within 24 hr of presentation.</p></sec><sec id="s4-5"><title>Healthy control patient selection and data collection</title><p>Healthy volunteers 25–80 years of age were recruited from University of Iowa faculty, staff, and graduate/professional students. Exclusion criteria were signs or symptoms of active infections, infection requiring antibiotics within the past month, infection requiring hospitalization in the past year, and chemotherapy or radiation in the past year. Demographic data including age, gender, and race were collected. EDTA-treated blood samples were collected at an initial visit to our research clinic.</p></sec><sec id="s4-6"><title>Human cell isolation and cryopreservation</title><p>Human cell isolation was adjusted from the previously described methodology (<xref ref-type="bibr" rid="bib39">Lauer et al., 2017</xref>). Briefly, whole blood was centrifuged, and plasma removed. ACK red blood cell lysis buffer was then added to the cell pellet and rested for 5 min at room temperature. Cells were again centrifuged, and supernatant was removed. Lysis and centrifugation was repeated one to two additional times. Cells were then washed with PBS three times before being counted and resuspended in cell freeze media (90%FCS [Hyclone] 10%DMSO [Fischer Scientific]). Cells were then stored at –80 °C until use. When used in vitro, PBL were rapidly thawed and placed into warmed complete media. Cells were then washed three times with warmed media and aggregates filtered prior to use.</p></sec><sec id="s4-7"><title>Cell isolation</title><p>Peripheral blood was collected by submandibular cheek bleeds to obtain PBL. Single-cell suspensions from spleen, liver, and lymph nodes were generated after mashing tissue through a 70 μm cell strainer without enzymatic digestion. Liver cells were subsequently run on a 35 % Percoll gradient. ACK lysis buffer was used for red blood cell lysis of PBL, spleen, and liver samples.</p></sec><sec id="s4-8"><title>Flow cytometry, peptides, and cytokine detection</title><p>Flow cytometry data were acquired on a FACSCanto or LSRII (BD Biosciences, San Diego, CA) and analyzed with FlowJo software (Tree Star, Ashland, OR). FlowJo Software was also used for FlowSOM and tSNE analysis. To determine expression of cell surface proteins, mAb were incubated at 4 °C for 20–30 min and cells were fixed using Cytofix/Cytoperm Solution (BD Biosciences) and, in some instances, followed by incubation with mAb for an additional 20–30 min to detect intracellular proteins. The following mAb clones were used to stain murine samples: CD8a (53–6.7; eBioscience), CD11a (M17/4; Biolegend), Thy1.1 (HIS51; eBioscience), KLRG1 (2F1; Biolegend), CD127 (eBioSB/199; eBioscience), CD62L (MEL-14; eBioscience), CX3CR1 (SA011F11; Biolegend), CXCR3 (CXCR3-173; Biolegend), CD27 (LG.7F9; eBioscience), CD69 (H1.2F3; Biolegend), CD103 (2E7; eBioscience), CD25 (PC61.5; eBioscience), CD122 (TM-b1; eBioscience), IFNγ (XMG1.2; eBioscience), IL-2 (JES6-5H4; eBioscience), Ki67 (B56; eBioscience) and BrdU (Bu20a; eBioscience). The following mAb clones were used staining of patient samples: CD45RA (HI100; Tonbo), CD45RO (UCHL1; Tonbo), CD3 (HIT3a; Biolegend), CD8a (HIT8a; Biolegend), and CCR7 (G043H7; Biolegend). Overnight fixation with FoxP3 fixation/permeabilization (eBioscience) buffer was used to stain Ki67 and BrdU. For BrdU staining, following fixation/ permeabilization cells were treated with DNAse I for 1 hr at 37 °C, then stained for intracellular BrdU.</p></sec><sec id="s4-9"><title>Cecal ligation and puncture (CLP) model of sepsis induction</title><p>Mice were anesthetized with ketamine/xylazine (University of Iowa, Office of Animal Resources), the abdomen was shaved and disinfected with Betadine (Purdue Products), and a midline incision was made (<xref ref-type="bibr" rid="bib70">Sjaastad et al., 2020a</xref>). The distal third of the cecum was ligated with Perma-Hand Silk (Ethicon), punctured once (for CLP<sub>20</sub>) or twice (for CLP<sub>50</sub>) using a 25-gauge needle, and a small amount of fecal matter extruded out of each puncture. The cecum was then returned to abdomen, the peritoneum was closed with 641 G Perma-Hand Silk (Ethicon), and skin sealed using surgical Vetbond (3 M). Following surgery, 1 mL PBS was administered s.c. to provide post-surgery fluid resuscitation. Bupivacaine (Hospira) was administered at the incision site, and flunixin meglumine (Phoenix) was administered for postoperative analgesia. Sham mice underwent identical surgery excluding cecal ligation and puncture.</p></sec><sec id="s4-10"><title>Normalized assessment of lymphopenia (<xref ref-type="fig" rid="fig2">Figure 2C</xref>)</title><p>Due to large differences in the number of naïve to antigen-experienced endogenous cells to antigen-experienced P14 CD8 T cells in order to compare the relative degree of lymphopenia the data for each population was normalized. Data are normalized as: % survival = (1-((# of [Naive, Endo, or P14] CD8 T cells in the PBL of the same mouse prior to surgery) - (# of [Naive, Endo, or P14] CD8 T cells in the PBL of a mouse at D2 post-surgery)) / (# of [Naive, Endo, or P14] CD8 T cells in the PBL of the same mouse prior to surgery)) * 100.</p></sec><sec id="s4-11"><title>BrdU administration</title><p>BrdU was administered by a single i.p. injection (2 mg/mouse) followed by ad libitum consumption in the drinking water (0.8 mg/mL) for 7 days.</p></sec><sec id="s4-12"><title>RNA-seq and gene set enrichment analysis</title><p>Total RNA was extracted from P14 (Thy1.1<sup>+</sup>CD8a<sup>lo</sup>CD11a<sup>hi</sup>) CD8 T cells sorted 1 day post-Sham or CLP and 31 days post-Sham or CLP, 2–3 biological replicates were obtained for each group. Libraries were sequenced on Illumina’s HiSeq2000 in single-end mode with the read length of 50 nucleotides. The RNA-seq data are deposited at the GEO (GSE174358) under the SuperSeries of GSE174359. RNA-seq was performed as previously described (<xref ref-type="bibr" rid="bib65">Shan et al., 2017</xref>). The sequencing quality of RNA-seq libraries was assessed by FastQC v0.11.4 (<ext-link ext-link-type="uri" xlink:href="http://www.bioinformatics.babraham.ac.uk/projects/fastqc/">http://www.bioinformatics.babraham.ac.uk/projects/fastqc/</ext-link>). Adaptor sequences were removed through Cutadapt. The reads were mapped to mouse genome mm9 using Tophat (v2.1.0) (<xref ref-type="bibr" rid="bib76">Trapnell et al., 2009</xref>). Mapped reads were then processed by Cuffdiff (v2.2.1) to estimate the expression level of all genes and identify differentially expressed genes. The expression level of a gene was expressed as a gene-level Fragments Per Kilobase of transcripts per Million mapped reads (FPKM) value. Upregulated or downregulated genes in when comparing groups were identified by requiring a greater than 1.5-fold expression change and a false discovery rate (FDR) &lt; 0.1, as well as a FPKM values &gt; 1.0. The reproducibility of RNA-seq data was evaluated by applying the principal component analysis for all genes between biological replicates. UCSC genes from the iGenome mouse mm9 assembly (<ext-link ext-link-type="uri" xlink:href="https://support.illumina.com/sequencing/sequencing_software/igenome.html">https://support.illumina.com/sequencing/sequencing_software/igenome.html</ext-link>) were used for gene annotation. Gene set enrichment and functional assignment were performed in software from the Broad Institute as described (<xref ref-type="bibr" rid="bib44">Martin et al., 2015</xref>; <xref ref-type="bibr" rid="bib65">Shan et al., 2017</xref>; <xref ref-type="bibr" rid="bib75">Subramanian et al., 2005</xref>). Enrichment was evaluated for Day 31 CLP samples relative to Day 31 Sham samples.</p></sec><sec id="s4-13"><title>ATAC-seq and data analysis</title><p>To determine the global impact of sepsis on chromatin accessibility, splenic memory P14 CD8 T cells were sorted from Sham and CLP hosts &gt; 30 days after surgery. 5 × 10<sup>4</sup> cells were prepared for sequencing as previously described (<xref ref-type="bibr" rid="bib5">Buenrostro et al., 2015</xref>; <xref ref-type="bibr" rid="bib66">Shan et al., 2021</xref>). The ATAC-seq data are deposited at the GEO (accession number GSE174357) under the SuperSeries of GSE174359. The sequencing quality of ATAC-seq libraries was assessed by FastQC v0.11.4 (<ext-link ext-link-type="uri" xlink:href="http://www.bioinformatics.babraham.ac.uk/projects/fastqc/">http://www.bioinformatics.babraham.ac.uk/projects/fastqc/</ext-link>) and adapters were removed through Cutadapt. The reads were mapped to mouse genome mm9 using Bowtie2 v2.2.5 and only uniquely mapped reads (MAPQ &gt;10) were retained. The mapped reads from multiple replicates were pooled for Sham or CLP CD8<sup>+</sup> T cells, respectively, and were processed with MACS v2.1. 1 (<xref ref-type="bibr" rid="bib85">Zhang et al., 2008</xref>) for peaks calling, with stringent criteria of ≥4 fold enrichment, <italic>P</italic>-value &lt; 1E–five and FDR &lt; 0.05. These sites were merged to generate a union pool of chromatin accessible sites containing 43,784 unique sites. For reproducibility analysis, reads at each site were counted in each ATAC-seq library, and then normalized by the total read-count of the union sites in the respective library. The resulting matrix was used for the principal component analysis. The read count matrix was used as input for edgeR (<xref ref-type="bibr" rid="bib57">Robinson et al., 2010</xref>) (v.3.20.7.2) (quasi-likelihood test, robust, fold-change 2.0 and FDR &lt; 0.01) to identify differential chromatin accessible sites between P14_Sham and P14_CLP conditions. A total of 304 Sham-specific and 1342 CLP-specific sites were identified, respectively.</p></sec><sec id="s4-14"><title>CFSE</title><p>Splenocytes (10<sup>7</sup> /mL) from CLP and Sham hosts were labeled with CarboxyFluorescein diacetate Succinimidyl Ester (CFSE; eBioscience) by incubating the cells at room temperature for 15 minutes with 1 μM or 0.1 μM CFSE, respectively. Labeled cells were then incubated for 5 minutes with 1 mL FCS on ice to remove any free CFSE, and washed three times with RPMI prior to stimulation.</p></sec><sec id="s4-15"><title>Peptide stimulation</title><p>CFSE labeled splenocytes from Sham and CLP hosts were mixed 1:1 and stimulated with 200 nM of GP<sub>33</sub> peptide or media control for 8 hr at 37 °C in the presence of Brefeldin A (BfA; BD Biosciences).</p></sec><sec id="s4-16"><title>Listeria challenge</title><p>Memory P14 CD8 T cells were isolated from either Sham or CLP hosts by positive selection, based on Thy1.1 expression, and naïve recipients received 2 × 10<sup>5</sup> of either P14 CD8 T cells each (controls did not receive cell transfer). Mice were subsequently infected the following day with 10<sup>5</sup> colony forming units (CFU) of virulent <italic>Listeria monocytogenes</italic> (10,403 s) express the GP<sub>33</sub> epitope (<italic>L.m</italic>.-GP33).</p></sec><sec id="s4-17"><title>Adhesion assay</title><p>Cellular adhesion was performed as previously described with some modification (<xref ref-type="bibr" rid="bib3">Bilal et al., 2015</xref>; <xref ref-type="bibr" rid="bib10">Chapman et al., 2012</xref>). Briefly, flat-bottomed 96-well plates (Thermo-Fisher) were coated with 0–10 μg of αCD3 (OKT3, Biolegend). P14 CD8 T cells were isolated by positive selection, based on Thy1.1. 5 × 10<sup>6</sup> P14 CD8 T cells were incubated on the plate for 30 min. Non-adherent cells were removed by quickly inverting the plate to empty contents. Adherent cells were stained with αCD8a-APC-Cy7 (53–6.7; Biolegend). Cells were washed twice with PBS before being imaged utilizing Licor Odyssey Infrared detector.</p></sec><sec id="s4-18"><title>TIRF microscopy</title><p>Images were taken using Leica AM TIRF MC imaging system as described with the following modifications (<xref ref-type="bibr" rid="bib3">Bilal et al., 2015</xref>). P14 CD8 T cells were isolated by positive selection, based on Thy1.1, and placed on glass chamber slides (5 × 10<sup>4</sup> cells/chamber; LabTek II) precoated with 10 μg/mL α-CD3 mAb. Cells were stimulated for 15 minutes, fixed with 4 % paraformaldehyde, and permeabilized with 0.25 % Triton-X. Cells were blocked with SEA blocking buffer (Thermo-Fisher) for 1 hour and stained with 5 µL rabbit α-human/mouse AKT antibody (11E7, Cell Signaling Technology) overnight at 4 °C. Cells were washed and incubated with DyLight 488-conjugated donkey α-rabbit IgG (poly4064, BioLegend) secondary antibody for 2 hr at room temperature. Cells were washed and fresh PBS was added to each well. Images were taken at room temperature using 100 X oil submersion lens and Leica AM TIRF MC imaging system at the University of Iowa Central Microscopy Research Facility. Laser intensity and exposure parameters remained constant within each experiment. TIRF microscopy images were analyzed using ImageJ software. Membrane AKT was quantified by measuring mean pixel intensity in the longest axis of cells.</p></sec><sec id="s4-19"><title>Statistical analysis</title><p>Unless stated otherwise data were analyzed using Prism8 software (GraphPad) using two-tailed Student t-test (for two individual groups, if unequal variance Mann-Whitney U test was used), one-way ANOVA with Bonferroni post-hoc test (for &gt;2 individual groups, if unequal variance Kruskal-Wallis with Dunn’s post-hoc test was used), two-way ANOVA (for multiparametric analysis of two or more individual groups, pairing was used for samples that came from the same animal), Fisher’s exact test (for categorical data from two individual groups) with a confidence interval of &gt;95% to determine significance (*p ≤ 0.05). Data are presented as standard error of the mean.</p></sec></sec></body><back><sec id="s5" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn><fn fn-type="COI-statement" id="conf2"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Writing – original draft, Writing – review and editing</p></fn><fn fn-type="con" id="con2"><p>Data curation, Formal analysis, Writing – review and editing</p></fn><fn fn-type="con" id="con3"><p>Data curation, Formal analysis, Writing – review and editing</p></fn><fn fn-type="con" id="con4"><p>Data curation, Methodology, Writing – review and editing</p></fn><fn fn-type="con" id="con5"><p>Data curation, Formal analysis, Visualization, Writing – review and editing</p></fn><fn fn-type="con" id="con6"><p>Methodology, Writing – review and editing</p></fn><fn fn-type="con" id="con7"><p>Resources, Writing – review and editing</p></fn><fn fn-type="con" id="con8"><p>Resources, Supervision, Writing – review and editing</p></fn><fn fn-type="con" id="con9"><p>Writing – review and editing</p></fn><fn fn-type="con" id="con10"><p>Resources, Supervision, Writing – review and editing</p></fn><fn fn-type="con" id="con11"><p>Conceptualization, Funding acquisition, Resources, Supervision, Writing – review and editing</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Human subjects: Patients were recruited at the University of Iowa Hospitals and Clinics, an 811-bed academic tertiary care center. Blood sample acquisition, patient data collection, and analysis were approved by the University of Iowa Institutional Review Board (ID #201804822). Informed consent was obtained from patients or their legally authorized representatives.</p></fn><fn fn-type="other"><p>Experimental procedures using mice were approved by University of Iowa Animal Care and Use Committee under ACURF protocol #6121915 and #9101915. The experiments performed followed Office of Laboratory Animal Welfare guidelines and PHS Policy on Humane Care and Use of Laboratory Animals. Cervical dislocation was used as the euthanasia method of all experimental mice. Inbred C57Bl/6 (B6, Thy1.2) and TCR-transgenic (TCR-Tg) P14 (Thy1.1) mice were purchased from the National Cancer Institute (Frederick, MD) and maintained in the animal facilities at the University of Iowa at the appropriate biosafety level according to the University of Iowa Animal Care and Use Committee and National Institutes of Health guidelines. Male and female mice &gt;6 weeks of age were used for experiments; no discernable differences were observed based on sex of the animals.</p></fn></fn-group></sec><sec id="s6" sec-type="supplementary-material"><title>Additional files</title><supplementary-material id="transrepform"><label>Transparent reporting form</label><media mime-subtype="docx" mimetype="application" xlink:href="elife-70989-transrepform1-v2.docx"/></supplementary-material></sec><sec id="s7" sec-type="data-availability"><title>Data availability</title><p>Sequencing data are deposited in GEO under accession code GSE174358. Source data for all figures are provided in associated excel files.</p><p>The following dataset was generated:</p><p><element-citation id="dataset1" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><name><surname>Peng</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2021">2021</year><data-title>Sepsis leads to lasting changes in phenotype and function of memory CD8 T cells (RNA-Seq)</data-title><source>NCBI Gene Expression Omnibus</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE174358">GSE174358</pub-id></element-citation></p></sec><ack id="ack"><title>Acknowledgements</title><p>We thank our labs and collaborators for their useful discussion. This work was supported by NIH Grants R01AI114543 (VPB), R21AI147064 (VPB), R35GM134880 (VPB), R21AI151183 (VPB), R01GM115462 (TSG), R35GM140881 (TSG), R01AI112579 (H-HX), R01AI121080 (H-HX and WP), R01AI139874 (H-HX and WP), R21AI157121 (JCH), T32AI007511 (IJJ), T32AI007485 (IJJ) and a Veterans Health Administration Merit Review Award I01B × 001324 (TSG). Research produced at the Central Microscopy Research Core at the University of Iowa was supported by the National Cancer Institute of the National Institutes of Health [P30CA086862].</p></ack><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Badovinac</surname><given-names>VP</given-names></name><name><surname>Haring</surname><given-names>JS</given-names></name><name><surname>Harty</surname><given-names>JT</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Initial T cell receptor transgenic cell precursor frequency dictates critical aspects of the CD8(+) T cell response to infection</article-title><source>Immunity</source><volume>26</volume><fpage>827</fpage><lpage>841</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2007.04.013</pub-id><pub-id pub-id-type="pmid">17555991</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baek</surname><given-names>KH</given-names></name><name><surname>Shin</surname><given-names>HJ</given-names></name><name><surname>Yoo</surname><given-names>JK</given-names></name><name><surname>Cho</surname><given-names>JH</given-names></name><name><surname>Choi</surname><given-names>YH</given-names></name><name><surname>Sung</surname><given-names>YC</given-names></name><name><surname>McKeon</surname><given-names>F</given-names></name><name><surname>Lee</surname><given-names>CW</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>p53 deficiency and defective mitotic checkpoint in proliferating T lymphocytes increase chromosomal instability through aberrant exit from mitotic arrest</article-title><source>Journal of Leukocyte Biology</source><volume>73</volume><fpage>850</fpage><lpage>861</lpage><pub-id pub-id-type="doi">10.1189/jlb.1202607</pub-id><pub-id pub-id-type="pmid">12773518</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bilal</surname><given-names>MY</given-names></name><name><surname>Zhang</surname><given-names>EY</given-names></name><name><surname>Dinkel</surname><given-names>B</given-names></name><name><surname>Hardy</surname><given-names>D</given-names></name><name><surname>Yankee</surname><given-names>TM</given-names></name><name><surname>Houtman</surname><given-names>JCD</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>GADS is required for TCR-mediated calcium influx and cytokine release, but not cellular adhesion, in human T cells</article-title><source>Cellular Signalling</source><volume>27</volume><fpage>841</fpage><lpage>850</lpage><pub-id pub-id-type="doi">10.1016/j.cellsig.2015.01.012</pub-id><pub-id pub-id-type="pmid">25636200</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Borges da Silva</surname><given-names>H</given-names></name><name><surname>Beura</surname><given-names>LK</given-names></name><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Hanse</surname><given-names>EA</given-names></name><name><surname>Gore</surname><given-names>R</given-names></name><name><surname>Scott</surname><given-names>MC</given-names></name><name><surname>Walsh</surname><given-names>DA</given-names></name><name><surname>Block</surname><given-names>KE</given-names></name><name><surname>Fonseca</surname><given-names>R</given-names></name><name><surname>Yan</surname><given-names>Y</given-names></name><name><surname>Hippen</surname><given-names>KL</given-names></name><name><surname>Blazar</surname><given-names>BR</given-names></name><name><surname>Masopust</surname><given-names>D</given-names></name><name><surname>Kelekar</surname><given-names>A</given-names></name><name><surname>Vulchanova</surname><given-names>L</given-names></name><name><surname>Hogquist</surname><given-names>KA</given-names></name><name><surname>Jameson</surname><given-names>SC</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>The purinergic receptor P2RX7 directs metabolic fitness of long-lived memory CD8+ T cells</article-title><source>Nature</source><volume>559</volume><fpage>264</fpage><lpage>268</lpage><pub-id pub-id-type="doi">10.1038/s41586-018-0282-0</pub-id><pub-id pub-id-type="pmid">29973721</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buenrostro</surname><given-names>JD</given-names></name><name><surname>Wu</surname><given-names>B</given-names></name><name><surname>Chang</surname><given-names>HY</given-names></name><name><surname>Greenleaf</surname><given-names>WJ</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>ATAC‐seq: A Method for Assaying Chromatin Accessibility Genome‐Wide</article-title><source>Current Protocols in Molecular Biology</source><volume>109</volume><elocation-id>21</elocation-id><pub-id pub-id-type="doi">10.1002/0471142727.mb2129s109</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cabrera-Perez</surname><given-names>J</given-names></name><name><surname>Condotta</surname><given-names>SA</given-names></name><name><surname>Badovinac</surname><given-names>VP</given-names></name><name><surname>Griffith</surname><given-names>TS</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Impact of sepsis on CD4 T cell immunity</article-title><source>Journal of Leukocyte Biology</source><volume>96</volume><fpage>767</fpage><lpage>777</lpage><pub-id pub-id-type="doi">10.1189/jlb.5MR0114-067R</pub-id><pub-id pub-id-type="pmid">24791959</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cabrera-Perez</surname><given-names>J</given-names></name><name><surname>Condotta</surname><given-names>SA</given-names></name><name><surname>James</surname><given-names>BR</given-names></name><name><surname>Kashem</surname><given-names>SW</given-names></name><name><surname>Brincks</surname><given-names>EL</given-names></name><name><surname>Rai</surname><given-names>D</given-names></name><name><surname>Kucaba</surname><given-names>TA</given-names></name><name><surname>Badovinac</surname><given-names>VP</given-names></name><name><surname>Griffith</surname><given-names>TS</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Alterations in Antigen-Specific Naive CD4 T Cell Precursors after Sepsis Impairs Their Responsiveness to Pathogen Challenge</article-title><source>Journal of Immunology</source><volume>194</volume><fpage>1609</fpage><lpage>1620</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1401711</pub-id><pub-id pub-id-type="pmid">25595784</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="web"><person-group person-group-type="author"><collab>CDC</collab></person-group><year iso-8601-date="2020">2020</year><article-title>Sepsis: Data &amp; Reports</article-title><ext-link ext-link-type="uri" xlink:href="https://www.cdc.gov/sepsis/datareports/index.html">https://www.cdc.gov/sepsis/datareports/index.html</ext-link><date-in-citation iso-8601-date="2020-08-01">August 1, 2020</date-in-citation></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>JT</given-names></name><name><surname>Wherry</surname><given-names>EJ</given-names></name><name><surname>Goldrath</surname><given-names>AW</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Molecular regulation of effector and memory T cell differentiation</article-title><source>Nature Immunology</source><volume>15</volume><fpage>1104</fpage><lpage>1115</lpage><pub-id pub-id-type="doi">10.1038/ni.3031</pub-id><pub-id pub-id-type="pmid">25396352</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chapman</surname><given-names>NM</given-names></name><name><surname>Yoder</surname><given-names>AN</given-names></name><name><surname>Houtman</surname><given-names>JCD</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Non-Catalytic Functions of Pyk2 and Fyn Regulate Late Stage Adhesion in Human T Cells</article-title><source>PLOS ONE</source><volume>7</volume><elocation-id>e53011</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0053011</pub-id><pub-id pub-id-type="pmid">23300847</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>C-W</given-names></name><name><surname>Mittal</surname><given-names>R</given-names></name><name><surname>Klingensmith</surname><given-names>NJ</given-names></name><name><surname>Burd</surname><given-names>EM</given-names></name><name><surname>Terhorst</surname><given-names>C</given-names></name><name><surname>Martin</surname><given-names>GS</given-names></name><name><surname>Coopersmith</surname><given-names>CM</given-names></name><name><surname>Ford</surname><given-names>ML</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Cutting Edge: 2B4-Mediated Coinhibition of CD4+ T Cells Underlies Mortality in Experimental Sepsis</article-title><source>Journal of Immunology</source><volume>199</volume><fpage>1961</fpage><lpage>1966</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1700375</pub-id><pub-id pub-id-type="pmid">28768726</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheung</surname><given-names>KP</given-names></name><name><surname>Yang</surname><given-names>E</given-names></name><name><surname>Goldrath</surname><given-names>AW</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Memory-like CD8+ T cells generated during homeostatic proliferation defer to antigen-experienced memory cells</article-title><source>Journal of Immunology</source><volume>183</volume><fpage>3364</fpage><lpage>3372</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.0900641</pub-id><pub-id pub-id-type="pmid">19675163</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cieri</surname><given-names>N</given-names></name><name><surname>Camisa</surname><given-names>B</given-names></name><name><surname>Cocchiarella</surname><given-names>F</given-names></name><name><surname>Forcato</surname><given-names>M</given-names></name><name><surname>Oliveira</surname><given-names>G</given-names></name><name><surname>Provasi</surname><given-names>E</given-names></name><name><surname>Bondanza</surname><given-names>A</given-names></name><name><surname>Bordignon</surname><given-names>C</given-names></name><name><surname>Peccatori</surname><given-names>J</given-names></name><name><surname>Ciceri</surname><given-names>F</given-names></name><name><surname>Lupo-Stanghellini</surname><given-names>MT</given-names></name><name><surname>Mavilio</surname><given-names>F</given-names></name><name><surname>Mondino</surname><given-names>A</given-names></name><name><surname>Bicciato</surname><given-names>S</given-names></name><name><surname>Recchia</surname><given-names>A</given-names></name><name><surname>Bonini</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>IL-7 and IL-15 instruct the generation of human memory stem T cells from naive precursors</article-title><source>Blood</source><volume>121</volume><fpage>573</fpage><lpage>584</lpage><pub-id pub-id-type="doi">10.1182/blood-2012-05-431718</pub-id><pub-id pub-id-type="pmid">23160470</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Condotta</surname><given-names>SA</given-names></name><name><surname>Rai</surname><given-names>D</given-names></name><name><surname>James</surname><given-names>BR</given-names></name><name><surname>Griffith</surname><given-names>TS</given-names></name><name><surname>Badovinac</surname><given-names>VP</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Sustained and incomplete recovery of naive CD8+ T cell precursors after sepsis contributes to impaired CD8+ T cell responses to infection</article-title><source>Journal of Immunology</source><volume>190</volume><fpage>1991</fpage><lpage>2000</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1202379</pub-id><pub-id pub-id-type="pmid">23355736</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Condotta</surname><given-names>SA</given-names></name><name><surname>Khan</surname><given-names>SH</given-names></name><name><surname>Rai</surname><given-names>D</given-names></name><name><surname>Griffith</surname><given-names>TS</given-names></name><name><surname>Badovinac</surname><given-names>VP</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Polymicrobial Sepsis Increases Susceptibility to Chronic Viral Infection and Exacerbates CD8+ T Cell Exhaustion</article-title><source>Journal of Immunology</source><volume>195</volume><fpage>116</fpage><lpage>125</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1402473</pub-id><pub-id pub-id-type="pmid">25980007</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Danahy</surname><given-names>DB</given-names></name><name><surname>Anthony</surname><given-names>SM</given-names></name><name><surname>Jensen</surname><given-names>IJ</given-names></name><name><surname>Hartwig</surname><given-names>SM</given-names></name><name><surname>Shan</surname><given-names>Q</given-names></name><name><surname>Xue</surname><given-names>HH</given-names></name><name><surname>Harty</surname><given-names>JT</given-names></name><name><surname>Griffith</surname><given-names>TS</given-names></name><name><surname>Badovinac</surname><given-names>VP</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Polymicrobial sepsis impairs bystander recruitment of effector cells to infected skin despite optimal sensing and alarming function of skin resident memory CD8 T cells</article-title><source>PLOS Pathogens</source><volume>13</volume><elocation-id>e1006569</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1006569</pub-id><pub-id pub-id-type="pmid">28910403</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Danahy</surname><given-names>DB</given-names></name><name><surname>Kurup</surname><given-names>SP</given-names></name><name><surname>Winborn</surname><given-names>CS</given-names></name><name><surname>Jensen</surname><given-names>IJ</given-names></name><name><surname>Harty</surname><given-names>JT</given-names></name><name><surname>Griffith</surname><given-names>TS</given-names></name><name><surname>Badovinac</surname><given-names>VP</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Sepsis-Induced State of Immunoparalysis Is Defined by Diminished CD8 T Cell-Mediated Antitumor Immunity</article-title><source>Journal of Immunology</source><volume>203</volume><fpage>725</fpage><lpage>735</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1900435</pub-id><pub-id pub-id-type="pmid">31189573</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davenport</surname><given-names>B</given-names></name><name><surname>Eberlein</surname><given-names>J</given-names></name><name><surname>van der Heide</surname><given-names>V</given-names></name><name><surname>Jhun</surname><given-names>K</given-names></name><name><surname>Nguyen</surname><given-names>TT</given-names></name><name><surname>Victorino</surname><given-names>F</given-names></name><name><surname>Trotta</surname><given-names>A</given-names></name><name><surname>Chipuk</surname><given-names>J</given-names></name><name><surname>Yi</surname><given-names>Z</given-names></name><name><surname>Zhang</surname><given-names>W</given-names></name><name><surname>Clambey</surname><given-names>ET</given-names></name><name><surname>Scott</surname><given-names>DK</given-names></name><name><surname>Homann</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Aging of Antiviral CD8+ Memory T Cells Fosters Increased Survival, Metabolic Adaptations, and Lymphoid Tissue Homing</article-title><source>Journal of Immunology</source><volume>202</volume><fpage>460</fpage><lpage>475</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1801277</pub-id><pub-id pub-id-type="pmid">30552164</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Delano</surname><given-names>MJ</given-names></name><name><surname>Ward</surname><given-names>PA</given-names></name></person-group><year iso-8601-date="2016">2016a</year><article-title>The immune system’s role in sepsis progression, resolution, and long-term outcome</article-title><source>Immunological Reviews</source><volume>274</volume><fpage>330</fpage><lpage>353</lpage><pub-id pub-id-type="doi">10.1111/imr.12499</pub-id><pub-id pub-id-type="pmid">27782333</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Delano</surname><given-names>MJ</given-names></name><name><surname>Ward</surname><given-names>PA</given-names></name></person-group><year iso-8601-date="2016">2016b</year><article-title>Sepsis-induced immune dysfunction: can immune therapies reduce mortality?</article-title><source>The Journal of Clinical Investigation</source><volume>126</volume><fpage>23</fpage><lpage>31</lpage><pub-id pub-id-type="doi">10.1172/JCI82224</pub-id><pub-id pub-id-type="pmid">26727230</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dombrovskiy</surname><given-names>VY</given-names></name><name><surname>Martin</surname><given-names>AA</given-names></name><name><surname>Sunderram</surname><given-names>J</given-names></name><name><surname>Paz</surname><given-names>HL</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Rapid increase in hospitalization and mortality rates for severe sepsis in the United States: a trend analysis from 1993 to 2003</article-title><source>Critical Care Medicine</source><volume>35</volume><fpage>1244</fpage><lpage>1250</lpage><pub-id pub-id-type="doi">10.1097/01.CCM.0000261890.41311.E9</pub-id><pub-id pub-id-type="pmid">17414736</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Donnelly</surname><given-names>JP</given-names></name><name><surname>Hohmann</surname><given-names>SF</given-names></name><name><surname>Wang</surname><given-names>HE</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Unplanned Readmissions After Hospitalization for Severe Sepsis at Academic Medical Center-Affiliated Hospitals</article-title><source>Critical Care Medicine</source><volume>43</volume><fpage>1916</fpage><lpage>1927</lpage><pub-id pub-id-type="doi">10.1097/CCM.0000000000001147</pub-id><pub-id pub-id-type="pmid">26082977</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Duong</surname><given-names>S</given-names></name><name><surname>Condotta</surname><given-names>SA</given-names></name><name><surname>Rai</surname><given-names>D</given-names></name><name><surname>Martin</surname><given-names>MD</given-names></name><name><surname>Griffith</surname><given-names>TS</given-names></name><name><surname>Badovinac</surname><given-names>VP</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Polymicrobial Sepsis Alters Antigen-Dependent and -Independent Memory CD8 T Cell Functions</article-title><source>Journal of Immunology</source><volume>192</volume><fpage>3618</fpage><lpage>3625</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1303460</pub-id><pub-id pub-id-type="pmid">24646738</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ehl</surname><given-names>S</given-names></name><name><surname>Hombach</surname><given-names>J</given-names></name><name><surname>Aichele</surname><given-names>P</given-names></name><name><surname>Hengartner</surname><given-names>H</given-names></name><name><surname>Zinkernagel</surname><given-names>RM</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>Bystander Activation of Cytotoxic T Cells: Studies on the Mechanism and Evaluation of In Vivo Significance in a Transgenic Mouse Model</article-title><source>The Journal of Experimental Medicine</source><volume>185</volume><fpage>1241</fpage><lpage>1251</lpage><pub-id pub-id-type="doi">10.1084/jem.185.7.1241</pub-id><pub-id pub-id-type="pmid">9104811</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gaieski</surname><given-names>DF</given-names></name><name><surname>Edwards</surname><given-names>JM</given-names></name><name><surname>Kallan</surname><given-names>MJ</given-names></name><name><surname>Carr</surname><given-names>BG</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Benchmarking the incidence and mortality of severe sepsis in the United States</article-title><source>Critical Care Medicine</source><volume>41</volume><fpage>1167</fpage><lpage>1174</lpage><pub-id pub-id-type="doi">10.1097/CCM.0b013e31827c09f8</pub-id><pub-id pub-id-type="pmid">23442987</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gerlach</surname><given-names>C</given-names></name><name><surname>Moseman</surname><given-names>EA</given-names></name><name><surname>Loughhead</surname><given-names>SM</given-names></name><name><surname>Alvarez</surname><given-names>D</given-names></name><name><surname>Zwijnenburg</surname><given-names>AJ</given-names></name><name><surname>Waanders</surname><given-names>L</given-names></name><name><surname>Garg</surname><given-names>R</given-names></name><name><surname>de la Torre</surname><given-names>JC</given-names></name><name><surname>von Andrian</surname><given-names>UH</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>The Chemokine Receptor CX3CR1 Defines Three Antigen-Experienced CD8 T Cell Subsets with Distinct Roles in Immune Surveillance and Homeostasis</article-title><source>Immunity</source><volume>45</volume><fpage>1270</fpage><lpage>1284</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2016.10.018</pub-id><pub-id pub-id-type="pmid">27939671</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gurung</surname><given-names>P</given-names></name><name><surname>Rai</surname><given-names>D</given-names></name><name><surname>Condotta</surname><given-names>SA</given-names></name><name><surname>Babcock</surname><given-names>JC</given-names></name><name><surname>Badovinac</surname><given-names>VP</given-names></name><name><surname>Griffith</surname><given-names>TS</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Immune Unresponsiveness to Secondary Heterologous Bacterial Infection after Sepsis Induction Is TRAIL Dependent</article-title><source>Journal of Immunology</source><volume>187</volume><fpage>2148</fpage><lpage>2154</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1101180</pub-id><pub-id pub-id-type="pmid">21788440</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hotchkiss</surname><given-names>RS</given-names></name><name><surname>Tinsley</surname><given-names>KW</given-names></name><name><surname>Swanson</surname><given-names>PE</given-names></name><name><surname>Schmieg</surname><given-names>RE</given-names><suffix>Jr</suffix></name><name><surname>Hui</surname><given-names>JJ</given-names></name><name><surname>Chang</surname><given-names>KC</given-names></name><name><surname>Osborne</surname><given-names>DF</given-names></name><name><surname>Freeman</surname><given-names>BD</given-names></name><name><surname>Cobb</surname><given-names>JP</given-names></name><name><surname>Buchman</surname><given-names>TG</given-names></name><name><surname>Karl</surname><given-names>IE</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Sepsis-Induced Apoptosis Causes Progressive Profound Depletion of B and CD4+ T Lymphocytes in Humans</article-title><source>Journal of Immunology</source><volume>166</volume><fpage>6952</fpage><lpage>6963</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.166.11.6952</pub-id><pub-id pub-id-type="pmid">11359857</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hotchkiss</surname><given-names>RS</given-names></name><name><surname>Monneret</surname><given-names>G</given-names></name><name><surname>Payen</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy</article-title><source>Nature Reviews. Immunology</source><volume>13</volume><fpage>862</fpage><lpage>874</lpage><pub-id pub-id-type="doi">10.1038/nri3552</pub-id><pub-id pub-id-type="pmid">24232462</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hotchkiss</surname><given-names>RS</given-names></name><name><surname>Moldawer</surname><given-names>LL</given-names></name><name><surname>Opal</surname><given-names>SM</given-names></name><name><surname>Reinhart</surname><given-names>K</given-names></name><name><surname>Turnbull</surname><given-names>IR</given-names></name><name><surname>Vincent</surname><given-names>JL</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Sepsis and septic shock</article-title><source>Nature Reviews. Disease Primers</source><volume>2</volume><elocation-id>16045</elocation-id><pub-id pub-id-type="doi">10.1038/nrdp.2016.45</pub-id><pub-id pub-id-type="pmid">28117397</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hou</surname><given-names>H</given-names></name><name><surname>Liu</surname><given-names>W</given-names></name><name><surname>Wu</surname><given-names>S</given-names></name><name><surname>Lu</surname><given-names>Y</given-names></name><name><surname>Peng</surname><given-names>J</given-names></name><name><surname>Zhu</surname><given-names>Y</given-names></name><name><surname>Lu</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>F</given-names></name><name><surname>Sun</surname><given-names>Z</given-names></name><name><surname>Lenz</surname><given-names>LL</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Tim-3 Negatively Mediates Natural Killer Cell Function in LPS-Induced Endotoxic Shock</article-title><source>PLOS ONE</source><volume>9</volume><elocation-id>e110585</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0110585</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jensen</surname><given-names>IJ</given-names></name><name><surname>Sjaastad</surname><given-names>FV</given-names></name><name><surname>Griffith</surname><given-names>TS</given-names></name><name><surname>Badovinac</surname><given-names>VP</given-names></name></person-group><year iso-8601-date="2018">2018a</year><article-title>Sepsis-Induced T Cell Immunoparalysis: The Ins and Outs of Impaired T Cell Immunity</article-title><source>Journal of Immunology</source><volume>200</volume><fpage>1543</fpage><lpage>1553</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1701618</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jensen</surname><given-names>IJ</given-names></name><name><surname>Winborn</surname><given-names>CS</given-names></name><name><surname>Fosdick</surname><given-names>MG</given-names></name><name><surname>Shao</surname><given-names>P</given-names></name><name><surname>Tremblay</surname><given-names>MM</given-names></name><name><surname>Shan</surname><given-names>Q</given-names></name><name><surname>Tripathy</surname><given-names>SK</given-names></name><name><surname>Snyder</surname><given-names>CM</given-names></name><name><surname>Xue</surname><given-names>H-H</given-names></name><name><surname>Griffith</surname><given-names>TS</given-names></name><name><surname>Houtman</surname><given-names>JC</given-names></name><name><surname>Badovinac</surname><given-names>VP</given-names></name><name><surname>Munz</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2018">2018b</year><article-title>Polymicrobial sepsis influences NK-cell-mediated immunity by diminishing NK-cell-intrinsic receptor-mediated effector responses to viral ligands or infections</article-title><source>PLOS Pathogens</source><volume>14</volume><elocation-id>e1007405</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1007405</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jensen</surname><given-names>I.J</given-names></name><name><surname>Jensen</surname><given-names>SN</given-names></name><name><surname>Sjaastad</surname><given-names>FV</given-names></name><name><surname>Gibson-Corley</surname><given-names>KN</given-names></name><name><surname>Dileepan</surname><given-names>T</given-names></name><name><surname>Griffith</surname><given-names>TS</given-names></name><name><surname>Mangalam</surname><given-names>AK</given-names></name><name><surname>Badovinac</surname><given-names>VP</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Sepsis impedes EAE disease development and diminishes autoantigen-specific naive CD4 T cells</article-title><source>eLife</source><volume>9</volume><elocation-id>e55800</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.55800</pub-id><pub-id pub-id-type="pmid">33191915</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jensen</surname><given-names>I.J</given-names></name><name><surname>McGonagill</surname><given-names>PW</given-names></name><name><surname>Berton</surname><given-names>RR</given-names></name><name><surname>Wagner</surname><given-names>BA</given-names></name><name><surname>Silva</surname><given-names>EE</given-names></name><name><surname>Buettner</surname><given-names>GR</given-names></name><name><surname>Griffith</surname><given-names>TS</given-names></name><name><surname>Badovinac</surname><given-names>VP</given-names></name></person-group><year iso-8601-date="2021">2021a</year><article-title>Prolonged Reactive Oxygen Species Production following Septic Insult</article-title><source>ImmunoHorizons</source><volume>5</volume><fpage>477</fpage><lpage>488</lpage><pub-id pub-id-type="doi">10.4049/immunohorizons.2100027</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jensen</surname><given-names>I.J</given-names></name><name><surname>McGonagill</surname><given-names>PW</given-names></name><name><surname>Butler</surname><given-names>NS</given-names></name><name><surname>Harty</surname><given-names>JT</given-names></name><name><surname>Griffith</surname><given-names>TS</given-names></name><name><surname>Badovinac</surname><given-names>VP</given-names></name></person-group><year iso-8601-date="2021">2021b</year><article-title>NK Cell–Derived IL-10 Supports Host Survival during Sepsis</article-title><source>The Journal of Immunology</source><volume>206</volume><fpage>1171</fpage><lpage>1180</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.2001131</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaech</surname><given-names>SM</given-names></name><name><surname>Cui</surname><given-names>W</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Transcriptional control of effector and memory CD8+ T cell differentiation</article-title><source>Nature Reviews. Immunology</source><volume>12</volume><fpage>749</fpage><lpage>761</lpage><pub-id pub-id-type="doi">10.1038/nri3307</pub-id><pub-id pub-id-type="pmid">23080391</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kutza</surname><given-names>AST</given-names></name><name><surname>Muhl</surname><given-names>E</given-names></name><name><surname>Hackstein</surname><given-names>H</given-names></name><name><surname>Kirchner</surname><given-names>H</given-names></name><name><surname>Bein</surname><given-names>G</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>High Incidence of Active Cytomegalovirus Infection Among Septic Patients</article-title><source>Clinical Infectious Diseases</source><volume>26</volume><fpage>1076</fpage><lpage>1082</lpage><pub-id pub-id-type="doi">10.1086/520307</pub-id><pub-id pub-id-type="pmid">9597229</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lauer</surname><given-names>FT</given-names></name><name><surname>Denson</surname><given-names>JL</given-names></name><name><surname>Burchiel</surname><given-names>SW</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Isolation, Cryopreservation, and Immunophenotyping of Human Peripheral Blood Mononuclear Cells</article-title><source>Current Protocols in Toxicology</source><volume>74</volume><elocation-id>18</elocation-id><pub-id pub-id-type="doi">10.1002/cptx.31</pub-id><pub-id pub-id-type="pmid">29117436</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lertmemongkolchai</surname><given-names>G</given-names></name><name><surname>Cai</surname><given-names>G</given-names></name><name><surname>Hunter</surname><given-names>CA</given-names></name><name><surname>Bancroft</surname><given-names>GJ</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Bystander activation of CD8+ T cells contributes to the rapid production of IFN-gamma in response to bacterial pathogens</article-title><source>Journal of Immunology</source><volume>166</volume><fpage>1097</fpage><lpage>1105</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.166.2.1097</pub-id><pub-id pub-id-type="pmid">11145690</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>H</given-names></name><name><surname>Liu</surname><given-names>L</given-names></name><name><surname>Zhang</surname><given-names>D</given-names></name><name><surname>Xu</surname><given-names>J</given-names></name><name><surname>Dai</surname><given-names>H</given-names></name><name><surname>Tang</surname><given-names>N</given-names></name><name><surname>Su</surname><given-names>X</given-names></name><name><surname>Cao</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>SARS-CoV-2 and viral sepsis: observations and hypotheses</article-title><source>The Lancet</source><volume>395</volume><fpage>1517</fpage><lpage>1520</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(20)30920-X</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Markwart</surname><given-names>R</given-names></name><name><surname>Condotta</surname><given-names>SA</given-names></name><name><surname>Requardt</surname><given-names>RP</given-names></name><name><surname>Borken</surname><given-names>F</given-names></name><name><surname>Schubert</surname><given-names>K</given-names></name><name><surname>Weigel</surname><given-names>C</given-names></name><name><surname>Bauer</surname><given-names>M</given-names></name><name><surname>Griffith</surname><given-names>TS</given-names></name><name><surname>Förster</surname><given-names>M</given-names></name><name><surname>Brunkhorst</surname><given-names>FM</given-names></name><name><surname>Badovinac</surname><given-names>VP</given-names></name><name><surname>Rubio</surname><given-names>I</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Immunosuppression after Sepsis: Systemic Inflammation and Sepsis Induce a Loss of Naïve T-Cells but No Enduring Cell-Autonomous Defects in T-Cell Function</article-title><source>PLOS ONE</source><volume>9</volume><elocation-id>e115094</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0115094</pub-id><pub-id pub-id-type="pmid">25541945</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marshall</surname><given-names>JC</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Why have clinical trials in sepsis failed?</article-title><source>Trends in Molecular Medicine</source><volume>20</volume><fpage>195</fpage><lpage>203</lpage><pub-id pub-id-type="doi">10.1016/j.molmed.2014.01.007</pub-id><pub-id pub-id-type="pmid">24581450</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martin</surname><given-names>MD</given-names></name><name><surname>Kim</surname><given-names>MT</given-names></name><name><surname>Shan</surname><given-names>Q</given-names></name><name><surname>Sompallae</surname><given-names>R</given-names></name><name><surname>Xue</surname><given-names>HH</given-names></name><name><surname>Harty</surname><given-names>JT</given-names></name><name><surname>Badovinac</surname><given-names>VP</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Phenotypic and Functional Alterations in Circulating Memory CD8 T Cells with Time after Primary Infection</article-title><source>PLOS Pathogens</source><volume>11</volume><elocation-id>e1005219</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1005219</pub-id><pub-id pub-id-type="pmid">26485703</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martin</surname><given-names>MD</given-names></name><name><surname>Shan</surname><given-names>Q</given-names></name><name><surname>Xue</surname><given-names>HH</given-names></name><name><surname>Badovinac</surname><given-names>VP</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Time and Antigen-Stimulation History Influence Memory CD8 T Cell Bystander Responses</article-title><source>Frontiers in Immunology</source><volume>8</volume><elocation-id>634</elocation-id><pub-id pub-id-type="doi">10.3389/fimmu.2017.00634</pub-id><pub-id pub-id-type="pmid">28642758</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martin</surname><given-names>MD</given-names></name><name><surname>Badovinac</surname><given-names>VP</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Defining Memory CD8 T Cell</article-title><source>Frontiers in Immunology</source><volume>9</volume><elocation-id>2692</elocation-id><pub-id pub-id-type="doi">10.3389/fimmu.2018.02692</pub-id><pub-id pub-id-type="pmid">30515169</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martin</surname><given-names>MD</given-names></name><name><surname>Badovinac</surname><given-names>VP</given-names></name><name><surname>Griffith</surname><given-names>TS</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>CD4 T Cell Responses and the Sepsis-Induced Immunoparalysis State</article-title><source>Frontiers in Immunology</source><volume>11</volume><elocation-id>1364</elocation-id><pub-id pub-id-type="doi">10.3389/fimmu.2020.01364</pub-id><pub-id pub-id-type="pmid">32733454</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Masopust</surname><given-names>D</given-names></name><name><surname>Vezys</surname><given-names>V</given-names></name><name><surname>Marzo</surname><given-names>AL</given-names></name><name><surname>Lefrançois</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Preferential Localization of Effector Memory Cells in Nonlymphoid Tissue</article-title><source>Science</source><volume>291</volume><fpage>2413</fpage><lpage>2417</lpage><pub-id pub-id-type="doi">10.1126/science.1058867</pub-id><pub-id pub-id-type="pmid">11264538</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Milner</surname><given-names>JJ</given-names></name><name><surname>Nguyen</surname><given-names>H</given-names></name><name><surname>Omilusik</surname><given-names>K</given-names></name><name><surname>Reina-Campos</surname><given-names>M</given-names></name><name><surname>Tsai</surname><given-names>M</given-names></name><name><surname>Toma</surname><given-names>C</given-names></name><name><surname>Delpoux</surname><given-names>A</given-names></name><name><surname>Boland</surname><given-names>BS</given-names></name><name><surname>Hedrick</surname><given-names>SM</given-names></name><name><surname>Chang</surname><given-names>JT</given-names></name><name><surname>Goldrath</surname><given-names>AW</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Delineation of a molecularly distinct terminally differentiated memory CD8 T cell population</article-title><source>PNAS</source><volume>117</volume><fpage>25667</fpage><lpage>25678</lpage><pub-id pub-id-type="doi">10.1073/pnas.2008571117</pub-id><pub-id pub-id-type="pmid">32978300</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mueller</surname><given-names>SN</given-names></name><name><surname>Gebhardt</surname><given-names>T</given-names></name><name><surname>Carbone</surname><given-names>FR</given-names></name><name><surname>Heath</surname><given-names>WR</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Memory T Cell Subsets, Migration Patterns, and Tissue Residence</article-title><source>Annual Review of Immunology</source><volume>31</volume><fpage>137</fpage><lpage>161</lpage><pub-id pub-id-type="doi">10.1146/annurev-immunol-032712-095954</pub-id><pub-id pub-id-type="pmid">23215646</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nolz</surname><given-names>JC</given-names></name><name><surname>Harty</surname><given-names>JT</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Protective Capacity of Memory CD8+ T Cells Is Dictated by Antigen Exposure History and Nature of the Infection</article-title><source>Immunity</source><volume>34</volume><fpage>781</fpage><lpage>793</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2011.03.020</pub-id><pub-id pub-id-type="pmid">21549619</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Olson</surname><given-names>MR</given-names></name><name><surname>McDermott</surname><given-names>DS</given-names></name><name><surname>Varga</surname><given-names>SM</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>The Initial Draining Lymph Node Primes the Bulk of the CD8 T Cell Response and Influences Memory T Cell Trafficking after a Systemic Viral Infection</article-title><source>PLOS Pathogens</source><volume>8</volume><elocation-id>e1003054</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1003054</pub-id><pub-id pub-id-type="pmid">23236277</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Palmer</surname><given-names>DC</given-names></name><name><surname>Guittard</surname><given-names>GC</given-names></name><name><surname>Franco</surname><given-names>Z</given-names></name><name><surname>Crompton</surname><given-names>JG</given-names></name><name><surname>Eil</surname><given-names>RL</given-names></name><name><surname>Patel</surname><given-names>SJ</given-names></name><name><surname>Ji</surname><given-names>Y</given-names></name><name><surname>Van Panhuys</surname><given-names>N</given-names></name><name><surname>Klebanoff</surname><given-names>CA</given-names></name><name><surname>Sukumar</surname><given-names>M</given-names></name><name><surname>Clever</surname><given-names>D</given-names></name><name><surname>Chichura</surname><given-names>A</given-names></name><name><surname>Roychoudhuri</surname><given-names>R</given-names></name><name><surname>Varma</surname><given-names>R</given-names></name><name><surname>Wang</surname><given-names>E</given-names></name><name><surname>Gattinoni</surname><given-names>L</given-names></name><name><surname>Marincola</surname><given-names>FM</given-names></name><name><surname>Balagopalan</surname><given-names>L</given-names></name><name><surname>Samelson</surname><given-names>LE</given-names></name><name><surname>Restifo</surname><given-names>NP</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Cish actively silences TCR signaling in CD8+ T cells to maintain tumor tolerance</article-title><source>The Journal of Experimental Medicine</source><volume>212</volume><fpage>2095</fpage><lpage>2113</lpage><pub-id pub-id-type="doi">10.1084/jem.20150304</pub-id><pub-id pub-id-type="pmid">26527801</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Poehlmann</surname><given-names>H</given-names></name><name><surname>Schefold</surname><given-names>JC</given-names></name><name><surname>Zuckermann-Becker</surname><given-names>H</given-names></name><name><surname>Volk</surname><given-names>HD</given-names></name><name><surname>Meisel</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Phenotype changes and impaired function of dendritic cell subsets in patients with sepsis: a prospective observational analysis</article-title><source>Critical Care</source><volume>13</volume><elocation-id>R119</elocation-id><pub-id pub-id-type="doi">10.1186/cc7969</pub-id><pub-id pub-id-type="pmid">19604380</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pribikova</surname><given-names>M</given-names></name><name><surname>Moudra</surname><given-names>A</given-names></name><name><surname>Stepanek</surname><given-names>O</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Opinion: Virtual memory CD8 T cells and lymphopenia-induced memory CD8 T cells represent a single subset: Homeostatic memory T cells</article-title><source>Immunology Letters</source><volume>203</volume><fpage>57</fpage><lpage>61</lpage><pub-id pub-id-type="doi">10.1016/j.imlet.2018.09.003</pub-id><pub-id pub-id-type="pmid">30243945</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rai</surname><given-names>D</given-names></name><name><surname>Pham</surname><given-names>NLL</given-names></name><name><surname>Harty</surname><given-names>JT</given-names></name><name><surname>Badovinac</surname><given-names>VP</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Tracking the Total CD8 T Cell Response to Infection Reveals Substantial Discordance in Magnitude and Kinetics between Inbred and Outbred Hosts</article-title><source>Journal of Immunology</source><volume>183</volume><fpage>7672</fpage><lpage>7681</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.0902874</pub-id><pub-id pub-id-type="pmid">19933864</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robinson</surname><given-names>MD</given-names></name><name><surname>McCarthy</surname><given-names>DJ</given-names></name><name><surname>Smyth</surname><given-names>GK</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>edgeR: a Bioconductor package for differential expression analysis of digital gene expression data</article-title><source>Bioinformatics</source><volume>26</volume><fpage>139</fpage><lpage>140</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btp616</pub-id><pub-id pub-id-type="pmid">19910308</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roquilly</surname><given-names>A</given-names></name><name><surname>McWilliam</surname><given-names>HEG</given-names></name><name><surname>Jacqueline</surname><given-names>C</given-names></name><name><surname>Tian</surname><given-names>Z</given-names></name><name><surname>Cinotti</surname><given-names>R</given-names></name><name><surname>Rimbert</surname><given-names>M</given-names></name><name><surname>Wakim</surname><given-names>L</given-names></name><name><surname>Caminschi</surname><given-names>I</given-names></name><name><surname>Lahoud</surname><given-names>MH</given-names></name><name><surname>Belz</surname><given-names>GT</given-names></name><name><surname>Kallies</surname><given-names>A</given-names></name><name><surname>Mintern</surname><given-names>JD</given-names></name><name><surname>Asehnoune</surname><given-names>K</given-names></name><name><surname>Villadangos</surname><given-names>JA</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Local Modulation of Antigen-Presenting Cell Development after Resolution of Pneumonia Induces Long-Term Susceptibility to Secondary Infections</article-title><source>Immunity</source><volume>47</volume><fpage>135</fpage><lpage>147</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2017.06.021</pub-id><pub-id pub-id-type="pmid">28723546</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roquilly</surname><given-names>A</given-names></name><name><surname>Jacqueline</surname><given-names>C</given-names></name><name><surname>Davieau</surname><given-names>M</given-names></name><name><surname>Mollé</surname><given-names>A</given-names></name><name><surname>Sadek</surname><given-names>A</given-names></name><name><surname>Fourgeux</surname><given-names>C</given-names></name><name><surname>Rooze</surname><given-names>P</given-names></name><name><surname>Broquet</surname><given-names>A</given-names></name><name><surname>Misme-Aucouturier</surname><given-names>B</given-names></name><name><surname>Chaumette</surname><given-names>T</given-names></name><name><surname>Vourc’h</surname><given-names>M</given-names></name><name><surname>Cinotti</surname><given-names>R</given-names></name><name><surname>Marec</surname><given-names>N</given-names></name><name><surname>Gauttier</surname><given-names>V</given-names></name><name><surname>McWilliam</surname><given-names>HEG</given-names></name><name><surname>Altare</surname><given-names>F</given-names></name><name><surname>Poschmann</surname><given-names>J</given-names></name><name><surname>Villadangos</surname><given-names>JA</given-names></name><name><surname>Asehnoune</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Alveolar macrophages are epigenetically altered after inflammation, leading to long-term lung immunoparalysis</article-title><source>Nature Immunology</source><volume>21</volume><fpage>636</fpage><lpage>648</lpage><pub-id pub-id-type="doi">10.1038/s41590-020-0673-x</pub-id><pub-id pub-id-type="pmid">32424365</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rudd</surname><given-names>KE</given-names></name><name><surname>Johnson</surname><given-names>SC</given-names></name><name><surname>Agesa</surname><given-names>KM</given-names></name><name><surname>Shackelford</surname><given-names>KA</given-names></name><name><surname>Tsoi</surname><given-names>D</given-names></name><name><surname>Kievlan</surname><given-names>DR</given-names></name><name><surname>Colombara</surname><given-names>DV</given-names></name><name><surname>Ikuta</surname><given-names>KS</given-names></name><name><surname>Kissoon</surname><given-names>N</given-names></name><name><surname>Finfer</surname><given-names>S</given-names></name><name><surname>Fleischmann-Struzek</surname><given-names>C</given-names></name><name><surname>Machado</surname><given-names>FR</given-names></name><name><surname>Reinhart</surname><given-names>KK</given-names></name><name><surname>Rowan</surname><given-names>K</given-names></name><name><surname>Seymour</surname><given-names>CW</given-names></name><name><surname>Watson</surname><given-names>RS</given-names></name><name><surname>West</surname><given-names>TE</given-names></name><name><surname>Marinho</surname><given-names>F</given-names></name><name><surname>Hay</surname><given-names>SI</given-names></name><name><surname>Lozano</surname><given-names>R</given-names></name><name><surname>Lopez</surname><given-names>AD</given-names></name><name><surname>Angus</surname><given-names>DC</given-names></name><name><surname>Murray</surname><given-names>CJL</given-names></name><name><surname>Naghavi</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Global, regional, and national sepsis incidence and mortality, 1990–2017: analysis for the Global Burden of Disease Study</article-title><source>The Lancet</source><volume>395</volume><fpage>200</fpage><lpage>211</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(19)32989-7</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sariol</surname><given-names>A</given-names></name><name><surname>Perlman</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Lessons for COVID-19 Immunity from Other Coronavirus Infections</article-title><source>Immunity</source><volume>53</volume><fpage>248</fpage><lpage>263</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2020.07.005</pub-id><pub-id pub-id-type="pmid">32717182</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sarkar</surname><given-names>I</given-names></name><name><surname>Pati</surname><given-names>S</given-names></name><name><surname>Dutta</surname><given-names>A</given-names></name><name><surname>Basak</surname><given-names>U</given-names></name><name><surname>Sa</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>T-memory cells against cancer: Remembering the enemy</article-title><source>Cellular Immunology</source><volume>338</volume><fpage>27</fpage><lpage>31</lpage><pub-id pub-id-type="doi">10.1016/j.cellimm.2019.03.002</pub-id><pub-id pub-id-type="pmid">30928016</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schenkel</surname><given-names>JM</given-names></name><name><surname>Fraser</surname><given-names>KA</given-names></name><name><surname>Vezys</surname><given-names>V</given-names></name><name><surname>Masopust</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Sensing and alarm function of resident memory CD8+ T cells</article-title><source>Nature Immunology</source><volume>14</volume><fpage>509</fpage><lpage>513</lpage><pub-id pub-id-type="doi">10.1038/ni.2568</pub-id><pub-id pub-id-type="pmid">23542740</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Serbanescu</surname><given-names>MA</given-names></name><name><surname>Ramonell</surname><given-names>KM</given-names></name><name><surname>Hadley</surname><given-names>A</given-names></name><name><surname>Margoles</surname><given-names>LM</given-names></name><name><surname>Mittal</surname><given-names>R</given-names></name><name><surname>Lyons</surname><given-names>JD</given-names></name><name><surname>Liang</surname><given-names>Z</given-names></name><name><surname>Coopersmith</surname><given-names>CM</given-names></name><name><surname>Ford</surname><given-names>ML</given-names></name><name><surname>McConnell</surname><given-names>KW</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Attrition of memory CD8 T cells during sepsis requires LFA-1</article-title><source>Journal of Leukocyte Biology</source><volume>100</volume><fpage>1167</fpage><lpage>1180</lpage><pub-id pub-id-type="doi">10.1189/jlb.4A1215-563RR</pub-id><pub-id pub-id-type="pmid">27286793</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shan</surname><given-names>Q</given-names></name><name><surname>Zeng</surname><given-names>Z</given-names></name><name><surname>Xing</surname><given-names>S</given-names></name><name><surname>Li</surname><given-names>F</given-names></name><name><surname>Hartwig</surname><given-names>SM</given-names></name><name><surname>Gullicksrud</surname><given-names>JA</given-names></name><name><surname>Kurup</surname><given-names>SP</given-names></name><name><surname>Van Braeckel-Budimir</surname><given-names>N</given-names></name><name><surname>Su</surname><given-names>Y</given-names></name><name><surname>Martin</surname><given-names>MD</given-names></name><name><surname>Varga</surname><given-names>SM</given-names></name><name><surname>Taniuchi</surname><given-names>I</given-names></name><name><surname>Harty</surname><given-names>JT</given-names></name><name><surname>Peng</surname><given-names>W</given-names></name><name><surname>Badovinac</surname><given-names>VP</given-names></name><name><surname>Xue</surname><given-names>H-H</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>The transcription factor Runx3 guards cytotoxic CD8+ effector T cells against deviation towards follicular helper T cell lineage</article-title><source>Nature Immunology</source><volume>18</volume><fpage>931</fpage><lpage>939</lpage><pub-id pub-id-type="doi">10.1038/ni.3773</pub-id><pub-id pub-id-type="pmid">28604718</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shan</surname><given-names>Q</given-names></name><name><surname>Hu</surname><given-names>S e</given-names></name><name><surname>Chen</surname><given-names>X</given-names></name><name><surname>Danahy</surname><given-names>DB</given-names></name><name><surname>Badovinac</surname><given-names>VP</given-names></name><name><surname>Zang</surname><given-names>C</given-names></name><name><surname>Xue</surname><given-names>HH</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Ectopic Tcf1 expression instills a stem-like program in exhausted CD8+ T cells to enhance viral and tumor immunity</article-title><source>Cellular &amp; Molecular Immunology</source><volume>18</volume><fpage>1262</fpage><lpage>1277</lpage><pub-id pub-id-type="doi">10.1038/s41423-020-0436-5</pub-id><pub-id pub-id-type="pmid">32341523</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Siegers</surname><given-names>GM</given-names></name><name><surname>Barreira</surname><given-names>CR</given-names></name><name><surname>Postovit</surname><given-names>LM</given-names></name><name><surname>Dekaban</surname><given-names>GA</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>CD11d β2 integrin expression on human NK, B, and γδ T cells</article-title><source>Journal of Leukocyte Biology</source><volume>101</volume><fpage>1029</fpage><lpage>1035</lpage><pub-id pub-id-type="doi">10.1189/jlb.3AB0716-326RR</pub-id><pub-id pub-id-type="pmid">27881604</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Singer</surname><given-names>M</given-names></name><name><surname>Deutschman</surname><given-names>CS</given-names></name><name><surname>Seymour</surname><given-names>CW</given-names></name><name><surname>Shankar-Hari</surname><given-names>M</given-names></name><name><surname>Annane</surname><given-names>D</given-names></name><name><surname>Bauer</surname><given-names>M</given-names></name><name><surname>Bellomo</surname><given-names>R</given-names></name><name><surname>Bernard</surname><given-names>GR</given-names></name><name><surname>Chiche</surname><given-names>J-D</given-names></name><name><surname>Coopersmith</surname><given-names>CM</given-names></name><name><surname>Hotchkiss</surname><given-names>RS</given-names></name><name><surname>Levy</surname><given-names>MM</given-names></name><name><surname>Marshall</surname><given-names>JC</given-names></name><name><surname>Martin</surname><given-names>GS</given-names></name><name><surname>Opal</surname><given-names>SM</given-names></name><name><surname>Rubenfeld</surname><given-names>GD</given-names></name><name><surname>van der Poll</surname><given-names>T</given-names></name><name><surname>Vincent</surname><given-names>J-L</given-names></name><name><surname>Angus</surname><given-names>DC</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3</article-title><source>JAMA</source><volume>315</volume><fpage>801</fpage><lpage>810</lpage><pub-id pub-id-type="doi">10.1001/jama.2016.0287</pub-id><pub-id pub-id-type="pmid">26903338</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sjaastad</surname><given-names>FV</given-names></name><name><surname>Condotta</surname><given-names>SA</given-names></name><name><surname>Kotov</surname><given-names>JA</given-names></name><name><surname>Pape</surname><given-names>KA</given-names></name><name><surname>Dail</surname><given-names>C</given-names></name><name><surname>Danahy</surname><given-names>DB</given-names></name><name><surname>Kucaba</surname><given-names>TA</given-names></name><name><surname>Tygrett</surname><given-names>LT</given-names></name><name><surname>Murphy</surname><given-names>KA</given-names></name><name><surname>Cabrera-Perez</surname><given-names>J</given-names></name><name><surname>Waldschmidt</surname><given-names>TJ</given-names></name><name><surname>Badovinac</surname><given-names>VP</given-names></name><name><surname>Griffith</surname><given-names>TS</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Polymicrobial Sepsis Chronic Immunoparalysis Is Defined by Diminished Ag-Specific T Cell-Dependent B Cell Responses</article-title><source>Frontiers in Immunology</source><volume>9</volume><elocation-id>2532</elocation-id><pub-id pub-id-type="doi">10.3389/fimmu.2018.02532</pub-id><pub-id pub-id-type="pmid">30429857</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sjaastad</surname><given-names>F.V</given-names></name><name><surname>Jensen</surname><given-names>IJ</given-names></name><name><surname>Berton</surname><given-names>RR</given-names></name><name><surname>Badovinac</surname><given-names>VP</given-names></name><name><surname>Griffith</surname><given-names>TS</given-names></name></person-group><year iso-8601-date="2020">2020a</year><article-title>ducing Experimental Polymicrobial Sepsis by Cecal Ligation and Puncture</article-title><source>Current Protocols in Immunology</source><volume>131</volume><elocation-id>e110</elocation-id><pub-id pub-id-type="doi">10.1002/cpim.110</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sjaastad</surname><given-names>F.V</given-names></name><name><surname>Kucaba</surname><given-names>TA</given-names></name><name><surname>Dileepan</surname><given-names>T</given-names></name><name><surname>Swanson</surname><given-names>W</given-names></name><name><surname>Dail</surname><given-names>C</given-names></name><name><surname>Cabrera-Perez</surname><given-names>J</given-names></name><name><surname>Murphy</surname><given-names>KA</given-names></name><name><surname>Badovinac</surname><given-names>VP</given-names></name><name><surname>Griffith</surname><given-names>TS</given-names></name></person-group><year iso-8601-date="2020">2020b</year><article-title>Polymicrobial Sepsis Impairs Antigen-Specific Memory CD4 T Cell-Mediated Immunity</article-title><source>Frontiers in Immunology</source><volume>11</volume><elocation-id>1786</elocation-id><pub-id pub-id-type="doi">10.3389/fimmu.2020.01786</pub-id><pub-id pub-id-type="pmid">32903436</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Slütter</surname><given-names>B</given-names></name><name><surname>Van Braeckel-Budimir</surname><given-names>N</given-names></name><name><surname>Abboud</surname><given-names>G</given-names></name><name><surname>Varga</surname><given-names>SM</given-names></name><name><surname>Salek-Ardakani</surname><given-names>S</given-names></name><name><surname>Harty</surname><given-names>JT</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Dynamics of influenza-induced lung-resident memory T cells underlie waning heterosubtypic immunity</article-title><source>Science Immunology</source><volume>2</volume><elocation-id>eaag2031</elocation-id><pub-id pub-id-type="doi">10.1126/sciimmunol.aag2031</pub-id><pub-id pub-id-type="pmid">28783666</pub-id></element-citation></ref><ref id="bib73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Souza-Fonseca-Guimaraes</surname><given-names>F</given-names></name><name><surname>Parlato</surname><given-names>M</given-names></name><name><surname>Fitting</surname><given-names>C</given-names></name><name><surname>Cavaillon</surname><given-names>JM</given-names></name><name><surname>Adib-Conquy</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>NK Cell Tolerance to TLR Agonists Mediated by Regulatory T Cells after Polymicrobial Sepsis</article-title><source>Journal of Immunology</source><volume>188</volume><fpage>5850</fpage><lpage>5858</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1103616</pub-id><pub-id pub-id-type="pmid">22566566</pub-id></element-citation></ref><ref id="bib74"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Strother</surname><given-names>RK</given-names></name><name><surname>Danahy</surname><given-names>DB</given-names></name><name><surname>Kotov</surname><given-names>DI</given-names></name><name><surname>Kucaba</surname><given-names>TA</given-names></name><name><surname>Zacharias</surname><given-names>ZR</given-names></name><name><surname>Griffith</surname><given-names>TS</given-names></name><name><surname>Legge</surname><given-names>KL</given-names></name><name><surname>Badovinac</surname><given-names>VP</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Polymicrobial Sepsis Diminishes Dendritic Cell Numbers and Function Directly Contributing to Impaired Primary CD8 T Cell Responses In Vivo</article-title><source>Journal of Immunology</source><volume>197</volume><fpage>4301</fpage><lpage>4311</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1601463</pub-id><pub-id pub-id-type="pmid">27798171</pub-id></element-citation></ref><ref id="bib75"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Subramanian</surname><given-names>A</given-names></name><name><surname>Tamayo</surname><given-names>P</given-names></name><name><surname>Mootha</surname><given-names>VK</given-names></name><name><surname>Mukherjee</surname><given-names>S</given-names></name><name><surname>Ebert</surname><given-names>BL</given-names></name><name><surname>Gillette</surname><given-names>MA</given-names></name><name><surname>Paulovich</surname><given-names>A</given-names></name><name><surname>Pomeroy</surname><given-names>SL</given-names></name><name><surname>Golub</surname><given-names>TR</given-names></name><name><surname>Lander</surname><given-names>ES</given-names></name><name><surname>Mesirov</surname><given-names>JP</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles</article-title><source>PNAS</source><volume>102</volume><fpage>15545</fpage><lpage>15550</lpage><pub-id pub-id-type="doi">10.1073/pnas.0506580102</pub-id><pub-id pub-id-type="pmid">16199517</pub-id></element-citation></ref><ref id="bib76"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trapnell</surname><given-names>C</given-names></name><name><surname>Pachter</surname><given-names>L</given-names></name><name><surname>Salzberg</surname><given-names>SL</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>TopHat: discovering splice junctions with RNA-Seq</article-title><source>Bioinformatics</source><volume>25</volume><fpage>1105</fpage><lpage>1111</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btp120</pub-id><pub-id pub-id-type="pmid">19289445</pub-id></element-citation></ref><ref id="bib77"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Unsinger</surname><given-names>J</given-names></name><name><surname>Kazama</surname><given-names>H</given-names></name><name><surname>McDonough</surname><given-names>JS</given-names></name><name><surname>Hotchkiss</surname><given-names>RS</given-names></name><name><surname>Ferguson</surname><given-names>TA</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Differential lymphopenia-induced homeostatic proliferation for CD4+ and CD8+ T cells following septic injury</article-title><source>Journal of Leukocyte Biology</source><volume>85</volume><fpage>382</fpage><lpage>390</lpage><pub-id pub-id-type="doi">10.1189/jlb.0808491</pub-id><pub-id pub-id-type="pmid">19088177</pub-id></element-citation></ref><ref id="bib78"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Unsinger</surname><given-names>J</given-names></name><name><surname>Kazama</surname><given-names>H</given-names></name><name><surname>McDonough</surname><given-names>JS</given-names></name><name><surname>Griffith</surname><given-names>TS</given-names></name><name><surname>Hotchkiss</surname><given-names>RS</given-names></name><name><surname>Ferguson</surname><given-names>TA</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Sepsis-Induced Apoptosis Leads to Active Suppression of Delayed-Type Hypersensitivity by CD8+ Regulatory T Cells through a TRAIL-Dependent Mechanism</article-title><source>Journal of Immunology</source><volume>184</volume><fpage>6766</fpage><lpage>6772</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.0904054</pub-id><pub-id pub-id-type="pmid">20483771</pub-id></element-citation></ref><ref id="bib79"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van Gassen</surname><given-names>S</given-names></name><name><surname>Callebaut</surname><given-names>B</given-names></name><name><surname>Van Helden</surname><given-names>MJ</given-names></name><name><surname>Lambrecht</surname><given-names>BN</given-names></name><name><surname>Demeester</surname><given-names>P</given-names></name><name><surname>Dhaene</surname><given-names>T</given-names></name><name><surname>Saeys</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>FlowSOM: Using self-organizing maps for visualization and interpretation of cytometry data</article-title><source>Cytometry. Part A</source><volume>87</volume><fpage>636</fpage><lpage>645</lpage><pub-id pub-id-type="doi">10.1002/cyto.a.22625</pub-id><pub-id pub-id-type="pmid">25573116</pub-id></element-citation></ref><ref id="bib80"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Walton</surname><given-names>AH</given-names></name><name><surname>Muenzer</surname><given-names>JT</given-names></name><name><surname>Rasche</surname><given-names>D</given-names></name><name><surname>Boomer</surname><given-names>JS</given-names></name><name><surname>Sato</surname><given-names>B</given-names></name><name><surname>Brownstein</surname><given-names>BH</given-names></name><name><surname>Pachot</surname><given-names>A</given-names></name><name><surname>Brooks</surname><given-names>TL</given-names></name><name><surname>Deych</surname><given-names>E</given-names></name><name><surname>Shannon</surname><given-names>WD</given-names></name><name><surname>Green</surname><given-names>JM</given-names></name><name><surname>Storch</surname><given-names>GA</given-names></name><name><surname>Hotchkiss</surname><given-names>RS</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Reactivation of Multiple Viruses in Patients with Sepsis</article-title><source>PLOS ONE</source><volume>9</volume><elocation-id>e98819</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0098819</pub-id><pub-id pub-id-type="pmid">24919177</pub-id></element-citation></ref><ref id="bib81"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wherry</surname><given-names>EJ</given-names></name><name><surname>Teichgräber</surname><given-names>V</given-names></name><name><surname>Becker</surname><given-names>TC</given-names></name><name><surname>Masopust</surname><given-names>D</given-names></name><name><surname>Kaech</surname><given-names>SM</given-names></name><name><surname>Antia</surname><given-names>R</given-names></name><name><surname>von Andrian</surname><given-names>UH</given-names></name><name><surname>Ahmed</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Lineage relationship and protective immunity of memory CD8 T cell subsets</article-title><source>Nature Immunology</source><volume>4</volume><fpage>225</fpage><lpage>234</lpage><pub-id pub-id-type="doi">10.1038/ni889</pub-id><pub-id pub-id-type="pmid">12563257</pub-id></element-citation></ref><ref id="bib82"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>White</surname><given-names>JT</given-names></name><name><surname>Cross</surname><given-names>EW</given-names></name><name><surname>Kedl</surname><given-names>RM</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Antigen-inexperienced memory CD8+ T cells: where they come from and why we need them</article-title><source>Nature Reviews. Immunology</source><volume>17</volume><fpage>391</fpage><lpage>400</lpage><pub-id pub-id-type="doi">10.1038/nri.2017.34</pub-id><pub-id pub-id-type="pmid">28480897</pub-id></element-citation></ref><ref id="bib83"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xie</surname><given-names>J</given-names></name><name><surname>Chen</surname><given-names>C -w</given-names></name><name><surname>Sun</surname><given-names>Y</given-names></name><name><surname>Laurie</surname><given-names>SJ</given-names></name><name><surname>Zhang</surname><given-names>W</given-names></name><name><surname>Otani</surname><given-names>S</given-names></name><name><surname>Martin</surname><given-names>GS</given-names></name><name><surname>Coopersmith</surname><given-names>CM</given-names></name><name><surname>Ford</surname><given-names>ML</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>creased attrition of memory T cells during sepsis requires 2B4</article-title><source>JCI Insight</source><volume>4</volume><elocation-id>e126030</elocation-id><pub-id pub-id-type="doi">10.1172/jci.insight.126030</pub-id></element-citation></ref><ref id="bib84"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamamoto</surname><given-names>A</given-names></name><name><surname>Taki</surname><given-names>T</given-names></name><name><surname>Yagi</surname><given-names>H</given-names></name><name><surname>Habu</surname><given-names>T</given-names></name><name><surname>Yoshida</surname><given-names>K</given-names></name><name><surname>Yoshimura</surname><given-names>Y</given-names></name><name><surname>Yamamoto</surname><given-names>K</given-names></name><name><surname>Matsushiro</surname><given-names>A</given-names></name><name><surname>Nishimune</surname><given-names>Y</given-names></name><name><surname>Morita</surname><given-names>T</given-names></name></person-group><year iso-8601-date="1996">1996</year><article-title>Cell cycle-dependent expression of the mouse Rad51 gene in proliferating cells</article-title><source>Molecular &amp; General Genetics</source><volume>251</volume><fpage>1</fpage><lpage>12</lpage><pub-id pub-id-type="doi">10.1007/BF02174338</pub-id><pub-id pub-id-type="pmid">8628240</pub-id></element-citation></ref><ref id="bib85"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>T</given-names></name><name><surname>Meyer</surname><given-names>CA</given-names></name><name><surname>Eeckhoute</surname><given-names>J</given-names></name><name><surname>Johnson</surname><given-names>DS</given-names></name><name><surname>Bernstein</surname><given-names>BE</given-names></name><name><surname>Nusbaum</surname><given-names>C</given-names></name><name><surname>Myers</surname><given-names>RM</given-names></name><name><surname>Brown</surname><given-names>M</given-names></name><name><surname>Li</surname><given-names>W</given-names></name><name><surname>Liu</surname><given-names>XS</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Model-based analysis of ChIP-Seq (MACS</article-title><source>Genome Biology</source><volume>9</volume><elocation-id>R137</elocation-id><pub-id pub-id-type="doi">10.1186/gb-2008-9-9-r137</pub-id><pub-id pub-id-type="pmid">18798982</pub-id></element-citation></ref></ref-list></back><sub-article article-type="decision-letter" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.70989.sa1</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Belz</surname><given-names>Gabrielle T</given-names></name><role>Reviewing Editor</role><aff><institution>The University of Queensland</institution><country>Australia</country></aff></contrib></contrib-group><contrib-group><contrib contrib-type="reviewer"><name><surname>Roquilly</surname><given-names>Antoine</given-names></name><role>Reviewer</role><aff><institution/><country>France</country></aff></contrib></contrib-group></front-stub><body><boxed-text id="box1"><p>In the interests of transparency, eLife publishes the most substantive revision requests and the accompanying author responses.</p></boxed-text><p><bold>Acceptance summary:</bold></p><p>This manuscript addresses the important issue of how sepsis influences the function particularly of CD8 T cells. It shows that while antigen-specific T cells respond to infection following transient sepsis and paralysis, embedded changes occur in the T cells influencing their long-term performance and capacity to mediate immune protection.</p><p><bold>Decision letter after peer review:</bold></p><p>Thank you for sending your article entitled &quot;Sepsis leads to lasting changes in phenotype and function of memory CD8 T cells&quot; for peer review at <italic>eLife</italic>. Your article is being evaluated by 2 peer reviewers, one of whom is a member of our Board of Reviewing Editors, and the evaluation is being overseen by Satyajit Rath as the Senior Editor. The following individual involved in review of your submission has agreed to reveal their identity: Antoine Roquilly (Reviewer #2).</p><p>A summary of the essential revisions required is provided below. The individual reviews from the reviewers are also provided for the sake of context.</p><p>Essential revisions:</p><p>1. The mice model used to discriminate endogen and transferred memory T cells is underexploited. While P14 T cells are LCMV-specific, they are not specific to the antigens produced during CLP surgery. The reasons to discriminate endogen (Thy 1.1neg) vs. P14 (Thy 1.1pos) during CLP are not clear. Most of the time, endogenous and P14 CD8 memory T cells have the same response (Figure 2C, 4D-E) while this information is missing and only P14 response is described in most of the experiments (Figure 3, Figure 4B-C, 4G, 5, 6 and 7). The comparison of endogenous CD8 memory T cells with P14 should be consistent throughout the study since the role of TCR signaling could be of importance (as suggested by the increased Cish gene which is involved in TCR functional inhibition, see RNAseq, Figure 5H). Finally, the in vivo functional assay of the memory T cells response (Figure 7E-G) does not exclude a bystander role of endogen cells since IL-2 production can act on both cell types.</p><p>2. The description by flow cytometry of different subsets of P14 cells during sepsis (Figure 3C-H) is of interest but the mechanisms explaining the increased in cluster 8 (CD62L+) is not clear. In addition, the definition of cell survival (Figure 2C) is not clear to me and should be better explained.</p><p>3. Clarification of RNA seq analyses: The authors endeavour to uncover a mechanism for the altered activity of the CD8 T cells and use bulk RNAseq. In this analysis they identify 3 clusters. It is not clear exactly how the 8 subsets identified by flow cytometry and the sequence clusters relate to each other. Cluster 3 is composed of 57 genes that are changed but none of the genes in this cluster were mentioned nor provided in a table for reviewer consideration.</p><p>The finding of a CM and EM signature in the transcriptomic analyses would have strengthened the results. Whether if this phenomena is common with endogen cells, and if this is associated with alteration of cell function is unknown. Notably, is the production of IL-2 during sepsis similar in CD62L+ and CD62L- cells?</p><p>Overall, the RNAsequencing analyses is difficult to interpret due to the highly curated presentation and lack of fuller datasets.</p><p><italic>Reviewer #1:</italic></p><p>In this work, the authors endeavoured to understand how CD8 T cells, and preexisting memory CD8 T cells, might be influenced by sepsis. This is a very important question. They uncover interestingly that memory cells can still respond to subsequent infections, but are indelibly modulated by their exposure to the septic environment. This work provides interesting insights to the modulation of T lymphocytes and subsequent responsiveness post sepsis.</p><p>This manuscript addresses the important issue of how sepsis influences the function particularly of CD8 T cells. It shows that while antigen-specific T cells respond to infection following transient sepsis and paralysis, embedded changes occur in the T cells influencing their long-term performance. Although the changes in T cells are interesting, these effects are not dissociated from the extrinsic influences of other cell types that might also be affected by sepsis.</p><p>Page 4, line 91/92: There appears to be a word or words missing.</p><p>More recent references eg. Roquilly et al., Immunity and Nature Immunology have not been referenced.</p><p>In the human samples, a gap in the study is that admission may not correspond to the onset of sepsis. Delineation of a surrogate for the timing would be useful and some de-identified data to provide a temporal perspective of the onset of sepsis. One possibility may be the timing of lymphopenia. Part of the information is provided in Table 1.</p><p>The initial data is developed through characterisation of the proportions and numbers of different subsets of CD8 T cells. The hypotheses that the differential expansion/contraction of these subsets is based on our knowledge of normal responses. It is not entirely clear that this will be the case during sepsis. Using clustering based on known surface receptor expression, the authors designate 8 different subsets which they posit a pattern of temporal development. They then go on to endeavour to uncover a mechanism for the altered activity of the CD8 T cells and use bulk RNAseq. In this analysis they identify 3 clusters. It is not clear exactly how the 8 subsets identified by flow cytometry and the sequence clusters relate to each other. Cluster 3 is composed of 57 genes that are changed but none of the genes in this cluster were mentioned nor provided in a table for reviewer consideration. The RNAsequencing analyses is difficult to interpret due to the highly curated presentation and lack of fuller datasets.</p><p>Overall, this is an interesting study but the data are presented in quite a superficial manner limiting the impact of the work.</p><p><italic>Reviewer #2:</italic></p><p>Isaac J. Jensen et al., investigated in septic humans and in a mice of peritonitis the time course of the modifications of memory T cells during and after sepsis. They tracked in vivo the fate of antigen-specific memory T cells by using an elegant Antigen-specific T cells transfer whose proliferation is induced by a first viral infection. Once the virus-specific memory T cells are well settled, they induced an intraabdominal sepsis to investigate the modification of memory T cells during and after sepsis. They found in septic humans that while the percentages of CD8 T cells among lymphocytes remained unchanged, the rates of proliferating naïve and memory CD8 T cells were increased during sepsis. In the mice models, they observed that the survival of memory T cells decreased during sepsis, but their number rapidly returned to control values due to high rate of in vivo proliferation. Yet, the recovery of the number of memory T cells is associated with modifications of the proportions of effector vs. central memory T cells, and of the tissue localization. Transcriptomic and epigenetic analyses confirmed modifications of the CD8 T cells functional programming during sepsis, with upregulation of cell survival and proliferation functions. Finally, the authors demonstrated that the cytokine production of antigen-specific memory T cells is not decreased during sepsis, and IL-2 being even increased. in vivo, the gain of function of antigen-specific CD8 T cells (high proliferation, high IL-2 production) are not associated with higher control of viral load during reinfection. Altogether, the authors demonstrated that while memory CD8 T cells gain function during sepsis, it is associated with a poorer control of viral infection. These data add in an interesting way to the ongoing discussion on whether sepsis induced training of immunity (gained functions and increased resistance to infection) or tolerance / immunosuppression (loss of functions and increased susceptibility to infection).</p><p>The conclusions of this paper are mostly well supported by data, but some aspects of data analysis need to be clarified and extended.</p><p>1) The mice model used to discriminate endogen and transferred memory T cells is underexploited. While P14 T cells are LCMV-specific, they are not specific to the antigens produced during CLP surgery. So the reasons to discriminate endogen (Thy 1.1neg) vs. P14 (Thy 1.1pos) during CLP are not clear. Most of the time, endogen and P14 CD8 memory T cells have the same response (Figure 2C, 4D-E) while this information is missing and only P14 response is described in most of the experiments (Figure 3, Figure 4B-C, 4G, 5, 6 and 7). The comparison of endogen CD8 memory T cells with P14 should be consistent throughout the study since the role of TCR signaling could be of importance (as suggested by the increased Cish gene which is involved in TCR functional inhibition, see RNAseq, Figure 5H). Finally, the in vivo functional assay of the memory T cells response (Figure 7E-G) does not exclude a bystander role of endogen cells since IL-2 production can act on both cell types.</p><p>2) The description by flow cytometry of different subsets of P14 cells during sepsis (Figure 3C-H) is of interest but the mechanisms explaining the increased in cluster 8 (CD62L+) is not clear. Are the modifications in phenotype observed in Figure 3 explained by the transcriptomic activity of cells? The finding of a CM and EM signature in the transcriptomic analyses would have strengthened the results. Whether if this phenomena is common with endogen cells, and if this is associated with alteration of cell function is unknown. Notably, is the production of IL-2 during sepsis similar in CD62L+ and CD62L- cells?</p><p>As a summary, data are sounds, but the demonstration that the alterations are specific, or not, to any memory CD8 T cells subsets; and are antigen-specific or not, would have significantly increased the gain of knowledge.</p><p>In general, the paper is difficult to follow because the studied cells frequently between Figures: endo. vs P14, CD62L+ vs. CD62Lneg, then 14 alone.</p><p>1 – I would recommend to analyse endogen and P14 cells together throughout the manuscript. Indeed, I think that more than the endogen vs. transfer feature, P14 cells are likely not responding directly to CLP-derived antigens.</p><p>2 – The definition of cell survival (Figure 2C) is not clear to me and should be better explained.</p><p>3 – While the data of CD62L+ vs CD62L- subsets are of interest (Figure 3), this information is not exploited in the RNAseq and ATAC-seq analyses. The comparison with public data set of effector memory and central memory T cells would likely reinforced the message of differential composition of these subsets.</p></body></sub-article><sub-article article-type="reply" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.70989.sa2</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Essential revisions:</p><p>1. The mice model used to discriminate endogen and transferred memory T cells is underexploited. While P14 T cells are LCMV-specific, they are not specific to the antigens produced during CLP surgery. The reasons to discriminate endogen (Thy 1.1neg) vs. P14 (Thy 1.1pos) during CLP are not clear.</p></disp-quote><p>We apologize for the lack of clarity. The true value of using the P14s in this system is because, as the reviewer indicates, they are not specific for the antigens evoked/released after sepsis and therefore their response can be truly delineated from a sepsis-induced ‘secondary’ antigen response.</p><p>Additionally, because novel effector CD8 T cell responses are anticipated/predicted during the septic event this would complicate sole analysis of all antigen experienced (effector and memory) CD8 T cells. Therefore, memory P14 CD8 T cells serve as a sentinel population to describe how sepsis influences those pre-existing memory CD8 T cells that exist prior to sepsis. After all, that is the question experimentally addressed in this submission.</p><p>Text clarifying and extended this point has been incorporated within the manuscript (line 172-177).</p><disp-quote content-type="editor-comment"><p>Most of the time, endogenous and P14 CD8 memory T cells have the same response (Figure 2C, 4D-E) while this information is missing and only P14 response is described in most of the experiments (Figure 3, Figure 4B-C, 4G, 5, 6 and 7). The comparison of endogenous CD8 memory T cells with P14 should be consistent throughout the study since the role of TCR signaling could be of importance (as suggested by the increased Cish gene which is involved in TCR functional inhibition, see RNAseq, Figure 5H).</p></disp-quote><p>The reason for the seemingly selective use of the P14s in the indicated figures is due to potential complicating factors of using the polyclonal CD8 T cell responses. For instance:</p><p>– With respect to Figure 3 the findings are subsequently evaluated for the polyclonal antigen experienced CD8 T cell population in Figure 4 E.</p><p>– With regard to Figures 5 and 6 these were done on the memory P14 CD8 T cells because of potential complications associated with using the polyclonal antigen experienced CD8 T cell population (e.g., novel CD8 T cell responses to antigens induced by sepsis and the potential for cross-reactivity between intestinal microflora with LCMV epitopes). This is particularly relevant to indicated TCR signaling which may be influenced by varying TCR signal strengths elicited due to novel microflora directed responses or potential secondary cross-reactive responses. We therefore contend that by focusing on memory P14 CD8 T cells wherein the TCR is a fixed variable this gives additional power to the analysis that would not be achievable in polyclonal populations. Text emphasizing this point has been now incorporated (line 318-321).</p><p>– With respect to Figure 7A-D we had continued to focus on memory P14 CD8 T cells due to convenience/clarity but are more than happy to include the data emphasizing GP33 stimulated cytokine (IFNγ and IL-2) production for the endogenous memory CD8 T cells, that showed a similar trend, as well (Please see new Figure 7—figure supplement 2 and line 384-386).</p><p>– Regarding 7E-G, however, transfer of endogenous cells would result in the same complications highlighted in the previous bullet point therefore it is our assertion that such assessments would be more confounding than illuminating to the impact of sepsis on pre-existing memory CD8 T cells.</p><disp-quote content-type="editor-comment"><p>Finally, the in vivo functional assay of the memory T cells response (Figure 7E-G) does not exclude a bystander role of endogen cells since IL-2 production can act on both cell types.</p></disp-quote><p>With regard to this point it is unclear what endogenous cells the reviewer is referring to. If the concern is with regard to endogenous cells generated either by LCMV or sepsis then we recognize that this could be a complicating factor and had therefore isolated the Thy1.1 memory P14 CD8 T cells prior to adoptive transfer. If the concern is with regard to potential bystander roles of the endogenous effector and/or memory CD8 T cells in the transfer recipients this seems unlikely given that the recipients are all naïve SPF mice that have neither experienced LCMV infection or undergone surgery. Thus, the mice are on equal standing with regard to the groups except with respect to which donor the memory P14s came from (if any) and would therefore reasonably rule out a bystander role for endogenous cells in either case. Text clarifying and extended this point has been incorporated within the manuscript (line 398-402).</p><disp-quote content-type="editor-comment"><p>2. The description by flow cytometry of different subsets of P14 cells during sepsis (Figure 3C-H) is of interest but the mechanisms explaining the increased in cluster 8 (CD62L+) is not clear. In addition, the definition of cell survival (Figure 2C) is not clear to me and should be better explained.</p></disp-quote><p>The mechanism, as we describe it, for the increased representation in Tcm (CD62L+) CD8 T cells is through the increased proliferative capacity of Tcm relative to Tem. Thus as the numeric recovery is achieved through homeostatic proliferation the Tcm gradually become overrepresented (relative to sham hosts). This mechanism is probed in Figure 4B-E of the manuscript. Additional text clarifying this point has been incorporated to reduce confusion (line 260-262).</p><p>We apologize for the lack of clarity in Figure 2C. This is calculated based off of the number of cells in peripheral blood (with respect to the indicated subset) at day 2 post-surgery divided by the average number of cells in the peripheral blood (with respect to the indicated subset) prior to surgery multiplied by 100 (to convert to a percentage). This transformation of the data is done to because there are highly different numbers in the different cell population (Naïve, endogenous, and P14 CD8 T cells) and is meant to demonstrate that all populations are equally susceptible to sepsis induced lymphopenia (in spite of differences in the cell number). Text clarifying this point is now included in the Materials and methods (line 1010-1016).</p><disp-quote content-type="editor-comment"><p>3. Clarification of RNA seq analyses: The authors endeavour to uncover a mechanism for the altered activity of the CD8 T cells and use bulk RNAseq. In this analysis they identify 3 clusters. It is not clear exactly how the 8 subsets identified by flow cytometry and the sequence clusters relate to each other.</p></disp-quote><p>Because of the differences in how these distinct analyses with discrete outputs are performed it is likely not best practice to overlay phenotypic clusters with changes in population RNA-seq. However, as stated in the text, cluster 1 demonstrates an enhancement of time-dependent changes in the CLP P14s. When considering how the memory CD8 T cell pool naturally changes overtime to have a reduced frequency of Tem and a higher frequency of Tcm this cluster reflects the Tem to Tcm conversion induced by sepsis. Thus, the changes in clusters 6 and 8 of the flow cytometry data likely are encompassed in this first cluster.</p><p>Additionally, we performed additional analyses (new Figure 6—figure supplement 1) and when we compared our gene expression changes with changes in a published data set (KAECH_DAY15_EFF_VS_MEMORY_CD8_TCELL), P14s from CLP hosts were more similar to memory CD8 T cells whereas P14s from Sham hosts had a more effector like signature further reflecting (and confirming) the shift toward central memory subset in CLP hosts. Text has been incorporated to discuss these additional analyses and better highlight this point (line 355-361).</p><disp-quote content-type="editor-comment"><p>Cluster 3 is composed of 57 genes that are changed but none of the genes in this cluster were mentioned nor provided in a table for reviewer consideration.</p></disp-quote><p>We apologize for this oversight and have included the requested information for all 3 gene clusters in Table II and the associated file “Figure 5-source data 2”.</p><disp-quote content-type="editor-comment"><p>The finding of a CM and EM signature in the transcriptomic analyses would have strengthened the results.</p></disp-quote><p>As indicated in the comment regarding the overlay of phenotypic clusters with RNA-seq clusters we feel that cluster 1 likely captures this transcription signature. Further, while the fold change in <italic>Sell</italic> (gene for CD62L) did not meet the 1.5X threshold change it did have a statistically significant change in expression (see Figure 5J) which further supports this conversion. Notably the fold change in the gene 1.2X mirror the relative phenotypic change 1.2X observed in Figure 4E (55%/45%).</p><p>Further, as suggested by the reviewer we have performed GSEA to compare sepsis induced changes with effector vs memory CD8 T cells to further highlight the compositional shift from T<sub>EM</sub> to T<sub>CM</sub>. Indeed, P14s from Sham hosts were biased toward effector cells while P14s from CLP hosts were biased toward memory cells. This reflects the time-dependent shift from effector to central memory, mirrored in the sepsis-induced changes in memory CD8 T cells (Figure 6—figure supplement 1and line 355-361).</p><disp-quote content-type="editor-comment"><p>Whether if this phenomena is common with endogen cells, and if this is associated with alteration of cell function is unknown.</p></disp-quote><p>While we did not perform RNA-seq/ATAC-seq on total endogenous cells for the reasons outlined in response to point number 1 we do believe the virus-specific memory P14 CD8 T cells are a faithful sensor population as they have behaved similarly when analyzed in comparison to the endogenous CD8 T cells (Martin et al., 2015 Plos Pathog. e1005219; Khan et al., 2019 Nature 571(7764):211-218). Further, in the event of differences it would be impossible to rule out that the differences were not due to changes in the pool of activated cells (inclusion of sepsis responsive effector or memory CD8 T cells or cross-reactivity epitopes between the LCMV infection with the septic event) rather than true differences between memory P14s and endogenous CD8 T cells.</p><disp-quote content-type="editor-comment"><p>Notably, is the production of IL-2 during sepsis similar in CD62L+ and CD62L- cells?</p></disp-quote><p>CD62L is shed from the cells surface during antigen encounter (Herndler-Brandstetter et al., 2005 J Immunol. 175(3)1566-1574) it is difficult to determine whether the cells CD62L- cells from the CLP hosts are actually generating IL-2 or if it is merely (likely) that the CD62L+ cells shed their CD62L following antigen encounter. However, given that it is widely reported that CD62L+ cells preferentially produce IL-2 (Martin and Badovinac 2018 Front. Immunol. 2692; Wherry et al., 2003 Nat. Immunol. 4:225-234) and that the increase in IL-2 production coincides with our similar observation of an increase in CD62L we feel that it is more reasonably the CD62L+ cells that are contributing the IL-2 following stimulation in Figure 7.</p><disp-quote content-type="editor-comment"><p>Overall, the RNAsequencing analyses is difficult to interpret due to the highly curated presentation and lack of fuller datasets.</p></disp-quote><p>We hope that the addition of the gene tables and the discussion mentioned provide now enough clarity to reviewers (and hopefully other scientist that will read our manuscript) to interpret/understand these data sets.</p><disp-quote content-type="editor-comment"><p>Reviewer #1:</p><p>In this work, the authors endeavoured to understand how CD8 T cells, and preexisting memory CD8 T cells, might be influenced by sepsis. This is a very important question. They uncover interestingly that memory cells can still respond to subsequent infections, but are indelibly modulated by their exposure to the septic environment. This work provides interesting insights to the modulation of T lymphocytes and subsequent responsiveness post sepsis.</p></disp-quote><p>We appreciate the reviewer’s assessment our manuscript.</p><disp-quote content-type="editor-comment"><p>This manuscript addresses the important issue of how sepsis influences the function particularly of CD8 T cells. It shows that while antigen-specific T cells respond to infection following transient sepsis and paralysis, embedded changes occur in the T cells influencing their long-term performance. Although the changes in T cells are interesting, these effects are not dissociated from the extrinsic influences of other cell types that might also be affected by sepsis.</p></disp-quote><p>We recognize that effects in memory CD8 T cell subsets are not the sole influence by which sepsis alter host immune status. While this study is focused on pre-existing memory CD8 T cells future assessments should/would harmonize these findings with alterations in other cell types.</p><disp-quote content-type="editor-comment"><p>Page 4, line 91/92: There appears to be a word or words missing.</p><p>More recent references eg. Roquilly et al., Immunity and Nature Immunology have not been referenced.</p><p>In the human samples, a gap in the study is that admission may not correspond to the onset of sepsis. Delineation of a surrogate for the timing would be useful and some de-identified data to provide a temporal perspective of the onset of sepsis. One possibility may be the timing of lymphopenia. Part of the information is provided in Table 1.</p><p>The initial data is developed through characterisation of the proportions and numbers of different subsets of CD8 T cells. The hypotheses that the differential expansion/contraction of these subsets is based on our knowledge of normal responses. It is not entirely clear that this will be the case during sepsis. Using clustering based on known surface receptor expression, the authors designate 8 different subsets which they posit a pattern of temporal development. They then go on to endeavour to uncover a mechanism for the altered activity of the CD8 T cells and use bulk RNAseq. In this analysis they identify 3 clusters. It is not clear exactly how the 8 subsets identified by flow cytometry and the sequence clusters relate to each other. Cluster 3 is composed of 57 genes that are changed but none of the genes in this cluster were mentioned nor provided in a table for reviewer consideration. The RNAsequencing analyses is difficult to interpret due to the highly curated presentation and lack of fuller datasets.</p></disp-quote><p>These comments have been addressed in the above response to the editor.</p><disp-quote content-type="editor-comment"><p>Overall, this is an interesting study but the data are presented in quite a superficial manner limiting the impact of the work.</p></disp-quote><p>We appreciate that these represent some of the more initial aspects of the long-term impacts of sepsis on pre-existing memory CD8 T cells but contend that they provide a substantive advance, uncover interesting and previously unknown biology, and lay the groundwork for future experiments that will further analyze/uncover/define role of sepsis in shaping vaccine and/or infection induced memory CD8 T cell pool and ability of the host to respond to pathogen (re)-encounter.</p><disp-quote content-type="editor-comment"><p>Reviewer #2:</p><p>Isaac J. Jensen et al., investigated in septic humans and in a mice of peritonitis the time course of the modifications of memory T cells during and after sepsis. They tracked in vivo the fate of antigen-specific memory T cells by using an elegant Antigen-specific T cells transfer whose proliferation is induced by a first viral infection. Once the virus-specific memory T cells are well settled, they induced an intraabdominal sepsis to investigate the modification of memory T cells during and after sepsis. They found in septic humans that while the percentages of CD8 T cells among lymphocytes remained unchanged, the rates of proliferating naïve and memory CD8 T cells were increased during sepsis. In the mice models, they observed that the survival of memory T cells decreased during sepsis, but their number rapidly returned to control values due to high rate of in vivo proliferation. Yet, the recovery of the number of memory T cells is associated with modifications of the proportions of effector vs. central memory T cells, and of the tissue localization. Transcriptomic and epigenetic analyses confirmed modifications of the CD8 T cells functional programming during sepsis, with upregulation of cell survival and proliferation functions. Finally, the authors demonstrated that the cytokine production of antigen-specific memory T cells is not decreased during sepsis, and IL-2 being even increased. in vivo, the gain of function of antigen-specific CD8 T cells (high proliferation, high IL-2 production) are not associated with higher control of viral load during reinfection. Altogether, the authors demonstrated that while memory CD8 T cells gain function during sepsis, it is associated with a poorer control of viral infection. These data add in an interesting way to the ongoing discussion on whether sepsis induced training of immunity (gained functions and increased resistance to infection) or tolerance / immunosuppression (loss of functions and increased susceptibility to infection).</p></disp-quote><p>We appreciate the reviewer’s assessment of our manuscript.</p><disp-quote content-type="editor-comment"><p>The conclusions of this paper are mostly well supported by data, but some aspects of data analysis need to be clarified and extended.</p><p>1) the mice model used to discriminate endogen and transferred memory T cells is underexploited. While P14 T cells are LCMV-specific, they are not specific to the antigens produced during CLP surgery. So the reasons to discriminate endogen (Thy 1.1neg) vs. P14 (Thy 1.1pos) during CLP are not clear. Most of the time, endogen and P14 CD8 memory T cells have the same response (Figure 2C, 4D-E) while this information is missing and only P14 response is described in most of the experiments (Figure 3, Figure 4B-C, 4G, 5, 6 and 7). The comparison of endogen CD8 memory T cells with P14 should be consistent throughout the study since the role of TCR signaling could be of importance (as suggested by the increased Cish gene which is involved in TCR functional inhibition, see RNAseq, Figure 5H). Finally, the in vivo functional assay of the memory T cells response (Figure 7E-G) does not exclude a bystander role of endogen cells since IL-2 production can act on both cell types.</p><p>2) The description by flow cytometry of different subsets of P14 cells during sepsis (Figure 3C-H) is of interest but the mechanisms explaining the increased in cluster 8 (CD62L+) is not clear. Are the modifications in phenotype observed in Figure 3 explained by the transcriptomic activity of cells? The finding of a CM and EM signature in the transcriptomic analyses would have strengthened the results. Whether if this phenomena is common with endogen cells, and if this is associated with alteration of cell function is unknown. Notably, is the production of IL-2 during sepsis similar in CD62L+ and CD62L- cells?</p></disp-quote><p>These comments have been addressed in the above response to the editor.</p><disp-quote content-type="editor-comment"><p>As a summary, data are sounds, but the demonstration that the alterations are specific, or not, to any memory CD8 T cells subsets; and are antigen-specific or not, would have significantly increased the gain of knowledge.</p></disp-quote><p>We recognize the reviewers point and this would be a highly relevant aspect for future consideration. While it would be ideal to observe different populations behaving discretely this is technically challenging, particularly so if the distinctions rely on cross-reactivity between existing memory CD8 T cells and gut microflora released during the septic insult. Text addressing these points has been incorporated in the discussion (line 456-460).</p><disp-quote content-type="editor-comment"><p>In general, the paper is difficult to follow because the studied cells frequently between Figures: endo. vs P14, CD62L+ vs. CD62Lneg, then 14 alone.</p><p>1 – I would recommend to analyse endogen and P14 cells together throughout the manuscript. Indeed, I think that more than the endogen vs. transfer feature, P14 cells are likely not responding directly to CLP-derived antigens.</p></disp-quote><p>We agree with the reviewer’s assessment in principal and have in the above response attempted to explain our rationale for lacking the analysis of the total endogenous memory CD8 T cell population in some cases and providing the additional results with bona-fide endogenous memory CD8 T cells where possible (new Figure 7—figure supplement 2 and line 384-386).</p><disp-quote content-type="editor-comment"><p>2 – The definition of cell survival (Figure 2C) is not clear to me and should be better explained.</p></disp-quote><p>This comment has been addressed in the essential revisions portion (please see above).</p><disp-quote content-type="editor-comment"><p>3 – While the data of CD62L+ vs CD62L- subsets are of interest (Figure 3), this information is not exploited in the RNAseq and ATAC-seq analyses. The comparison with public data set of effector memory and central memory T cells would likely reinforced the message of differential composition of these subsets.</p></disp-quote><p>The reviewer’s point is of interest. We performed the requested analysis, discussed response to the above editor comment. Data are presented in Figure 6—figure supplement 1 and discussed in the text (line 355-361).</p></body></sub-article></article>